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General Introduction 
1
1.1. Molecular self-assembly as a fabrication tool for 
nanomaterials 
Nanotechnology is a field of science that deals with the engineering and 
manufacturing of structures with sizes in the 1-100 nm range in at least one 
dimension 1. It is believed that nanotechnology will play a key role in the 
construction of future generations of materials required for solving problems in 
fields such as water, energy, and health 2. Currently, high-tech nanostructured 
materials can already be found in many applications: in high performance 
electronics materials, as biomaterials, in sensors, water filters, fuel cells and 
batteries, medicine, and many consumer products 3,4. 
Important concepts of material fabrication used in nanotechnology are the “top-
down” and “bottom-up” approaches. The top-down fabrication is a subtractive 
process in which material undergoes a particular treatment involving use of, for 
instance, electron beams, radiation, masking or etching, to produce features of a 
controlled shape 5,6. The “bottom-up” fabrication is an additive process in 
which components (particles or bigger molecules) are used to build up desired 
nanostructures 7. Nowadays, the “bottom-up” approach becomes more and 
more employed in the construction of modern materials 5,7. These approach 
largely relies on molecular self-assembly (Fig. 1.1), i.e. the spontaneous 
organisation of molecules (or particles) into structurally well-defined 
arrangements through numerous weak noncovalent bonds such as hydrogen 
bonds, ionic bonds, π-π stacking, hydrophobic interactions and van der Waals’ 
interactions 6. 
Figure 1.1: A schematic representation of molecular self-assembly, where green complementary 
units form self-assemblies that organise into more complex macrostructures. 
Although association constants for single noncovalent bonds are rather low, 
collectively, many of these weak bonds can guarantee well-defined and very 
stable macroscopic structures, called supramolecular structures 8. Many 
inspiring examples of self-assembled supramolecular structures formed by 
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noncovalent bonds can be found in nature: the DNA double helix, phospholipid 
cell membranes, large protein machines such as ribosomes, and complex 
networks of structural proteins such as collagen and elastin, to mention just a 
few. Indeed, nature exclusively uses “bottom-up” approach, building up 
molecular assemblies bit by bit 9. It is important to mention that the structural 
complexity of these assemblies is strongly associated with their biological 
function. The sophistication and success of the natural “bottom-up” 
nanofabrication process is a great inspiration for material scientists, and 
although not yet fully understood, it serves as source of ideas for the fabrication 
of novel supramolecular nanostructured materials with complex 
functionalities 10-12. 
The formation of supramolecular materials is usually studied in liquid phases, 
since the components must be able to move with respect to one another in order 
to assemble 10. The characteristics of individual components such as shape, 
surface properties, charge, polarizability and mass are very important, since 
these encode the weak interactions that lead to the formation of supramolecular 
structures. Any component has to be chemically complementary and 
structurally compatible with the rest to assure a proper formation of physical 
bonds. The type of self-assembly and the final properties of the self-assembled 
materials can be controlled by chemically tailoring the different components 13. 
Additionally, the interactions between these components can be manipulated by 
controlling the environment in which they interact. By testing and mixing 
different self-assembling components, scientists have discovered many novel 
self-assembled structures with various functionalities 9. 
In this thesis we are concerned with a particular class of self-assembling 
molecules, viz. proteins. Over the last decade, significant progress has been 
made in the development of self-assembled, nanostructured protein materials 14-
16. Building on this progress, in this thesis we explore the biotechnological
production and use of specific organizing protein elements: small 
heterodimer-forming protein modules that can be used to organise 
supramolecular structures. To introduce this topic, we first briefly review the 
structure of peptides and proteins, and then review the basis of their self-
assembly into nanomaterials. 
1.2. Self-assembling protein polymers 
Proteins consist of amino acid units connected by peptide bonds into long 
chains. There are twenty DNA-encoded amino acids, which means that, for 
instance, for a 100-residue amino acid chain there are 20100 different possible 
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sequences. In addition, there is a wide range of possible post-translational 
modifications. The variation of amino acid side-chains is very important for the 
protein folding, since interactions are partly determined by the nature of the 
side-chains. Aliphatic groups give rise to a locally hydrophobic environment, 
and aromatic groups allow for π-π stacking. Hydrophilic groups allow for 
hydrogen bond formation, and charged groups can be involved in ionic 
interactions. The spontaneous process of protein folding and protein assembly 
is best described as occurring at different levels. A first step is the formation of 
secondary structure elements (α-helix, β-sheet, random coil). Next, secondary 
structure elements combine into a three-dimensional tertiary structure. Finally, 
the quaternary structure is the arrangement of multiple proteins into complexes, 
as determined by a range of weak interactions such as salt bridges, hydrogen 
bonding, and disulfide bonds. This hierarchical process of the protein folding 
can be considered as a reflection of the evolution process. Nature evolved 
dozens of small protein motifs with specific functions that subsequently, 
stimulated by environment, started to self-assemble into bigger and bigger 
structures with combined functionalities. Indeed, next to the amino acid 
sequence, nature assigned an important role in the protein folding also to the 
cell environment, which consists of many elements 17. Due to that, it is 
extremely difficult to predict the in vitro folding behaviour, however by 
observing nature we can try to mimic its successful solutions. 
Various natural protein motifs have been analysed in great detail and 
knowledge generated from these studies is very useful in the fields of the de 
novo protein design 15,18. An especially fruitful area has been that of self-
assembling peptides, where thanks to recent advances in peptide synthesis, 
many different sequences have been explored with respect to their capabilities 
to self-assemble into functional nanostructured materials. Self-assembled 
peptide- and protein materials are now raising the interest of material scientists 
in a very broad range of application areas, including for example, food, 
medicine or electronics 19-22. 
Rather than with the self-assembly of chemically synthesized peptides, in this 
thesis we are concerned with the self-assembly of much larger polypeptides. 
Specifically, we are concerned with so-called protein-based block 
copolymers 22, that we will also refer to as protein polymers. In brief the idea is 
to use simple amino acid motifs as building blocks for repetitive polypeptides, 
or protein-based polymers. Two or more types of protein-based polymers can 
be combined into fusions, thus obtaining protein-based block-copolymers (Fig. 
1.2). By incorporating blocks that can guide self-assembly process between 
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these copolymers, several supramolecular structures can be formed. Examples 
of such structures formed by protein polymers in aqueous solution are micelles, 
fibrils, ribbons, sheets, and even more complex networks, called hydrogels 23. 
Supramolecular structures can be very useful especially as biological materials 
for 2D and 3D tissue cultures, regenerative and reparative medicine, tissue 
engineering, as well as therapeutic delivery and medical imaging 20,24-26. 
Protein-based hydrogels are of particular interest in the medical industry 
because of their great resemblance to the extracellular matrix (ECM) 27,28. Some 
prototypical examples of protein blocks developed to mimic ECM are silk-like, 
resilin-like, collagen-like, elastin-like, coiled coils and various peptide 
amphiphiles 22. Hydrogels made of different protein polymers, obviously, have 
different rheological, structural and biological properties 29. A great advantage 
is that by varying the length or composition of the different blocks in the 
protein polymer these properties can be tuned very precisely (at the amino acid 
level) to optimize them for a given application. Since protein blocks are derived 
from natural sources (i.e. amino acids), such hydrogels are typically 
biodegradable and biocompatible, which can be also considered as very 
important advantages 14. 
Figure 1.2: Different protein blocks can be combined in an arbitrary fashion into protein block 
copolymers. Each block has a specific function, which influences the self-assembly of the protein 
block copolymers: (H) triple helix formation, (A) nonpolar, (B) β-sheet formation, (P) polar,  (D) 
degradation. 
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1.3. Biosynthesis of protein polymers 
In the past, many protein polymer sequences have been designed by using 
motifs obtained from natural protein materials 30,31. Now that relations between 
amino acid sequence, secondary structure and self-assembly are becoming 
more and more clear, especially at the level of short peptides, de novo design of 
self-assembling protein polymers becomes an increasingly realistic 
possibility 15. In order to actually obtain protein polymers, one has to use 
genetic engineering since the chemical synthesis of very long polypeptides is 
still technically challenging and very expensive 22. The genetic engineering 
approach allows the production of arbitrary sequences and additionally, in 
principle, offers absolute control over their molecular weight and 
composition 24. In this strategy, the protein polymer sequence to be produced is 
first reversely translated into a DNA sequence. Chemically synthesised DNA 
sequences encoding different pieces of the protein polymer can be combined 
into single artificial protein polymer genes. With help of the biotechnology 
toolbox such genes can be transferred into any chosen expression system. 
Popular expression systems include for example, the bacterium Escherichia 
coli and the yeasts Saccharomyces cerevisiae and Pichia pastoris 32. Each of 
these systems has its own advantages and disadvantages. We focus on 
heterologous expression in P. pastoris. P. Pastoris based expression system is 
able to produce proteins at high yields, can grow to very high cell densities and 
does not need an expensive carbon sources for growth. Additionally, P. 
pastoris as a protein production host is able to secrete high titres of properly 
folded, post-translationally processed and active recombinant proteins into the 
culture media. 
The process of protein production in P. pastoris is rather straightforward 33. The 
gene encoding protein of interest is placed in to an expression vector that 
allows integration of this gene with the chromosomal DNA of Pichia cell via 
homologous recombination. The expression vector chosen for this study is 
pPIC9. This vector is easy to handle and guarantees a high percentage of 
correct transformants. For the secretion of the protein polymers to the medium, 
α-MF signal peptide from S. cerevisiae was chosen. The α-MF signal sequence 
has proven to be most effective in directing proteins through the secretory 
pathway in P. pastoris. The ability to secret protein outside the host cell is a big 
advantage especially from the downstream processing point of view. To control 
protein synthesis, we use the alcohol oxidase (AOX1) promoter, which is 
tightly regulated by presence of methanol in the medium. This allows partial 
uncoupling of the yeast growth from the production phase of heterologous 
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proteins. Thanks to AOX1, a considerable amount of biomass is accumulated 
prior to protein overexpression.  
1.4. Blocks and sequence motifs 
In our group, we have developed a diverse collection of protein polymer blocks 
that can be produced in P. pastoris at high yield, to be discussed in more detail 
below. Each of these blocks presents a different functionality and most of them 
are stimulus-responsive. As described above, these protein polymer blocks can 
be freely combined in diblocks, triblocks, and etc. Furthermore, they can also 
be easily extended with biofunctional blocks such as comprising RGD and 
other cell-recognition motifs, enzymatic degradation sides, blocks that 
selectively bind certain biological compounds or protein motifs, etc. 34. In this 
thesis we extend our list of protein block copolymer designs by incorporation 
of terminal blocks that specifically interact with each other to form (hetero)-
dimers, with the purpose to obtain additional control over self-assembly. 
1.4.1. Collagen-inspired blocks 
The structural proteins that belong to collagen family are the most abundant 
components of the extracellular matrix. Many distinct collagen types have been 
identified to date on the basis of protein and/or DNA sequence 35. The 
characteristic feature of collagens is sequence that contains domains with 
repetitions of the proline-rich tripeptide Gly-X-Y involved in the formation of 
trimeric collagen triplehelices 36. In this tripeptide the position X is often 
occupied by proline and Y is frequently hydroxyproline (which is a product of 
post-translational modification performed by the enzyme prolyl 4-
hydroxylase) 37. Collagen provides structural support and tensile strength to 
various tissues of the human body; therefore it has proven itself to be a very 
versatile material for many medical applications 38. The common form of 
collagen in use is gelatine. Gelatine is a denatured collagen typically isolated 
from bovine or porcine skin or bone by acid or base extraction 35. There are 
increasing concerns with the continued use of animal-derived collagens and 
gelatines such as biocompatibility issues, the ability to transmit pathogenic 
vectors or lack of product homogeneity, to name a few 39. In order to avoid 
issues related to animal-derived material and to be able to produce collagens in 
large quantities, the collagen production is increasingly shifting towards 
recombinant technologies 38. Genetic engineering has made great progress in 
the areas of recombinant collagen and gelatine expression, and now these 
materials can be even custom-designed to enhance product performance 38. 
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In our group, P. pastoris has been utilized to produce several custom-designed 
collagen-inspired blocks 40-42. Two of these blocks, namely C block and T9  
block, are used in this thesis (Fig. 1.3). As first described by Werten et al 41, the 
C block is a 99 amino acids long sequence consisting of Gly-X-Y repeats, 
where proline is the second after glycine most abundant amino acid. The C 
block was developed in two variants, CP and CR, which have the same 
molecular weight and amino acid composition, but variant CR is a randomized 
version of CP 42. Both variants are highly hydrophilic and assume a random coil 
conformation, irrespective of pH and temperature. In this thesis, we used only 
CP variant and to simplify the nomenclature, in some chapters, the superscript 
P was omitted. The C block has been successfully used to construct many 
different protein polymers 42-44. The number in subscript indicates how many 
blocks of the same type are repeated in tandem within the entire protein 
polymer. In most cases, the C block serves mainly as a stabilizing spacer, 
however its nature also allows easy protein purification from the fermentation 
broth by ammonium sulfate precipitation 45. The T9 block consists of nine 
amino acid triplets Pro-Gly-Pro and, incorporated as a terminal block, is able to 
form helical homotrimers. The process of T9 block self-assembly is dependent 
on temperature and concentration 46. In addition, the type of neighbouring 
blocks influences the concentration at which T9 triple helixes can be formed 
47. 
Figure 1.3: Schematic representation of the hydrogel formed by T9-C4-T9 protein polymer. Triple 
helixes formed by T9 block facilitate self-assembly, while C4 block acts as hydrophilic spacer. 
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1.4.2. Silk-inspired blocks 
Silks are natural protein fibers produced by spiders of the Arachnida class and 
several worms of the order Lepidoptera 48. The most popular silk, which is 
widely used for millennia in the textile industry, is obtained from the cocoons 
of Bombyx mori. Typically, silks fibers are composites of two main proteins, 
sericin and fibroin, and other associated macromolecules, i.e. polysaccharides 
and lipids 49. Relatively conserved fibroin sequences consist of big hydrophobic 
domains with highly repetitive motifs of Ala, Ala-Gly or Ala-Gly-Ser, which 
are interrupted by small hydrophilic domains 50. The hydrophobic domains can 
form tightly packed anti-parallel β-sheets and are responsible for the 
remarkable strength and resiliency of silk fibers 30,51 (Fig 1.4A). These 
impressive mechanical properties of silks as well as their biocompatibility and 
biodegradability have inspired the preparation of silk-mimetic proteins 52-54. 
Figure 1.4: (A) Schematic representation of fibrils formation via β-sheets stacking by silk-inspired 
protein polymers. (B) An image of fibrils formed by C2-SH48-C2 protein polymer obtained by 
atomic force microscopy. 
A sequence consisting of repeating (Gly-Ala)3Gly-Glu octapeptides 
52, denoted 
as SE block, was a first silk-inspired product obtained in P. pastoris in our 
laboratory 55. In the SE block, the hydrophobic fragments consisting of Gly-Ala 
repeats facilitate the process of self-assembly, as it is in the natural silks, while 
the presence of glutamic acid imparts self-assembly at low pH values 55 (Fig 
1.4B). The other variant of S block frequently used in our protein polymers is 
SH block, where glutamic acid was replaced by histidine. In the SH block, 
histidine at neutral and high pH values becomes uncharged, which allows the 
formation of anti-parallel β-sheets and protein self-assembly 56. Usually, the S 
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block is fused to other blocks in form of multimers, for instance, C2-S
H
8-C2, 
C2-S
H
24-C2, C2-S
H
48-C2 
57. In this thesis we used one of the protein polymers 
that consist SH48, namely C2-S
H
48-C2, which can form fibrillar hydrogels at 
neutral pH values. It has been reported that C2-S
H
48-C2 hydrogels can 
reassemble after rupture, which is called self-healing 43. Moreover, as shown by 
Biegun-Wlodarczyk et al., they constitute an attractive material for medical 
applications 34. 
1.4.3. Coiled coils motifs 
Predictions based on analyses of primary sequences indicate that approximately 
10% of all protein amino acid sequences in eukaryotic cells form coiled coils 58. 
There are many functions assigned to different coiled coils, for instance, 
oligomerization, regulatory function, DNA binding, membrane fusion, or 
energy transfer 59. The arrangements of coiled coils are also very diverse. They 
can consist of two to seven parallel or antiparallel amphipathic α-helices that 
are wrapped around each other in superhelical fashion 60 (Fig. 1.5A). 
Figure 1.5: (A) 3-D structure of antiparallel coiled-coil determined by X-ray crystallography. 
(B) Helical wheel diagram showing interacting residues in a coiled coil. 
Moreover, they can be either left-handed or right-handed 61. Here, we discuss 
only small, left-handed and parallel coiled coils, called leucine zippers 62. This 
name is derived from leucine that occurs periodically every seven residues in 
the sequence. The sequence consists of a heptad repeat pattern (abcdefg)n, 
where n is the number of repeats (Fig. 1.5B). Positions a and d are typically 
occupied by hydrophobic amino acids that form the hydrophobic core of the 
coiled coil. The amino acids located at positions e and g often contain 
complementary charged side chain functional groups, which stabilize the 
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strands through salt bridges. Recently, many de novo designed coiled coils have 
been reported that show selective and specific binding properties 63. Due to that 
coiled coils have stimulated the interest in the use of these motifs for directed 
self-assembly 61. 
In this thesis we aimed to test use of two pairs of heterodimer-forming leucine 
zippers to direct self-assembly of chosen protein polymers. The first pair was 
developed by Moll et al. to target a radionuclide to tumor-specific antibodies 64. 
The complementary units are 47 amino acids long and form heterodimers with 
the melting temperature of 74 °C, dissociation constant of 1.3×10−11 M and 
molecular weight of 11 kDa (See Table 3.1, Chapter 3 for amino acid 
sequence). The second pair was developed as a universal peptide capture and 
delivery system 65. The complementary units are 21 amino acids long and form 
heterodimers with the free energy of unfolding equal 9.6 kcal×mol-1, 
dissociation constant of 7×10−8 M and molecular weight of 4 kDa (See Table 
4.1, Chapter 4 for amino acid sequence). Both couples have been shown to 
form heterodimers in very selective and specific manner 64,65. Although 
Dooling et al. reported use of coiled coils as midblocks 66, here we tested only 
terminal orientation. 
1.4.4. WW domain motifs 
WW domains can be found in various natural proteins. With 35–40 amino acid 
residues, WW domains are among the smallest independently folding 
domains 67. Their sequence has a high content of aromatic, hydrophobic and 
proline residues, and two highly conserved tryptophans (hence WW domain). 
In aqueous solutions, the domain assumes a slightly bent three-stranded 
antiparallel β-sheet, the concave side of which forms a binding pocket for the 
ligand 68 (Fig. 1.6A). The ligands that WW domains recognise and bind in a 
specific manner are small proline-rich peptides with the core motif PPXY 69,70. 
It has been shown that the interaction between WW domain and a proline-rich 
peptide can be successfully employed to form supramolecular structures 71
(Fig. 1.6B). 
In this thesis, we explore two types of WW domains and two proline-rich 
motifs as an alternative to coiled coils described above. The WW domains that 
we have chosen are WWP1-1 and CC43. The first one is derived from the 
human ubiquitin ligase homolog WWP1 73 and the second one was designed 
with the aid of computer modelling, by Russ et al. 74. As proline-rich ligands 
we analysed a PPxY peptide derived from the p53-binding protein-2 73 and 
PPxY-1,  derived from p45 murine activation domain 75. According to Russ et 
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al., the dissociation constant for CC43 and PPxY heterodimer is approximately 
1.7 ×10−5 M 74. The combination of PPxY and WWP1-1 was among the best 
performing pairs tested by Pirozzi et al. 73, but to our knowledge no dissociation 
constant values have been published. The possibility to use WW domains and 
their PPxY ligands as parts of longer constructs (two component hydrogels) has 
been described previously 71. Both the WW and PPxY modules can be used in 
the middle of a sequence or at its end, in this thesis we have explored using 
them as terminal blocks in protein-polymer designs. 
Figure 1.6: (A) Schematic representation of WW domain 72 bound to its proline-rich ligand 
(red) .  (B) An example of WW domain and its ligand incorporated in the protein polymer chain 
(black) . 
1.5. Aim and organisation of the thesis 
We use the incorporation of heterodimer-forming modules to obtain additional 
control over protein polymer self-assembly. Specifically, this thesis is aimed at 
the design, biosynthetic production and characterization of protein polymers 
with complementary terminal blocks A and B, where A and B are small, A-B 
heterodimer forming domains. The idea is that the A and B modules act as 
linkers, physically coupling the two different protein polymers to which the A 
and B domains are attached (Fig. 1.7). The ability to precisely control the 
process in which protein polymers are assembled into supramolecular structures 
is very important for their final applications. 
In the next chapter, Chapter 2, we review various protein-engineering 
approaches that have been used to obtain control over the assembly of protein 
polymers. We discuss techniques that allow for the design of complex, 
hierarchical polypeptide self-assemblies and hybrid materials, and techniques to 
cross-link and stabilize weak supramolecular structures, or to incorporate into 
these structures, specific bio-functional groups via self-assembly. 
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Figure 1.7: The exemplary application of A/B heterodimer-forming modules (red/purple) 
for directed self-assembly of protein polymers. A/B can be incorporated in to the fibril-forming 
protein polymer (blue) (A) in order to organise fibrils into bundles (B), or they can be used 
for mixing-induced network formation, where block in yellow can form homotrimers and blocks 
in green serve as spacers (C). 
Next, in Chapter 3, 4 and 5 we study the capability of three different 
heterodimer-forming A-B peptide couples to act as linkers. These peptides were 
attached either to previously developed CP4 protein polymer or to its modified 
variant called T9-C
P
4. Obviously, a mixture of T9-C
P
4-A with T9-C
P
4-B 
should also form a network, if A and B together form A-B heterodimers, and 
thus, we chose to construct T9-C
P
4-A and T9-C
P
4-B. For comparison, A-C
P
4-
A and B-CP4-B, which should form long chains upon mixing, and the even 
simpler CP4-A and C
P
4-B, which should form dimers, were also constructed. 
All the protein polymers discussed in this thesis were designed via genetic 
engineering and produced via fermentation process in yeast P. pastoris. 
In Chapter 3 we study production of protein polymers with incorporated 
heterodimer-forming coiled coils. We present the strategy allowing significant 
reduction of product proteolysis during fermentation. Furthermore, 
we investigate self-assembling properties of di- and triblock protein 
polymers. We show that coiled coils attached to protein polymers, are 
functional and can couple, otherwise non-interacting protein polymers. Here 
we also highlight that this type of linkers can form homo-multimers, 
which can be avoided by introduction of certain concentration regime. 
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In Chapter 4 another type of coiled coils incorporated into di- and triblocks is 
investigated. Here, we report the case of proteolytic product degradation and 
several approaches in order to obtain intact product. We show that these coiled 
coils can be used to form protein polymer network, however we could not 
exclude that homodimers also participate in the network formation. 
In Chapter 5 we discuss production and characterization of diblocks 
containing heterodimer-forming WW and proline-rich domains. We also 
analyse a case of Picha-derived glycosylation of polymer variant with proline-
rich domain and we show the steps undertaken to escape glycosylation. In this 
study, we confirm that WW and proline-rich domains incorporated into protein 
polymers are functional and do not form homo-assemblies. Additionally, in the 
appendix to this chapter, we discuss the study on production and primary 
characterization of triblocks. 
In Chapter 6, we study the heterodimer-forming couple, described in Chapter 
3, built into silk-like protein polymer that can, already without the A/B linkers 
self-organize into long, pH-responsive nanofibrils. First we analyse the impact 
of pH on the linkers incorporated into the fibrils. Furthermore, we investigate 
whether, by mixing A/B polymer variants with linker-free polymers, we can 
control the level of interaction between fibrils. Since at the higher 
concentrations silk-like protein polymers can form hydrogel, we also explore 
the impact of introducing these linkers on the mechanical properties of such 
hydrogels. 
Finally, in Chapter 7, we provide a general discussion of the results obtained 
in this thesis. We summarize our results, recommend further steps, place 
our findings into the broader context of possible applications, and analyse 
possible risk that such application may entail. 
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Protein cross-linking tools for the 
construction of nanomaterials 
Abstract 
Across bioengineering there is a need to couple proteins to other proteins, or 
to peptides. Although traditional chemical conjugations have dominated in the 
past, more and more highly specific coupling strategies are becoming 
available that are based on protein engineering. Here we review the use of 
protein modification approaches such as enzymatic and autocatalytic protein-
protein coupling, as well as the use of hetero-dimerizing (or hetero-
oligomerizing) modules, applied to the specific case of linking together de 
novo designed recombinant polypeptides into precisely structured 
nanomaterials. Such polypeptides are increasingly being investigated for 
biomedical and other applications. In this chapter, we describe the protein-
engineering based cross-linking strategies that dramatically expand the 
repertoire of possible molecular structures and, hence, the range of materials 
that can be produced from them. 
Published as: Domeradzka, N.E..; Werten, M.W.T.; de Wolf, F.A; de Vries, R. 
Curr Opin Biotechnol 2016, 39, 61-67. 
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2.1. Introduction 
Self-assembling proteins are intensively being investigated as building blocks 
for nanostructured soft materials 1,2. Sequence motifs from natural structural 
proteins can be used to design novel protein materials consisting of 
polypeptides with simple repetitive sequences (“protein-based polymers”, or 
simply “protein polymers”) 3,4, or one can design entirely novel peptide or 
polypeptide sequences with predictable self-assembly behaviour 5,6. Self-
assembling (poly)peptides can be either chemically synthesized or genetically 
engineered 7,8. The latter route, which is the focus of this chapter, allows the 
production of long precisely defined amino acid sequences, thus offering a 
level of control that is highly attractive in a range of biomedical applications 8-
14. 
These applications depend on precise control over the way in which the 
polypeptides are assembled into their final supramolecular structure. It is here 
that novel protein-engineering techniques for cross-linking can play a crucial 
role. Although chemical cross-linking reactions can, and have been used 
extensively 15, they typically lack the specificity needed to create precisely 
defined polypeptide nanomaterials. Various protein-engineering tools such as 
enzymatic coupling 16-20 and the use of bio-recognition modules 21 do offer such 
specificity. By bio-recognition modules, we here specifically refer to the use of 
peptide- or small protein domains that can be incorporated in polypeptide 
chains in order to mediate self-assembly of polypeptides 22 via hetero-
dimerization (or hetero-oligomerization). Although these engineering tools can 
be used to link specific bioactive groups to proteins 23-25, this chapter mainly 
focusses on their use in linking designed polypeptides into higher order 
nanostructures. An overview of the tools discussed is given in Table 2.1. 
2.2. Covalent protein cross-linking 
For permanently linking different protein subunits into larger assemblies, a 
range of cross-linking enzymes and autocatalytic protein modules are available. 
Protein cross-linking enzymes differ substantially in their degree of substrate 
specificity. First we consider enzymes with a rather broad substrate specificity. 
They are especially useful for the creation of irreversibly cross-linked 
(hydrogel) networks. Key examples are: Transglutaminase 26, Horse-radish 
Peroxidase (HRP), Lysyl Oxidase (LOX) and Plasma Amine Oxidase (PAO), 
which couple one specific type of amino acid to another, as illustrated in Fig. 
2.1 (e.g. TG couples lysines to glutamines). 
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Their substrate specificity is broad in the sense that these enzymes typically 
provide the engineer with considerable freedom to choose the residues flanking 
those to be cross-linked. A second group of enzymes and autocatalytic modules 
have a much more narrow substrate specificity: Sortase A (SrtA), Inteins, 
SpyTag/SpyCatcher, see Fig. 2.2. These tools are particularly useful for 
creating molecular conjugates with precisely defined architectures. 
2.2.1. Transglutaminase 
TGs catalyse the formation of isopeptide bonds between glutamine and lysine 
residues 27 and are found in both microbial 28 and mammalian cells 27. They are 
quite promiscuous with respect to the residues flanking the lysine substrate in 
the polypeptide chain 29,30, but less so with respect to the preferred context of 
the glutamine 31,32. For de novo designed polypeptides one can often exploit 
some freedom of design, such that TG can be a very useful tool to create well-
defined polypeptide architectures. Collier and Messersmith showed that TG can 
be used to couple the glutamines in the self-assembling peptide Q11 
(QQKFQFQFEQQ) to lysines in other peptides and proteins 33. The same group 
proposed more TG substrate peptides, including an amine donor sequence K 
(EDGFFKI) that can be targeted by TG when placed at the C-terminus 34, and 
which can be coupled to the amine acceptor substrate peptide Q (APQQEA) 35. 
The Chilkoti group studied elastin-like polypeptide (ELP) sequences, tandem 
repeats of the motif VPGXG(VPAGVG)6, and showed that variants for which 
X is either lysine (K) or glutamine (Q), were efficiently cross-linked by tissue-
derived TGs 36. Bozzini et al. designed protein polymers with an (A-B)8
structure, where A is an ELP sequence and B is the motif 
AAAAAAKAAAKAAQGFL. These protein polymers were efficiently cross-
linked by microbial TG 37. Finally, Davis et al. developed a protein hydrogel 
system that was cross-linkable by TG 38. This system consists of two de novo 
designed protein polymers Kn and (BQ)n, where the Kn block contains lysines, 
B is a random coil hydrophilic block, and the Q block serves as the glutamine 
substrate. 
2.2.2. Lysyl oxidase and plasma amine oxidase 
LOX are a family of oxido-deaminases that cross-link components of the 
extracellular matrix, in particular collagen and elastin 39. LOX cross-linking is 
based on the oxidation of the primary amine of lysine to an aldehyde. This 
aldehyde can spontaneously react with another amine and form a Schiff base or 
undergo an aldol condensation with another aldehyde 40. In this way a covalent 
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bond is established between two lysines. PAO is a commercially available 
alternative, which also functions by oxidation of primary amines. Bakota et al. 
showed that LOX and PAO can cross-link the self-assembled structures of the 
de novo designed peptide K2(SL)6K2 26. It appears that the activity of LOX is 
less affected by sequence context than that of TG 19, although some preferences 
for the residues surrounding the lysines have been identified 41. Because LOX is 
naturally present in serum 42, it may be employed for in vivo cross-linking of 
polypeptide nanomaterials. 
2.2.3. Horse radish peroxidase 
HRP is used for a range of different biochemical applications 43. The enzyme 
catalyses redox reactions between hydrogen peroxide and a reducing substrate. 
Typical substrates include aromatic phenols, phenolic acids, indoles, amines 
and sulfonates. It can be used for protein cross-linking when tyrosines are 
available that are sufficiently accessible. Minamihata et al. showed that HRP 
can be used for site-specific cross-linking of recombinant proteins that contain 
a tyrosine tag (GGGGY or GGYYY) 44. The Kaplan laboratory explored the 
use of HRP to generate highly elastic hydrogels by cross-linking tyrosines in 
natural silk proteins 45 and recombinant resilin-like proteins 46. A potential 
problem is that prolonged cross-linking may lead to the formation of tri-
tyrosines and higher order cross-links 47,48. 
Figure 2.1: Enzymatic cross-linking with broad specificity. Transglutaminase catalyses protein 
crosslinking through a transamination reaction between lysine and glutamine. Lysyl oxidase and 
plasma amine oxidase convert the amino group of lysines into aldehydes, which can form a Schiff 
base with the amino group of another lysine. Horseradish peroxidase mediates a redox reaction 
between hydrogen peroxide and tyrosine. 
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2.2.4. Sortase A 
Sortase A is a highly specific cross-linking enzyme derived from Gram-positive 
bacteria, and belongs to the group of transpeptidases. In vitro, SrtA catalyses 
the transpeptidation by cleaving between threonine and glycine in a C-terminal 
LPXTG recognition motif and subsequently joining the carboxyl group of 
threonine to the amino group of an N-terminal glycine of other molecule 49 
(Fig. 2.2A). Many de novo designed peptides have been screened as potential 
SrtA substrates 50. Piluso et al. used SrtA to functionalize a self-assembling 
ionic-responsive, peptide hydrogel with a DNA-binding protein (Tus) 51. A 
diglycine sequence was incorporated at the N-terminal side of self-assembling 
peptide P1 (GGFEFEFKFKK) and the Tus protein featured an LPETGG 
sequence at its C-terminus. The conjugated Tus protein remained functional 
and accessible in the hydrogel. Similarly, Kim et al. functionalized ELP-based 
micelles with bioactive protein domains using sortase-mediated 
bioconjugation 52. Relatively large proteins (40 kDa) were coupled to the 
micelles without loss of activity. Not much work has been reported yet where 
SrtA is used specifically to engineer novel self-assembling architectures, which 
may be due to the fact that SrtA conjugations are quite difficult to drive to 
complete conversion. Also, in some cases, side reactions can occur 53. 
2.2.5. Inteins 
Inteins are part of a larger class of proteins known as Hedgehog/intein (Hint) 
domains. An intein carries out a unique auto-processing event known as protein 
splicing, in which it excises itself from a larger precursor polypeptide through 
the cleavage of two peptide bonds and ligates the previously flanking protein 
sequences through the formation of a new peptide bond. Inteins have been 
exploited in the chemoenzymatic synthesis of N‐terminally modified 
proteins 54, protein purification 55 and in protein biotinylation 56. The so-called 
split-inteins 54 contain two separately encoded fragments that can assemble into 
a functional intein through non-covalent interactions. Such pairs both exist 
naturally, and have been created artificially by splitting a contiguous intein into 
an N-terminal and a C-terminal fragment. A protein containing one half of a 
split-intein pair can thus be coupled to another protein containing the other half, 
through reconstitution of the functional intein and subsequent self-excision; a 
process known as trans-splicing (Fig. 2.2B). Ramirez et al. used this approach 
to generate a hydrogel by mixing two soluble protein block copolymers, each 
containing a trimerizing CutA domain and half of a split-intein pair 57. 
Although split-inteins are certainly interesting for linking de novo designed 
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polypeptides into higher order nanostructures, it must be mentioned that 
flanking residues can considerably influence splicing efficiency 58. 
Figure 2.2: Enzymatic cross-linking with narrow substrate specificity (A) Sortase A cleaves 
between threonine and glycine at an LPXTG recognition motif and subsequently joining the 
carboxyl group of threonine to an amino group of glycine. (B) An Intein, after association and 
refolding of split fragments, regains the ability to auto-catalytically excise itself and form a 
covalent bond between the previously flanking residues. (C) SpyTag and SpyCatcher undergo 
autocatalytic isopeptide bond formation between Asp117 on SpyTag and Lys31 on SpyCatcher. 
2.2.6. SpyTag/SpyCatcher 
The SpyTag/SpyCatcher system originates from the fibronectin binding protein 
FbaB of Streptococcus pyogenes 59. This biotechnologically exploited system 
consists of a small protein (SpyCatcher, 12kDa) and a peptide (SpyTag, 
1.1kDa). The Howarth group demonstrated that upon mixing, SpyTag and 
SpyCatcher undergo autocatalytic isopeptide bond formation between Asp117 
on SpyTag and Lys31 on SpyCatcher 
59 (Fig. 2.2C). The Tirrell group used this 
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system in order to design new ELP polypeptide topologies 60. Neither SpyTag 
nor SpyCatcher needs to be at a terminus, which allowed ELP designs that 
formed 3-arm, 4-arm, and H-shape ELP topologies 60. The SpyTag-SpyCatcher 
approach can also be used to biofunctionalize self-assembled protein 
nanomaterials 61,62. The SpyTag/SpyCatcher system is highly attractive for 
creating precisely defined polypeptide nanostructures, since it appears to be 
quite robust with respect to reaction conditions and is reported to have a high 
yield. A drawback for some applications, however, may be the relatively large 
size of the SpyCatcher protein, as this may influence the nanostructure’s 
physicochemical properties and possibly its biocompatibility. 
2.3. Reversible cross-linking via biorecognition modules 
In some cases, links between polypeptides in nanomaterials should be 
reversible rather than irreversible, for example, in self-healing materials, 
injectable gels, etc. Such reversible physical bonds can be engineered via “bio-
recognition” modules: small proteins/peptides known to have specific 
interactions with each other. Much work in the past has dealt with homo-
oligomerizing domains that can be used to direct self-assembly of larger 
polypeptide constructs. Examples are: silk-inspired blocks, collagen-like triple 
helices 63, and condensed phases of elastin-like polypeptides 64. Here we will 
restrict ourselves to more recent work on domains that can be used to 
physically couple different polypeptides via hetero-oligomerizing domains, 
which offer more control over macromolecular topology and allow assembly 
upon mixing different components. 
2.3.1.Coiled coils and triple helices 
Alpha-helical coiled coils are structural motifs present in many different 
proteins 65. The fundamentals of coiled-coil sequence design have been very 
well studied and as a consequence, hetero-oligomeric coiled coils are 
increasingly being used in the fabrication of protein nanoarchitectures 66-71. The 
power of using sets of orthogonal coiled coils was beautifully illustrated by the 
“protein origami” work of the Jerala group, in which a sequence of orthogonal 
coiled-coils was expressed as a single self-assembling recombinant 
polypeptide 72. Zhang et al. have developed a hetero-hexameric coiled coil 
system that was used to physically cross-link self-assembling nanofibers, 
leading to formation of injectable hydrogels 73. We have shown that 
heterodimer-forming coiled coils can be fused to hydrophilic random coil and 
self-assembling polypeptides, and can be produced efficiently by secretory 
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expression in the yeast Pichia pastoris 74. Although coiled coils are important 
structural motifs with great potential in directing the assembly of de novo 
designed polypeptides into higher order structures, a potential problem is that 
homodimerization may compete with heterodimerization, especially at high 
concentrations 74. 
Figure 2.3: Reversible cross-linking via biorecognition modules. (A) Coiled coils, assembling into 
heterodimers. (B) Biorecognition modules such as WW domains or PDZ domains specifically (but 
typically weakly) interact with their peptide ligands. The example shows protein polymers with 
multiple WW domains interacting with  multiple PPxY ligands to form injectable hydrogels 80. 
2.3.2. Protein modules that bind peptide ligands 
Many protein-protein or protein-peptide interactions in nature are elicited by 
small and well-delimited domains of the interacting polypeptide chains. Such 
small domains can be exploited as selective binding modules in de novo 
designed recombinant polypeptides, for the construction of supramolecular 
nanostructures and materials. So far, only a limited number of them has been 
exploited to direct supramolecular assembly. The so-called WW domains are 
small protein modules with two highly conserved tryptophans that have been 
identified in many signalling and regulatory proteins 75. These modules, and 
their engineered variants 76 have a specific binding affinity for proline-rich 
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peptide motifs in vitro 77-79 (Fig. 2.3B). They have been used for engineering 
self-assembly in particular by the group of Heilshorn, which has developed 
two-component hydrogels based on the WW domain and proline-rich 
peptide 80-83. Since the protein–peptide ligand interaction is relatively weak, the 
authors incorporated multiple WW and multiple proline-rich motifs. Other 
well-known protein interaction domains are the so-called PDZ domains that 
typically interact with C-terminal parts of target proteins through beta-strand 
addition 84,85. Guan et al. used a single-domain PDZ protein called Tip-1 for 
constructing a two component self-assembling hydrogel system, where the 
interaction was reinforced by an engineered disulphide linkage 86. A similar set 
of specifically interacting domains with disulphide locking is the Cys-tag/Ad-C 
pair derived from human RNase I 87, but it has so far not been employed for the 
construction of protein nanomaterials. 
2.4. Conclusion and outlook 
The examples discussed here illustrate the potential of using cross-linking tools 
to assemble designed polypeptides into precisely structured nanomaterials. 
Given the rapid progress in biomolecular engineering, it can be expected that in 
the near future these tools will become still more precise and versatile: new 
cross-linking enzymes, autocatalytic cross-linking modules and hetero-
oligomerizing modules may become available via genomic and data mining 
studies, whereas existing ones may be improved for engineering purposes, e.g. 
via combinations of targeted engineering and directed evolution. For example, 
directed evolution was already used to identify SrtA mutants with improved 
catalytic activity 88. Such improved tools will allow for the creation of novel 
protein materials with still better controlled structures at the nanoscale, and 
hence, for biomedical materials with more precisely defined interactions with 
living cells and organisms. 
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Production in Pichia pastoris of protein-
based polymers with small heterodimer-
forming modules 
Abstract 
Some combinations of leucine zipper peptides are capable of forming α-
helical heterodimeric coiled coils with very high affinity. These can be used as 
physical cross-linkers in the design of protein-based polymers that form 
supramolecular structures, for example hydrogels, upon mixing solutions 
containing the complementary modules. Such two-component physical 
networks are of interest for many applications in biomedicine, pharmaceutics 
and diagnostics. This chapter describes the efficient secretory production of A 
and B type leucine zipper peptides fused to protein-based polymers in Pichia 
pastoris. By adjusting the fermentation conditions, we were able to 
significantly reduce undesirable proteolytic degradation. The formation of A-
B heterodimers in mixtures of the purified products was confirmed by size 
exclusion chromatography. Our results demonstrate that protein-based 
polymers incorporating functional heterodimer-forming modules can be 
produced with P. pastoris in sufficient quantities for use in future 
supramolecular self-assembly studies and in various applications. 
Published as: Domeradzka, N.E.; Werten, M.W.T.; de Vries, R. and de Wolf, 
F.A., Production in Pichia pastoris of protein-based polymers with small 
heterodimer-forming blocks Biotechnol Bioeng 2016, 113: 953–960. 
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3.1. Introduction 
Protein materials with precisely defined novel functionalities can now be 
designed via recombinant DNA technology. Indeed, de novo designed 
functional polypeptide blocks can be fused together into protein block 
copolymers and be produced as heterologous proteins in recombinant host cells 
by the expression of synthetic genes 1,2. Such recombinant protein block 
copolymers can be tailored to self-organize into various nano- and higher order 
structures, often in response to external stimuli 3-5. 
As compared to chemically synthesized block copolymers, recombinant protein 
polymers can offer superior purity, monodispersity, biocompatibility, 
biodegradability, and tunability of in vivo half-life 2,6. This makes protein 
polymers attractive candidate materials for medical applications such as drug 
encapsulation, controlled drug release, tissue engineering, tissue augmentation, 
and biosensors 7-11. 
In our laboratory, we have developed a range of self-assembling protein 
polymers containing silk-, collagen-, and elastin-inspired blocks, and produced 
these as secreted proteins in the yeast Pichia pastoris at g L-1 levels 12-15. Self-
assembly of these polymers is mainly controlled by pH and temperature of the 
environment. For several medical applications, it would be desirable to be able 
to physically link together different protein polymers or protein domains, at a 
user-chosen time, by simple mixing of separately produced A and B proteins. 
For example, a possible application could be injectable gels that quickly self-
assemble in situ after mixing of protein polymers A and B. 
In this chapter we investigate the incorporation, into some of our previously 
developed protein polymer designs, of short leucine zipper peptides capable of 
forming high affinity α-helical heterodimeric coiled coils. We chose a well 
characterized pair of leucine zipper peptides, that was first studied by Moll et 
al. 16, and later used by Glasgow et al. 17 to physically couple single-chain 
antibody fragments to adenovirus proteins. 
The more acidic peptide of the pair will further be denoted as DA, the more 
basic peptide as DB. For proof-of-concept, we genetically incorporated DA and 
DB domains at the C-terminus of a previously-developed T9-C
P
4 diblock 
copolymer. The C-terminal domain of this diblock protein polymer, CP4, is a 
highly hydrophilic random coil and consists of four identical copies of a 99 
amino acid long sequence 18. The N-terminal domain, T9, is a collagen-inspired 
(Pro-Gly-Pro)9 peptide capable of forming temperature-sensitive 
homotrimers 15. The combination of T9 and C
P
4 blocks has been studied 
previously, for example in the hydrogel-forming triblock copolymer T9-C
P
4-
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T9 
15,19. As a control, to study DA/DB dimer formation in the absence of any 
other supramolecular structure formation, the DA or DB modules were also 
incorporated into a CP4 protein polymer without T9 blocks. 
The secretory production in P. pastoris of the four protein polymers CP4-DA, 
CP4-D
B, T9-C
P
4-D
A, and T9-C
P
4-D
B initially resulted in partial proteolytic 
degradation. By altering the fermentation conditions, essentially intact protein 
polymers were recovered from benchtop bioreactors in gram quantities. We 
show that the heterodimerizing modules are functional and can indeed 
physically couple two different (otherwise non-interacting) protein polymers in 
solution. 
3.2. Materials and Methods 
3.2.1. Construction of Expression Vectors and Strains 
The double-stranded gene fragments encoding the more acidic heterodimer-
forming leucine zipper peptide DA and the more basic peptide DB (previously 
denoted as RR12EE345L and EE12RR345L, respectively 
16) were assembled via 
overlap extension PCR 20 from the oligonucleotides shown in Table 3.S1. For 
the amino acid sequences of DA and DB see Table 3.1. 
Table 3.1. Amino acid sequences of DA and DB. In our design, both sequences end C-terminally in 
the cloning-derived amino acid sequence PAGG (not indicated), which also prevents removal of the 
C-terminal Lys residue of both leucine zippers by the P. pastoris Kex1 carboxypeptidase. 
Dimer-forming 
modules 
Amino acid sequence 
D
A
 = RR
12
EE
345
L LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETRYGPLGGGK
D
B
 = EE
12
RR
345
L LEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGGGK
The gene fragments were digested with XhoI/EcoRI and cloned into 
XhoI/EcoRI-digested vector pMTL23ΔBsaI 12, in order to obtain two vectors 
pMTL23ΔBsaI-DA and pMTL23ΔBsaI-DB. The vector pMTL23-CP4 contains 
the sequence coding for CP4 
18. The vector pMTL23-T9-C
P
4, encodes, at the N-
terminal side of CP4, an additional T9 sequence 
15. The vectors were opened at 
the 3’ end of the CP4 or T9-C
P
4 gene with EcoRI/Van91I. The newly prepared 
constructs pMTL23ΔBsaI-DA and pMTL23ΔBsaI-DB were digested with 
EcoRI/DraIII to release inserts DA and DB. The inserts were ligated to the 
opened vectors, resulting in pMTL23-CP4-D
A, pMTL23-T9-C
P
4-D
A, pMTL23-
CP4-D
B and pMTL23-T9-C
P
4-D
B. All four inserts were then released with 
XhoI/EcoRI and cloned into the likewise-digested Pichia pastoris expression 
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vector pPIC9 (Invitrogen). This resulted in the construction of the vectors: 
pPIC9-CP4-D
A, pPIC9-T9-C
P
4-D
A, pPIC9-CP4-D
B and pPIC9-T9-C
P
4-D
B, 
respectively. The vectors were linearized with SalI to target for integration at 
the his4 locus. Transformation of P. pastoris GS115 by electroporation and 
selection of Mut+ transformants were performed as described previously 21. 
Vectors pPIC9-CP4-D
B and pPIC9-CP4-D
A were also used for transformation of 
the protease A deficient strain SMD1168 (Invitrogen). 
3.2.2. Fermentation 
The fermentation setup consisted of a 2.5-L Bioflo 3000 stirred-tank bioreactor 
(New Brunswick Scientific) interfaced with BioCommand Software (New 
Brunswick Scientific) and a homebuilt methanol sensor-controller. The 
fermentations were performed as described previously 15, as follows. A starting 
volume of 1.25 L minimal basal salts medium 22 was used. The cultures were 
always inoculated with precultures grown to similar OD600. Growth 
temperature was 30 °C and the pH was controlled at 3.0 throughout the entire 
fermentation. The inlet air was supplemented with 20% oxygen for the duration 
of the glycerol fed-batch phase and the methanol fed-batch phase, which is 
achieved by the bioreactor by interrupting the air stream with short pulses of 
pure oxygen. During the induction phase, methanol levels were kept at a 
constant level of 0.2% (w/v). Agitation control in this phase was programmed 
to maintain dissolved oxygen levels at 20%, for as long as the oxygen demand 
of the methanol non-limited cells did not exceed the maximum oxygen transfer 
capacity of the bioreactor. Where indicated in Results, some of the fermentation 
parameters were varied in an attempt to reduce proteolysis. This involved 
various combinations of (a) a culture pH of 5.0 throughout the entire 
fermentation, (b) supplementation of the medium with 1% casamino acids, (c) 
supplementation of the medium with 10 mM ascorbic acid, and not 
supplementing the inlet air with oxygen during the methanol fed-batch phase, 
and (d) a growth temperature of 20 °C during the induction phase. In case of 
medium supplementation, casamino acids or ascorbic acid were added 
approximately 10 min. before methanol induction. For induction at 20 °C, the 
temperature was linearly decreased from 30 °C to 20 °C during the last 40 min. 
prior to methanol induction. The induction phase lasted two or three days, for 
fermentations at 30 °C or 20 °C, respectively, where dissolved oxygen levels 
typically reached 0% by one or two days, respectively. 
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3.2.3. Protein Purification 
Purification of all protein polymers was done by ammonium sulfate 
precipitation essentially as described, which typically results in a purity of 
~99% at the protein level 15. Shortly, the pH of the cell-free broth was raised to 
8.0 by addition of sodium hydroxide to allow precipitation of medium salts. 
After centrifugation for 30 min. at 20,000 × g (RT), the protein was precipitated 
from the supernatant by addition of ammonium sulfate to 40% of saturation, 
followed by incubation on ice for 30 min and centrifugation for 30 min. at 
20,000 × g (4 °C). The protein pellet was resuspended in Milli-Q water and 
precipitated once more. The pellet was then resuspended in Milli-Q water, 
desalted by extensive dialysis against Milli-Q water, and finally lyophilized. 
3.2.4. SDS-PAGE, Densitometry, and N-Terminal Protein Sequencing 
SDS-PAGE was performed using the NuPAGE Novex System with 10% Bis-
Tris gels, MES SDS running buffer, and SeeBlue Plus2 pre-stained molecular 
mass markers. Prior to electrophoresis, all samples were heated for 10 min. at 
70 °C in NuPAGE LDS Sample Buffer with NuPAGE Sample Reducing 
Agent, as per manufacturer’s recommendations for denaturing and reducing 
PAGE. For gel staining, Coomassie SimplyBlue SafeStain (Invitrogen) was 
used. Gel images were acquired using a GS-800 calibrated densitometer and 
Quantity One software (Bio-Rad). Densitometric analyses were done using 
both lane-based density traces and band-based quantification in Quantity One, 
and were in good mutual accordance. Blotting of proteins for N-terminal 
sequencing by Edman degradation was described previously 21. Protein 
sequencing was performed by Midwest Analytical (St. Louis, MO). 
3.2.5. Mass Spectrometry 
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry was 
performed using an ultrafleXtreme mass spectrometer (Bruker). Samples were 
prepared by the dried droplet method on a 600 µm AnchorChip target 
(Bruker), using 5 mg mL-1 2,5-dihydroxyacetophenone, 1.5 mg mL-1 
diammonium hydrogen citrate, 25% (v/v) ethanol and 3% (v/v) trifluoroacetic 
acid as matrix. Spectra were derived from ten 500-shot (1,000 Hz) 
acquisitions taken at non-overlapping locations across the sample. 
Measurements were made in the positive linear mode, with ion source 1, 
25.0 kV; ion source 2, 23.3 kV; lens, 6.5 kV; pulsed ion extraction, 680 ns. 
Protein Calibration Standard II (Bruker) was used for external calibration. 
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3.2.6. Size Exclusion Chromatography 
To determine whether both DA and DB modules incorporated into protein-based 
polymers are functional, size exclusion chromatography (SEC) was performed 
on the CP4-D
A and CP4-D
B diblocks. The polymers containing a T9 block are 
not suitable for this study, owing to the fact that triple-helix formation would 
complicate the analysis of heterodimer formation. The lyophilized proteins 
were dissolved in 0.5 M sodium phosphate buffer (pH 7) and incubated 
overnight at 4 °C to allow dimerization. CP4-D
A and CP4-D
B were mixed in 
such a way that the final molar concentration of each diblock was 30 μM. The 
samples were prepared with different molar fractions of CP4-D
A in the mixture 
of CP4-D
A and CP4-D
B. The following fractions of CP4-D
A were chosen: 0.75, 
0.67, 0.60, 0.55, 0.50, 0.45, 0.40, and 0.33. As controls for homodimerization 
we tested these diblocks alone at 30 μM concentration. As a molecular size 
marker we used CP4 alone 
21 and T9-C
P
8-T9 alone 
23, both at 30 μM 
concentration. Void volume was determined using Dextran Blue 2000 (GE 
Healthcare). Samples were injected in a volume of 50 μL on a Superdex 200 
Increase 10/300 GL column (GE Healthcare) at ambient temperature. The 
column was connected to a Biologic DuoFlow Chromatography system (Bio-
Rad). Elution was done using 0.5 M sodium phosphate buffer (pH 7) at a flow 
rate of 0.5 mL min-1. The eluate was monitored at 214 nm. Prior to injection, 
the column was equilibrated with the elution buffer. 
3.3. Results 
3.3.1. Production of T9-C
P
4-D
A and T9-C
P
4-D
B 
T9-C
P
4-D
A and T9-C
P
4-D
B strains were grown at 30 °C and pH 3, and proteins 
were purified from the cell-free broth by precipitation with 40% ammonium 
sulfate and subsequent dialysis and lyophilisation 15. The average 
gravimetrically determined yield obtained after purification for these two 
proteins was 0.6 ± 0.04 g L-1 of culture, with a mean productivity of 14 ± 2 mg 
L-1 per h, and a mean biomass-specific productivity of 25 ± 4 µg h-1 per g of 
wet biomass. Next, the protein polymers were analyzed by SDS-PAGE. The 
theoretical molecular weights of T9-C
P
4-D
A and T9-C
P
4-D
B are 44,971 and 
45,053 Da, respectively. It should be noted, however, that proteins containing 
the CP4 block are known to migrate very slowly in SDS-PAGE owing to their 
highly hydrophilic character and consequent low binding of SDS 15,18. For both 
polymers, two bands were detected in SDS-PAGE, at positions corresponding 
to marker bands of ~98 kDa and ~188 kDa (Fig. 3.1, lanes 1 and 2). Although 
40
aberrant migration of the proteins was expected, the presence of two bands 
suggests partial degradation. Because attachment of a short peptide with varied 
amino acid composition previously increased the migration rate of CP2 in SDS-
PAGE 24, the lower bands seen here may well correspond to the intact T9-C
P
4-
DA and T9-C
P
4-D
B proteins, and the upper bands may represent the proteins 
with most of the leucine zipper peptides missing owing to degradation. In 
agreement with this notion, Fig. 3.1.S1 shows that the upper band in T9-C
P
4-
DB migrates at similar speed as the related control protein T9-C
P
4-T9, known to 
migrate at similar speed as CP4 
15. We further investigated the molecular weight 
distribution of purified T9-C
P
4-D
A and T9-C
P
4-D
B by MALDI-TOF mass 
spectrometry (Fig. 3.2A). Also in MALDI-TOF, two peaks were observed for 
each of these proteins: 44,959 Da and 39,648 Da for T9-C
P
4-D
A, and 45,033 
Da and 39,844 Da for T9-C
P
4-D
B. The main peaks correspond, within 
experimental error, to the expected molecular weights of intact T9-C
P
4-D
A and 
T9-C
P
4-D
B mentioned above. In agreement with the observations in SDS-
PAGE, the minor peaks of 39,648 Da and 39,844 Da, respectively, most likely 
correspond to proteins with almost the entire DA and DB peptides cleaved off, 
as the T9-C
P
4 part alone has an expected mass of 39,293 Da. The majority of 
the T9-C
P
4-D
A and T9-C
P
4-D
B molecules remained intact, but apparently, in a 
minor fraction of the molecules, the DA and DB peptides are degraded by an 
endogenous protease of P. pastoris. 
Figure 3.1: SDS-PAGE. Protein-based polymers produced according to the standard protocol: 
lane 1, T9-CP 4-DA, lane 2, T9-CP4-DB. Protein-based polymers produced after optimization of 
fermentation conditions: lane 3, T9-CP 4-DA, lane 4, T9-CP4-DB, lane 5, CP 4-DA, and lane 6, CP 4-
DB. Lanes M: protein molecular weight marker. The lower arrows point to the bands 
corresponding to the intact proteins and the upper arrows indicate the partly degraded products. 
13 μg of protein was applied in each lane. 
3.3.2. Production using the protease A deficient strain SMD1168  
We first attempted to remedy the observed protein degradation by using the 
protease A deficient strain SMD1168 25, while leaving the fermentation 
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conditions unchanged. Preliminary indications suggested that the proteins were 
still degraded, and in view of the relatively poor and unreliable growth of this 
strain, and a low protein yield (~0.2 g L-1 of culture), no further attempts at 
using this strain were made. 
3.3.3. Production at pH 5 
One of the most crucial factors influencing proteolysis is known to be the 
culture pH 21,26,27. As our standard fermentation conditions for CP4-type 
polymers involve pH 3, we now attempted pH 5 for the GS115 strain 
transformed with T9-C
P
4-D
A. The protein yield was comparable to that 
obtained in the fermentation at pH 3. SDS-PAGE again showed two bands and 
the upper band was even more present than at pH 3. Accordingly, MALDI-TOF 
again showed two peaks corresponding to intact and degraded T9-C
P
4-D
A, but 
this time the two peaks had similar intensity (Fig. 3.1.S2). Apparently, 
degradation of the protein only increased by changing the pH to 5. 
3.3.4. Production under ‘best guess’ conditions 
Next, rather than changing one parameter at a time, we chose a ’best 
guess’ combination of culture conditions known to sometimes remedy 
problems with proteolysis: (i) the temperature of the induction phase was 
reduced to 20 °C, (ii) the medium was supplemented with 1% casamino 
acid, and (iii) 10 mM ascorbic acid was included in the medium. Temperature 
reduction can reportedly reduce proteolysis of secreted proteins in P. pastoris 
28,29. Addition of casamino acids has likewise been helpful for several 
proteins produced in P. pastoris 21,30. Inclusion of ascorbic acid as an 
antioxidant can reportedly reduce proteolysis related to cell death resulting 
from oxidative stress. This stress is caused by intracellular accumulation of 
reactive oxygen species generated by the yeast’s oxygen-dependent methanol 
metabolism 31. Because the bioreactor used adds pure oxygen in a pulsed 
manner to obtain a time-averaged constant supplementation of the 
inlet air with 20% oxygen, we omitted oxygen supplementation from 
these fermentations as a precaution, so as to further minimize oxidative 
stress that might be caused by momentary high oxygen levels to cells near 
the sparger during a pure oxygen pulse. 
Under these combined conditions, fermentation of T9-C
P
4-D
A and T9-C
P
4-
DB in the GS115 strain resulted in a purified protein yield of 0.5 ± 0.05 g L-1 of 
culture, with a mean productivity of 8 ± 0.6 mg L-1 per h, and a mean biomass-
specific productivity of 17 ± 0.8 µg h-1 per g of wet biomass. For both proteins, 
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SDS-PAGE again showed the same two bands, although the relative intensity 
of the upper bands was now much reduced (Fig. 3.1, lanes 3 and 4). MALDI-
TOF (Fig. 3.2B) showed major peaks of 44,955 Da and 45,044 Da, 
respectively, which correspond well to the expected sizes of the intact proteins. 
Figure 3.2: (A) T9-CP4-DA and T9-CP4-DB produced according to the standard protocol; peaks at 
~40 kDa indicate significant product degradation. (B) T9-CP4-DA, T9-CP4-DB, CP 4-DA and CP4-DB 
produced after optimization of the fermentation conditions. 
The minor peak of ~39.6 kDa for the degraded species was hardly visible in 
T9-C
P
4-D
A and completely absent in T9-C
P
4-D
B. Apparently, the altered 
fermentation conditions indeed led to the production of nearly intact proteins, 
albeit at somewhat lower yields. Also CP4-D
A and CP4-D
B were produced 
under these conditions. SDS-PAGE again showed only minor degradation, as 
evident from the faint upper band (Fig. 3.1, lanes 5 and 6). MALDI-TOF (Fig. 
3.2B) showed only one peak of 42,504 Da for CP4-D
A and one peak of 42,587 
43
Da for CP4-D
B, which match their theoretical molecular weights of 42,510 and 
42,593 Da, respectively. Therefore, also for these proteins, the ’best guess’ 
fermentation conditions resulted in nearly intact proteins. 
As mentioned above, and even though MALDI-TOF suggests the proteins are 
(nearly) intact, both T9-C
P
4-D
A and T9-C
P
4-D
B produced under improved 
conditions still show faint upper bands in SDS-PAGE, although much less 
intense than before. To verify the nature of both the upper and lower bands in 
SDS-PAGE, they were subjected to N-terminal sequencing. The sequence of 
the lower bands matched the expected N-termini of T9-C
P
4-D
A and T9-C
P
4-D
B. 
Approximately 20% of the signal corresponded to Glu-Ala extended species, 
which is commonly observed and is due to incomplete processing of the α-
factor prepro secretory signal 21. There was no sign of further secondary 
reactions, which, in accordance with its migration rate in SDS-PAGE, suggests 
this band indeed corresponds to the intact protein. Analysis of the faint upper 
band also revealed sequences matching the expected N-termini of T9-C
P
4-D
A 
and T9-C
P
4-D
B (again with traces of a Glu-Ala extension), but additionally 
contained ~25% of ambiguous minor components such as Gly, Gln, Ser and 
Asn. Since these amino acids are abundant in CP4 this could indicate internal 
degradation, but may also just be background. Given their slow migration rate 
and ~75% intact N-terminus, the proteins in these bands most likely correspond 
mainly to C-terminally truncated species (with almost the entire coiled-coil 
domain removed), as hypothesized above. Nonetheless, it is clear from 
MALDI-TOF and the faint staining of the upper bands in SDS-PAGE that the 
preparations contain only negligible amounts of these degraded species. Indeed, 
densitometry of samples separated by SDS-PAGE shows that proteins produced 
under standard conditions were degraded for roughly 30-40%, whereas samples 
obtained under improved conditions contained only around 5-15% of degraded 
protein. Possibly, the minor fraction of degraded species remaining under ‘best 
guess’ conditions is barely visible in MALDI-TOF owing to preferential 
crystallization/ionization of the intact proteins. 
3.3.5. Influence of temperature, casamino acids, and ascorbic acid on 
product degradation 
After establishing that for this new set of fermentation conditions nearly intact 
products were obtained, we set out to investigate which of the modified 
conditions were essential for eliminating proteolysis. A number of 
fermentations were performed, in which each time either one, or two of the 
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fermentation conditions were changed from the ’best guess’ conditions 
described above, as detailed in Table 3.2. 
Table 3.2: Break-down of fermentation parameters involved in product degradation. Numbers 
between parentheses refer to numbered fermentation conditions in the text. Qualifications of 
protein integrity are based on MALDI-TOF (Fig. 3.1.S3). Note that ‘degraded’ in all cases reflects 
only moderate degradation compared to standard conditions (30 °C, no ascorbic acid, no casamino 
acids). 
  Level of product degradation 
Condition Culture parameters T
9
-C
P
4
-D
A
 T
9
-C
P
4
-D
B
 
‘Best guess’ 
(Fig. 3.2B) 
20 °C 
Ascorbic acid 
Casamino acids 
Nearly intact Nearly intact 
No ascorbic acid (1) 
(Fig. 3.1.S3A) 
20 °C 
No ascorbic acid 
Casamino acids 
Nearly intact Nearly intact 
No casamino acids (2) 
(Fig. 3.1.S3B) 
20 °C 
Ascorbic acid 
No casamino acids 
Degraded Nearly intact 
Normal temperature,  
no ascorbic acid (3) 
(Fig. 3.1.S3C) 
30 °C 
No ascorbic acid 
Casamino acids 
Degraded Degraded 
When the fermentations were repeated in the absence of ascorbic acid (with 
normal oxygen-supplemented air supply), under otherwise identical conditions 
(condition 1 in Table 3.2; Fig. 3.1.S3A), T9-C
P
4-D
A and T9-C
P
4-D
B remained 
as intact as under ’best guess’ conditions (Fig. 3.2B). This implies that the use 
of ascorbic acid, and thereby a putative reduction of oxidative stress 31, was not 
a critical parameter. When the optimized fermentation at 20 °C was repeated 
without addition of casamino acids (condition 2 in Table 3.2; Fig. 3.1.S3B), 
only minor degradation of T9-C
P
4-D
A occurred and negligible degradation of 
T9-C
P
4-D
B. Also when the fermentation was performed at 30 °C in the 
presence of casamino acids (condition 3 in Table 3.2; Fig. 3.1.S3C), only minor 
degradation occurred, albeit slightly more, particularly for T9-C
P
4-D
B, than 
under condition 2. Apparently, both addition of casamino acids and a growth 
temperature of 20 °C are effective in reducing proteolysis of the polymers, with 
the latter parameter having the largest effect on both proteins. The purified 
protein yield for all fermentations at 20 °C in Table 3.2 was similar (0.4 - 0.5 g 
L-1 of culture). As the final optimized conditions for ongoing work in our 
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laboratory involving these protein polymers we chose condition 1 (20 °C, 
supplementation with casamino acids, no ascorbic acid). 
3.3.6. Heterodimer formation 
To test the functionality of the heterodimer-forming modules incorporated into 
protein-based polymers, we used size exclusion chromatography (SEC) to 
analyse DA/DB dimer formation in mixtures of CP4-D
A  and CP4-D
B. For this 
analysis, the T9-C
P
4-D
A  and T9-C
P
4-D
B triblocks could not be used because 
the T9 module can form trimeric (T9)3 intermolecular cross-links, which would 
have disturbed the analysis. As a molecular weight marker we used CP4. This 
polymer has already previously been characterized by e.g. SEC and MALDI-
TOF 18 and does not form any aggregates. Its molecular weight of ~ 37 kDa is 
fairly close to that of CP4-D
A  and CP4-D
B (~ 42.5 kDa). As a second molecular 
weight marker, for lack of e.g. a CP8 polymer, we used T9-C
P
8-T9 
23. At a low 
concentration, many of the trimer-forming T9 blocks will be present in a 
monomeric state, such that also the monomeric form of the T9-C
P
8-T9 protein 
will be visible in SEC, in addition to trimers and larger supramolecular forms. 
The molecular weight of monomeric T9-C
P
8-T9 is ~78 kDa, which is roughly 
similar to that of a CP4-D
A/CP4-D
B dimer (~85 kDa). CP4 eluted from 16.8 mL 
to 18.4 mL, and the monomer fraction of T9-C
P
8-T9 eluted from 14 mL to 16 
mL (Fig. 3.1.S4). The fraction of T9-C
P
8-T9 eluting in the void volume of the 
column at up to 14 mL (Fig. 3.1.S4) represents large multimeric forms. 
Figure 3.3: SEC of CP4-DA alone, CP 4-DB alone, and a mixture of CP4-DA and CP4-DB. The 
retention volume decreases with increasing size of the molecules: (a) void, (b) dimer, and (c) 
monomer. Each sample was applied at a concentration of 30 μM. 
When individually applied to the column, each at a concentration of 30 µM, 
CP4-D
A and CP4-D
B eluted with a similar retention volume as the CP4 reference 
(Fig. 3.3), which showed that in isolated form, CP4-D
A and CP4-D
B occurred as 
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monomers at this concentration. After overnight incubation at 4 °C, a mixture 
of 30µM each of CP4-D
A and CP4-D
B was applied to the column. The 
chromatogram showed two peaks (Fig. 3.3). A minor peak was detected at a 
similar retention volume as monomeric CP4-D
A, CP4-D
B, or CP4, and a major 
peak was detected at a smaller retention volume of 14.4 mL to 16.6 mL, similar 
to the retention volume of the monomeric form of T9-C
P
8-T9, which is about 
twice as large as CP4-D
A or CP4-D
B. The latter indicates the coexistence of 
CP4-D
A::CP4-D
B dimers. To further analyze the binding stoichiometry, we 
analyzed mixtures of CP4-D
A and CP4-D
B with different CP4-D
A/CP4-D
B ratios 
(fA) (Fig. 3.4). The fraction of dimer was taken to be the ratio of the area under 
the dimer peak in the chromatogram divided by the total area under the 
monomer and dimer peaks. The largest fraction of dimers is obtained at fA = 
0.52, indicating an approximate 1:1 binding stoichiometry. 
Figure 3.4: Dimer formation in CP4-DA and CP4-DB mixtures containing different fractions of CP 4-
DA (fA). The fraction of dimer was taken to be the ratio (Adimer/Atotal) of the area under the dimer 
peak in the chromatogram, divided by the total area under the monomer and dimer peaks. The 
dashed line indicates the largest fraction of dimers. 
3.4. Discussion 
We have shown that small modules forming heterodimers with high specificity 
and affinity can be incorporated into protein polymers, which can be produced 
in secretory fashion at g L-1 levels using Pichia pastoris. The heterodimer 
forming modules are functional in the context of the protein polymers, thus 
allowing us to design and produce further two-component systems in the future. 
With respect to fermentation conditions, we found that a lower induction 
temperature and, to a slightly lesser degree, also the addition of casamino acids 
reduced the extent of proteolysis. A low induction temperature has reportedly 
been effective also in the production of a fusion protein consisting of Candida 
antarctica lipase B and a cellulose-binding domain 32. Low temperature can 
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reduce proteolysis simply for thermodynamic reasons, and because of reduced 
cell death and accompanying release of proteases into the medium 29. 
Degradation of herring antifreeze protein in shake flask cultures was also 
reduced by growth at a low temperature 28. Addition of casamino acids, mainly 
acting as competitive protease inhibitors, has been helpful for several proteins 
produced in P. pastoris 21,30. For our protein polymers, the combination of both 
low temperature and addition of casamino acids resulted in the lowest level of 
degradation, indicating that at least for some proteins the effects of both 
strategies can be additive. The low growth temperature did result in ~20% less 
protein recovered per culture volume, an ~46% lower mean productivity, and 
an ~30% lower mean productivity per unit of biomass. Nonetheless, the ~1g of 
purified protein obtained per benchtop fermentation is more than adequate for 
laboratory studies. 
We did not find a significant effect on proteolysis of supplementing the culture 
medium with ascorbic acid. This contrasts findings for the production of the 
peptide hirudin, where addition of ascorbic acid was found to reduce oxidative 
stress and thereby reduce product degradation 31. Of course different proteases 
may be involved in the degradation of hirudin and the protein polymers 
described here. Furthermore, oxidative stress may play a lesser role in our 
process because methanol non-limited cultures quickly become oxygen-
limited 33,34, whereas Xiao et al. 31 maintained dissolved oxygen levels at >40%. 
When studying the interaction between CP4-D
A and CP4-D
B using SEC, the 
maximal extent of heterodimer formation was found at the expected DA/DB 
mixing ratio of about 1:1. However, at this mixing ratio and 30 µM of each of 
the protein polymer components, about 20% of the molecules were still present 
as monomers (see Fig. 3.3). This is likely caused by the combined effects of 
association-dissociation kinetics and chromatographic separation of dimers and 
monomers 35, and by the 5-15% of degraded molecules remaining in the 
polymers. 
From the SEC analysis we also conclude that DB modules self-interact at higher 
concentrations; a finding that had not been reported prior to our study. At a 
concentration of 100 μM of CP4-D
B, in addition to the monomer peak, the 
chromatogram also shows a peak between 12 and 14 mL (Fig. 3.1.S5), which 
corresponds to the void volume of the column (Fig. 3.1.S4). The CP4-D
B 
diblock probably forms oligomers with sizes exceeding the separation range of 
the column (105 g mol-1 for dextrans). According to Moll et al. 16 the melting 
temperatures of the DA and DB homodimers are below 0°C, which implies that 
homomerization cannot take place at room temperature. Unfortunately, the 
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authors do not mention the protein concentration at which they did their 
experiments. Our analysis of their data shows that this concentration must have 
been around 10 µM, and that for a DB concentration of 100 µM the Tm of the 
homodimer must be around room temperature. This, in retrospect, explains the 
DB self-interaction we report here. We observed that equimolar mixtures of T9-
CP4-D
A and T9-C
P
4-D
B form hydrogels at high concentrations, in accordance 
with the possibility of network formation through the occurrence of DA/DB 
heterodimers and (T9)3 collagen-like trimers (Fig. 3.1.S6). However, the 
unexpected interactions between DB domains at higher concentrations likely 
also play a role in these network structures. 
It appears, therefore, that the present DA/DB pair of heterodimerizing leucine 
zippers is best used at low concentrations, where the homodimer melting 
temperatures are low, and one can safely assume that homodimerization does 
not occur. For example, we have previously designed and produced silk-like 
protein polymers that form fibrillar hydrogels 12,13,36. By mixing in a very small 
fraction of fibril-forming silk-like protein polymers that additionally have DA 
and DB domains, we may be able to bundle and/or cross-link the fibrils in order 
to modulate the mechanical properties of the gels, as required by many 
biomedical applications of protein polymer hydrogels 37-39. The DA/DB pair 
could also serve as a means of attaching bioactive domains to self-assembled 
supramolecular structures 41, or could be used in nanocomposite hydrogels. For 
example, inspired by a study by Appel, et al. 41, we envision using the 
dimerizing modules to establish connections between self-assembling protein 
polymers and nanoparticles. This approach is increasingly being explored to 
develop shear-thinning injectable gels 42,43. 
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3.1 Supplementary data  
Table 3.1.S1: Oligonucleotides used in gene construction. 
Insert 
Oligonucleotide 
Name 
Oligonucleotide sequences 
D
A
 
A-FW1 
5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTTTAGAAAT
TAGAGCTGCCTTTTTGAGACAG-3’
A-RV1 
5’GTCTCTGAACCTCTTGTTCCAACTCTGCAACTTCAGTCCTCAAAGCGGTA
TTACGCTGTCTCAAAAAGGCAGCTC-3’
A-FW2 
5’GGAACAAGAGGTTCAGAGACTTGAAAACGAAGTCTCTCAATATGAGACTA
GATACGGTCCACTTGGA-3’
A-RV2 
5’GTACGAATTCTATTAGCCACCGGCTGGCTTTCCACCTCCAAGTGGACCGT
ATCTAG-3’
D
B
 
B-FW1 
5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTTTGGAAAT
TGAAGCCGCCTTTCTTGAGC-3’
B-RV1 
5’GAACCCTTTGTCTAAGCTCAGCAACTCTGGTTTCTAAAGCAGTGTTCTCA
CGCTCAAGAAAGGCGGCTTC-3’
B-FW2 
5’CTGAGCTTAGACAAAGGGTTCAAAGGTTGAGAAATAGAGTCTCTCAGTAT
AGAACTCGTTACGGTCCATTG-3’
B-RV2 
5’GTACGAATTCTATTAGCCACCGGCTGGCTTTCCACCTCCCAATGGACCGT
AACGAGTT-3’
Figure 3.1.S1: SDS-PAGE migration rate comparison. Lane 1, T9-CP4-DB; lane 2, control protein 
T9-CP 4-T9, known to migrate at similar speed as CP4 15; lane M: protein molecular weight 
marker. 13 μg of protein was applied in each lane. 
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Figure 3.1.S2: MALDI-TOF spectrum of T9-CP 4-DA produced at pH 5. 
Figure 3.1.S3:  MALDI-TOF of T9-CP4-DA and T9-CP4-DB produced under various conditions. (A) 
without ascorbic acid (at 20 °C with casamino acids; condition 1), (B) without casamino acids (at 
20 °C, with ascorbic acid; condition 2) (C) at 30 °C and without ascorbic acid (with casamino 
acids; condition 3). 
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Figure 3.1.S4. SEC of size markers Dextran Blue 2000, T9-CP 8-T9, and CP 4. The retention volume 
decreases with increasing size of the molecules: (a) void, (b) T9-CP 8-T9 monomer, (c) CP 4 
monomer. Dextran Blue is used to determine the void volume of the column. Proteins were applied 
at a concentration of 30 μM. Owning to its collagen-like homotrimer-forming T9 blocks, T9-CP8-T9 
at low concentrations is present in solution as monomers, and, eluting in the void, as trimers and 
multimers. CP 4 does not form multimers. 
Figure 3.1.S5. SEC of CP 4-DB at a concentration of 100 μM, showing (a) multimer and (c) 
monomer peaks. 
Figure 3.1.S6. Inverted tube test for an equimolar mixture of T9-CP 4-DA and T9-CP 4-DB. (A) At 20 
°C. (B) Immediately after heating to 45 °C. The final concentration of each protein was 3 mM. 
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Production in Pichia pastoris of small 
coiled coils incorporated into hydrogel-
forming protein-based polymers
Abstract 
In this chapter we focus on the design, biosynthesis in Pichia pastoris and 
purification of protein polymers T9-C
P
4-D containing small C-terminal 
heterodimeric coiled coils DE = (EIAALEK)3 and D
K = (KIAALKE)3. The 
CP4 is a hydrophilic random coil polypeptide, and the T9 block is a trimer-
forming collagen-like block, such that the T9-C
P
4-D
E/T9-C
P
4-D
K couple is 
expected to form networks upon mixing. We found that protein polymers 
containing the DK module were partially degraded. A different culture pH, and 
the use of a yapsin 1 protease disruptant did not resolve this problem, but we 
did show that cation exchange chromatography can be used to purify the intact 
fraction of CP4-D
K diblocks (that were produced as non-gelling controls). 
Using dynamic light scattering-based microrheology and oscillation rheology, 
we show that T9-C
P
4-D
E forms thermosensitive hydrogels, apparently via 
homotypic interactions of the DE modules. At the same concentrations, T9-
CP4-D
K shows a thermosensitive increase in viscosity, but does not gel, 
indicating the presence of homotypic association of the DK, but not as strong 
as in the case of the DE module. Mixed systems T9-C
P
4-D
E/T9-C
P
4-D
K form 
hydrogels similarly as the T9-C
P
4-D
E system, indicating that both the 
heterotypic and homotypic associations may be involved in the hydrogel 
formation. 
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4.1. Introduction 
As discussed in previous chapters, recombinant protein polymers 1,2 can be 
used as biocompatible, biodegradable, non-toxic, and non-
immunogenic biomaterials, that can additionally contain specific biofunctional 
domains such as cell attachment sites. These properties make protein 
polymers a promising class of polymers for a variety of medical 
applications 3-6. Several research groups, including ours, successfully 
demonstrated high-level expression of recombinant protein polymers 
composed of collagen-like 7-9, elastin-like 10,11 or silk-like 12,13 peptide blocks. 
Many of these protein polymers can self-assemble into supramolecular 
nanostructures that often are reversible and stimulus responsive 14-18. 
Although for protein polymers we have very good control over the 
primary sequence, it is still difficult to design sequences that will result in a 
given type of self-assembly. One way of engineering an additional level 
of control over supramolecular self-assembly is by the introduction, into the 
protein polymers, of blocks that can self-assemble with very high specificity 19. 
In Chapter 3, we have shown that by using heterodimerization of two 
complementary coiled coils we can bring together two protein polymers, 
which alone do not show ability to self-assemble. Whereas the coiled-coils 
used in that chapter were rather long, in this chapter we explore the use 
of much smaller, de novo designed coiled coils. This pair of coiled coils was 
developed by Litowski et al. in to be used as an expression tag/affinity 
purification system 20. According to Litowski et al, the heterodimeric couple 
can form fully folded coiled-coil with a high conformational stability, despite 
its small size (21 residues) 20. The peptide with the highest glutamic acid 
content (EIAALEK)3 will further be denoted as D
E, and the peptide with 
the highest lysine content (KIAALKE)3 as D
K. Similar to the dimer-
forming modules described in Chapter 3, the DE and  DK peptides were 
fused to previously developed protein polymers CP4, and T9-C
P
4, at the C-
terminus. The CP4 block is a highly hydrophilic random coil 
21 and T9 
stands for the collagen-inspired sequence (Pro-Gly-Pro)9 
8 that forms trimers 
at low temperatures and high concentrations, such that the T9-C
P
4-D
E/T9-
CP4-D
K couple is expected to form networks upon mixing. 
In this chapter, we describe the high-yield secretory production of the 
protein polymers in Pichia pastoris and their characterization. The protein 
polymers CP4-D
E and T9-C
P
4-D
E were produced intact and recovered from 
the cell-free broth in g L-1 quantities. However, we found that the CP4-D
K and 
T9-C
P
4-D
K protein polymers were partially degraded. Neither the 
fermentation  with a yapsin 1  protease disruptant nor the fermentation  at 
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pH 5 resulted the intact product, but we were able to demonstrate that cation 
exchange chromatography can be used to purify intact CP4-D
K, and to estimate 
the fraction of intact CP4-D
K diblocks. Next, we study the rheology of the 
(partially degraded) protein polymers, both the T9-C
P
4-D
E and T9-C
P
4-D
K 
triblocks separately, and mixtures of the two. We find that T9-C
P
4-D
E forms 
thermosensitive hydrogels, apparently via homotypic interactions of the 
DE modules. At the same concentrations, T9-C
P
4-D
K shows a 
thermosensitive increase in viscosity, but does not gel, indicating the 
presence of homotypic association of the DK, but not as strong as in the case 
of the DE modules. Mixed systems T9-C
P
4-D
E/T9-C
P
4-D
K form hydrogels 
similarly as the T9-C
P
4-D
E system, indicating that both the heterotypic and 
homotypic associations may be involved in the hydrogel formation. 
Although the intent of this work was to control self-assembly via 
heterodimerization, the DE modules might thus still be an interesting 
homooligomer-forming module for the construction of self-assembling 
systems. 
4.2. Materials and Methods 
4.2.1. Construction of expression vectors and strains 
The coiled coils used here are short peptides with common amino acid 
sequence (XIAALXY)3 
20. The peptide (EIAALEKE)3 is here denoted as D
E; 
and the complementary peptide (KIAALKE)3 is denoted as D
K. For the amino 
acid sequences of DE and DK see Table 4.1. The double-stranded gene 
fragments encoding the coiled coils were assembled via overlap extension 
PCR 22 from the oligonucleotides shown in Table 4.2. The gene fragments were 
digested with XhoI/EcoRI and cloned into XhoI/EcoRI-digested vector 
pMTL23ΔBsaI 23, in order to obtain two vectors pMTL23ΔBsaI-DE and 
pMTL23ΔBsaI-DK. The vector pMTL23-CP4 contains the sequence coding for 
CP4 
21. The vector pMTL23-T9-C
P
4, encodes, at the N-terminal side of C
P
4, an 
additional T9 sequence 
8. The vectors were opened at the 3’ end of the CP4 or 
T9-C
P
4 gene with EcoRI/Van91I. The newly prepared constructs 
pMTL23ΔBsaI-DE and pMTL23ΔBsaI-DK were digested with EcoRI/DraIII to 
release inserts DE and DK. The inserts were ligated to the opened vectors, 
resulting in pMTL23-CP4-D
E, pMTL23-T9-C
P
4-D
E, pMTL23-CP4-D
K and 
pMTL23-T9-C
P
4-D
K. All four inserts were then released with XhoI/EcoRI and 
cloned into the likewise-digested Pichia pastoris expression vector pPIC9 
(ThermoFisher, Bleiswijk, The Netherlands). This resulted in the construction 
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of the vectors: pPIC9-CP4-D
E, pPIC9-T9-C
P
4-D
E, pPIC9-CP4-D
K and pPIC9-
T9-C
P
4-D
K, respectively. 
The vectors were linearized with SalI to target for integration at the his4 locus. 
Transformation of P. pastoris GS115 by electroporation and selection of Mut+ 
transformants were performed as described previously 24. Vector pPIC9-T9-
CP4-D
K was also used for transformation of the yps1 single-gene disruptant 
strain 25. 
Table 4.1: Amino acid sequences of DE and DK. In our design, both sequences end C-terminally in 
the cloning-derived amino acid sequence PAGG (not indicated), which also prevents removal of the 
C-terminal lysine residues of the DE module by the P. pastoris Kex1 carboxypeptidase. 
Dimer-forming module Amino acid sequence 
D
E
 = IAAL E3 EIAALEKEIAALEKEIAALEK
D
K
 = IAAL K3 KIAALKEKIAALKEKIAALKE
Table 4.2: Oligonucleotides used in gene construction  
Insert 
Oligonucleotide 
Name 
Oligonucleotide sequences 
D
E
 
E-FW 
5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTGAAAT
TGCTGCCTTGGAAAAGGAGATCGCAG-3’
E-RV 
5’GTACGAATTCTATTAGCCACCGGCTGGCTTCTCAAGAGCGGCAATTT
CTTTCTCCAAAGCTGCGATCTCCTTTTCCAAG-3’
D
K
 
K-FW 
5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTAAGAT
CGCCGCCTTGAAGGAAAAGATTGCAGCTCT-3’
K-RV 
5’GTACGAATTCTATTAGCCACCGGCTGGTTCTTTCAAAGCAGCAATTT
TCTCTTTAAGAGCTGCAATCTTTTCCTTC-3’
4.2.2. Fermentation 
The fermentation setup consisted of a 2.5-L Bioflo 3000 stirred-tank bioreactor 
(New Brunswick Scientific, Nijmegen, The Netherlands) interfaced with 
BioCommand Software (New Brunswick Scientific, Nijmegen, The 
Netherlands) and a homebuilt methanol sensor controller. The fermentations 
were performed as described previously 8, as follows. A starting volume of 1.25 
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L minimal basal salts medium 26 was used. Growth temperature was 30 °C. The 
pH was controlled at 3.0, except the one fermentation, where the pH was 
maintained at 5.0. The air was supplemented with 20% (v/v) oxygen during the 
glycerol fed-batch phase and the methanol fed-batch phase. During the latter 
protein production phase, lasting two days, methanol levels were kept at 0.2% 
(w/v). After harvesting, cells were removed from the broth by centrifugation for 
20 min. at 15,000 × g (RT), followed by microfiltration.  
4.2.3. Protein purification 
Purification of all protein polymers was done by ammonium sulfate 
precipitation essentially as described, which typically results in a purity of 
~99% at the protein level 8. Shortly, the pH of the cell-free broth was raised to 
8.0 by addition of sodium hydroxide to allow precipitation of medium salts. 
After centrifugation for 30 min. at 20,000 × g (RT), the protein was precipitated 
from the supernatant by addition of ammonium sulfate to 40% of saturation, 
followed by incubation on ice for 30 min and centrifugation for 30 min. at 
20,000 × g (4 °C). The protein pellet was resuspended in Milli-Q water and 
precipitated once more. The pellet was then resuspended in Milli-Q water, 
desalted by extensive dialysis against Milli-Q water, and finally lyophilized. 
The proteins purified in this manner were used for rheology and Isothermal 
Titration Calorimetry. 
4.2.4. SDS-PAGE 
SDS-PAGE was performed using the NuPAGE Novex System (ThermoFisher, 
Bleiswijk, The Netherlands) with 10% Bis-Tris gels, MES SDS running buffer, 
and SeeBlue Plus2 prestained molecular mass markers. Prior to electrophoresis, 
all samples were heated for 10 min. at 70 °C in NuPAGE LDS Sample Buffer 
with NuPAGE Sample Reducing Agent, as per manufacturer's 
recommendations for denaturing and reducing PAGE. Gels were stained using 
Coomassie SimplyBlue SafeStain (ThermoFisher, Bleiswijk, The Netherlands). 
4.2.5. Mass spectrometry 
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry was performed using an ultrafleXtreme mass spectrometer 
(Bruker, Leiderdorp, The Netherlands). Proteins were desalted using Micro 
Bio-Spin P-6 columns (Bio-Rad, Veenendaal, The Netherlands), and samples 
were prepared by the dried droplet method on a 600 μm AnchorChip target 
(Bruker, Leiderdorp, The Netherlands), using 5 mg mL-1 2,5- 
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dihydroxyacetophenone, 1.5 mg mL-1 diammonium hydrogen citrate, 
25% (v/v) ethanol and 3% (v/v) trifluoroacetic acid as matrix. Spectra were 
derived from ten 500-shot (1,000 Hz) acquisitions taken at non-overlapping 
locations across the sample. Measurements were made in the positive linear 
mode, with ion source 1, 25.0 kV; ion source 2, 23.3 kV; lens, 6.5 kV; pulsed 
ion extraction, 680 ns. Protein Calibration Standard II (Bruker, Leiderdorp, The 
Netherlands) was used for external calibration. 
4.2.6. Cation-exchange chromatography 
Both lyophilized proteins CP4-D
K and T9-C
P
4-D
K were dissolved in 20 mM 
sodium citrate buffer (pH 4) to concentration of 1g L-1 and incubated overnight 
at RT to allow proper dissolution. After incubation, both samples were 
centrifuged at 12 000 g for 20 min at RT and finally filtered through 0.45 μm 
pore Minisart-Plus filters (Sigma-Aldrich, Zwijndrecht, The Netherlands). 
Samples were injected in a volume of 1 mL on an ENrich S High-Resolution 
Ion Exchange Chromatography Column (Bio-Rad Laboratories, Veenendaal, 
The Netherlands) for separation by cation exchange. The column was 
connected to a Biologic DuoFlow Chromatography system (Bio-Rad 
Laboratories, Veenendaal, The Netherlands). Prior to injection, the column was 
equilibrated with the 20 mM sodium citrate buffer at pH 4 (Buffer A), at a flow 
rate of 1 mL min-1. After injection, the column was washed with 3 ml (3 
bed volumes) of Buffer A in order to remove unbound proteins. The 
elution was performed at RT. Proteins were eluted from the column with a 
linear gradient from 0 to 2 M NaCl over 30 ml (30 bed volumes) and then an 
isocratic gradient at 2 M over 1.5 ml (1.5 bed volumes). 1-ml fractions were 
collected throughout the linear gradient. The eluate was monitored at 214 
nm. Fractions eluting between 230 mM and 600 mM NaCl were analysed by 
SDS-PAGE. The same fractions were desalted on Micro Bio-Spin P6 
column (Bio-Rad, Veenendaal, The Netherlands) and analysed by MALDI-
TOF. 
4.2.7. Dynamic light scattering (DLS)-based microrheology 
Dynamic light scattering (DLS)-based microrheology was performed using a 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) equipped with a 4 mW 
HeNe laser beam with a wavelength of 633 nm, at a scattering angle of 
173°. Carboxyl latex microspheres (kindly provided by dr Joris Sprakel) 
with a diameter of 112 nm were used as tracer particles 27. Prior to use, the 
particles were diluted to a final weight to volume fraction of 0.1% and 
vortexed. Similar latex microspheres had been used for micro-rheology on 
T9-C4-T9 hydrogels, 
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and showed no undesired interactions with the protein 28. The lyophilized 
protein polymers T9-C
P
4-D
E and T9-C
P
4-D
K, purified by ammonium sulfate 
precipitation, were dissolved in 10 mM sodium phosphate buffer (pH 7), 
vortexed and incubated overnight at RT. The concentration of both solutions 
was 80 g L-1. T9-C
P
4-D
E and T9-C
P
4-D
K solutions were mixed in a 1:1 ratio 
and 10 mM sodium phosphate buffer (pH 7) was added to adjust concentration. 
Two samples were measured, where the final molar concentration of each 
triblock was 20 g L-1 or 40 g L-1 (note that total protein concentration was twice 
higher). As controls for homodimerization we tested these triblocks alone at 
concentrations 40 g L-1 and 80 g L-1. Prior to the measurement, all samples 
were incubated at 50 °C for at least 20 min to prevent the triple helix formation 
by the T9 block. The tracer particles were then introduced at a final weight-to-
volume fraction of 0.05%, and mixed with the protein solutions by vortexing. 
The samples with tracer particles were then introduced into a capped cuvette 
(Malvern Instruments, Malvern, UK) and incubated for 5 min. at 50 °C. The 
temperature was decreased step-wise from 50 °C with steps of 5 °C until it 
reached 10 °C. At each step, 40 measurements were performed, 120 sec each. 
The Dispersion Technology Software (Malvern Instruments, Malvern, UK) was 
used to calculate the z-averaged diffusion constant D of the tracer particles. The 
relative viscosity (η/η0) (where η0 is the viscosity of the aqueous solvent, and η 
is the viscosity of the polymer solution) was taken to be equal to the ratio D0/D, 
where D0 is the z-averaged diffusion constant of the tracer particles in aqueous 
solvent, and D is the z-averaged diffusion constant of the particles in the 
polymer matrix 
4.2.8. Rheology 
Freeze-dried proteins purified by AS precipitation were first dissolved in 10 
mM sodium phosphate buffer, then vortexed and incubated overnight at RT to 
allow proper dissolution. T9-C
P
4-D
E and T9-C
P
4-D
K solutions were mixed in a 
1:1 ratio. Two samples were prepared at concentration 80 g L-1 and 160 g L-1. 
As controls for homodimerization we tested these triblocks alone at 
concentrations 80 g L-1. Prior to the measurement all samples were heated at 50 
°C for at least 20 min to allow any triple helices in the sample to melt 
completely. Rheological measurements were done with an Anton Paar MCR 
501 rheometer equipped with C10/TI Couette geometry, with bob and cup 
diameter of 9.991 and 10.840 mm, respectively. The temperature was 
controlled by a Peltier system, which allows quick heating and cooling. A 
solvent trap containing oil was used to minimize evaporation. The couette was 
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preheated (50 °C) before adding sample solutions. After inserting the bob into 
the cup, the temperature was lowered to 20 °C. The gel formation was 
monitored by applying a sinusoidal deformation to the hydrogel (frequency 
1 Hz and amplitude 1%). 
4.3. Results and discussion 
4.2.1. Protein production and characterisation 
The basepair sequences encoding the aminoacid sequence of the coiled coils 
were introduced at the 3’ end of the genes encoding either CP4 protein 
polymer 21 or T9-C
P
4 protein polymer. The protein polymers C
P
4-D
E, CP4-D
K, 
T9-C
P
4-D
E and T9-C
P
4-D
K were secreted by P. pastoris into the fermentation 
medium upon induction with methanol. Proteins were purified from the cell-
free medium by differential ammonium sulfate precipitation, and subsequently 
dialyzed and lyophilized. As previously reported for the protein polymers 
containing CP4 block, this purification technique typically results in a purity of 
~99% at the protein level 21. The gravimetrically determined yields, expressed 
in grams of purified protein per litre of cell-free broth, are listed in Table 4.3. 
The yields obtained for all protein polymers are in the same g L-1 range as for 
CP4 
21. In order to assess the product identity, lyophilized samples were 
characterized by SDS-PAGE and MALDI-TOF. The theoretical molecular 
weights for the protein polymers were calculated based on their amino acid 
content and are listed in Table 4.3. 
Table 4.3: Molecular weights (Da) of predesigned protein polymers estimated based on their 
amino acids composition. 
Protein polymer code Yield (g L
-1
)*
Theoretical 
molecular weight 
(Da) 
Molecular weight determined by 
MALDI-TOF (Da) 
C
P
4
-D
E
 2.3 39373 39379 
T
9
-C
P
4
-D
E
 1.6 41834 41833 
C
P
4
-D
K
 2.5 39370 39372** 
T
9
-C
P
4
-D
K
 2 41831 41845** 
* The gravimetrically determined yield is expressed as g of lyophilized product per L of cell-free
broth 
**The product additionally contained degraded species 
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For the protein polymers with a DE module, two bands were detected with an 
apparent molecular weight in SDS-PAGE of ~120 kDa and ~188 kDa (Fig. 4.1, 
lanes 1 and 2). In both cases, the upper bands were barely visible. The SDS-
PAGE of both DK variants showed a clear band of ~98 kDa and three less 
visible upper bands (Fig 4.1, lanes 3 and 4). The occurrence of more than one 
band in SDS-PAGE suggests that the products may be partly degraded, and this 
seems most pronounced for protein polymers containing the DK module. 
Figure 4.1: SDS-PAGE of purified protein polymers (12 µg). Lane 1, T9-CP 4-DE; lane 2, CP 4-DE; 
lane 3, T9-CP 4-DK; lane 4, CP 4-DK; lane M, protein molecular weight marker  
It is well known that CP4 shows aberrant migration behavior in SDS-
PAGE 8,10,21,23,29. The CP4
 block is highly hydrophilic, and therefore its capacity 
to bind SDS is very low, as has been described before 21. According to our 
previous findings, the attachment of peptides that improve SDS binding 
increased the mobility of C2– or C4–containing polymers 
29,30. Because the 
upper bands in Fig. 4.1 migrate at similar positions as CP4 and T9-C
P
4-T9 
8,21, 
and because the lower bands show increased mobility, the lower bands most 
probably correspond to the intact protein polymers, whereas the upper bands 
likely represent proteins that lack parts of the coiled coils sequences. The 
difference in the mobility between DE and DK variants is certainly related to the 
amino acid composition and the net charge of both modules. The DK module is 
positively charged and probably attracts more anionic SDS molecules than DE 
in accordance with earlier findings on the effect of protein charge on SDS 
binding 31. 
The molecular weight distribution was further investigated by MALDI-TOF. 
For all analyzed protein polymers, the molecular mass corresponding to main 
peaks matched the theoretical mass within experimental error, as shown in 
Table 4.3. For both CP4-D
E and T9-C
P
4-D
E proteins, only one peak was 
detected in the MALDI-TOF spectrum (Fig 4.2), which corresponds well to the 
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expected molecular mass. Because the upper bands in SDS-PAGE are barely 
visible, the degree of degradation or contamination is probably too low for 
detection in MALDI-TOF. We did not further investigate the nature of the 
upper bands at this point and assumed the proteins were sufficiently intact and 
pure for initial tests. The MALDI-TOF spectra of CP4-D
E and T9-C
P
4-D
E 
showed a small shoulder to the right of the main peak. As previously discussed, 
such species with slightly higher mass frequently occur in P. pastoris and 
originate from incomplete removal of the Glu-Ala spacer located between the 
α-factor prepro leader and the protein of interest 24. 
Figure 4.2: MALDI-TOF of purified protein polymers. (A) CP 4-DE, (B) T9-CP 4-DE. 
In contrast, the MALDI-TOF spectrum for both CP4-D
K and T9-C
P
4-D
K 
contained three minor peaks corresponding to a lower molecular mass than the 
main peak (Fig 4.3 A and B). This MALDI-TOF analysis confirms the 
observations from SDS-PAGE that the CP4-D
K and T9-C
P
4-D
K samples 
probably constitute a mix of the intact protein and several degraded species 
from which different fragments of the DK block are missing. 
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Figure 4.3: MALDI-TOF of purified protein polymers. (A) CP 4-DK, (B) T9-CP 4-DK. 
4.3.2. Attempts to minimize proteolytic degradation of T9-C
P
4-D
K 
MALDI-TOF of T9-C
P
4-D
K showed a similar spectrum, yet shifted towards 
higher mass, as CP4-D
K. This suggests that both protein polymers undergo the 
same degradation of the DK module. Most probably the amino acid sequence 
of the DK module is digested in several places by endoproteases. For T9-C
P
4-
DK, we made the two following attempts to remedy the observed 
protein degradation: (i) fermentation was performed at pH 5 instead of pH 
3 32, and (ii) the yapsin 1 deficient strain yps1 25 was used instead of the 
wild-type GS115 strain, under otherwise unchanged standard fermentation 
conditions. First, we tested the change of pH, since pH is often an 
important factor influencing proteolysis 24,33,34. The protein yield of ~1.9 
g L-1, obtained at pH 5, was comparable to that obtained in the 
fermentation at pH 3. SDS-PAGE again showed a few bands and the 
top band was even more present than at pH 3 (Fig 4.4, lane 1). 
Accordingly, MALDI-TOF showed several peaks corresponding to intact 
and degraded T9-CP4-DK, but this time the intensity of the main peak 
relative to that of the other peaks decreased (Fig 4.4B). 
Apparently, degradation of the protein only increased by changing the 
pH to 5. Yapsin 1 (Yps1) is a well-characterized protease found at the 
plasma membrane, the extracellular medium and in the late secretory 
pathway 35. The involvement of Yps1 in the degradation of secreted 
heterologous proteins in yeast  has been previously reported 35, and was 
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involved in the degradation of protein polymers produced in P. pastoris 36. 
The protease specifically cleaves C-terminal to Lys or Arg residues, 
although little is known about its exact sequence specificity. Because two of 
the three peaks corresponding to degraded fragments in the mass spectrum 
of T9-C
P
4-D
K seemed to precisely match cleavage after Lys residues 
present in the DK module (not shown), yapsin 1 may well be involved in the 
observed degradation. To test this, we performed a fermentation with a yapsin 
1 deficient strain (yps1) previously constructed in our laboratory 25. This 
fermentation resulted in a yield of ~2.3 g L-1. A similar yield was obtained 
for the strain GS115. Unfortunately, SDS-PAGE again showed several 
bands (Fig 4.4, lane 2). Similarly, MALDI-TOF revealed peaks with the exact 
same masses as in the wild type (not shown), although the peaks 
corresponding to the degraded species were perhaps less intense than before 
(Fig 4.4C). Apparently, other yapsins, or completely different proteases, are 
(also) involved in the degradation of the DK module. 
Figure 4.4: Analysis of purified T9-CP 4-DK protein polymers. (A) SDS-PAGE of protein polymer 
(12 µg): lane 1, protein produced in Δyps strain and lane 2, produced at pH 5. MALDI-TOF of 
protein polymer (A) produced in Δyps strain and (B) produced at pH 5 
4.3.3. Cation exchange chromatography 
For many medical applications monodispersity of protein-based materials is 
crucial 37. Unfortunately the steps that we undertook in order to remedy the 
observed degradation of T9-C
P
4-D
K were unsuccessful, and most probably a 
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similar outcome could be expected for CP4-D
K. Although optimizing culture 
conditions can sometimes solve proteolysis problems 38, there is no guarantee 
that this would be effective in this particular case, and further tests could be 
very time consuming. With a view for future use of protein polymers 
containing the DK module, we therefore tested whether cation-exchange 
chromatography can be used for the removal of degraded species from both 
CP4-D
K and T9-C
P
4-D
K. This will furthermore allow us to estimate the fraction 
of intact material. The DK module has a positive net charge at pH 4 and 
therefore, the intact protein containing the full length DK module will probably 
bind better to the column than degraded molecules without DK module. The 
latter will elute first. The lyophilized protein polymers were dissolved, filtered 
and then subjected to column chromatography. The chromatogram showed 
several peaks for both CP4-D
K and T9-C
P
4-D
K (Fig 4.5). 
Figure 4.5: Typical chromatograms for CP4-DK and T9-CP4-DK. (A) CP 4-DK and (B) T9-CP 4-DK. 
The upper dots indicate collected fractions, the numbers in red indicate the fractions analyzed by 
SDS-PAGE, and the red upper dots indicate fractions analyzed by MALDI-TOF. The star indicates 
the fractions containing the intact protein polymer. 
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The last peaks (indicated by a star) probably correspond to intact protein, since 
it binds to the column the strongest and should be retained on the column until 
the salt concentration will be sufficiently high to allow elution. The peaks 
detected at early stage of elution represent the degraded species. The more the 
DK module is degraded, the fewer positive charges it will contain, and the less 
it will bind to the column. Hence, the first peak will probably correspond to the 
peptide with the most truncated version of DK module. 
The eluted fractions corresponding to the various peaks were analysed by SDS-
PAGE (Fig 4.6A). Elution fraction 8 of CP4-D
K showed only one protein band 
in SDS-PAGE, migrating to the position of the ~188 kDa marker band. From 
fraction 9 to fraction 14, more bands were present, and the intensity of the band 
at ~ 98 kDa was gradually increasing while the upper bands were less and less 
visible in each subsequent fraction. In fractions 15 to 18, only one band was 
observed at ~ 98 kDa. The fraction 8, 15 and 17 were analysed with MALDI-
TOF (Fig 4.7A). For both fractions 15 and 17, MALDI-TOF showed a major 
peak at m/z 39,382, which is in good agreement with the expected molecular 
weight of intact CP4-D
K. In fraction 8 the major peak was detected at m/z 
36,970 indicating degraded form of CP4-D
K. 
Figure 4.6: SDS-PAGE of the fractions (A) CP4-DK and (B) T9-CP 4-DK pulled from cation-
exchange chromatography. The lines 9-18 correspond respectively to the fraction number, line C is 
a bulk sample as control and line M is a protein molecular weight maker. The red numbers indicate 
fractions chosen for MALDI-TOF analysis. 
From the SDS-PAGE of T9-C
P
4-D
K, we can conclude that this separation 
apparently did not proceed as efficiently as in case of the diblock (Fig 4.6B). 
The SDS-PAGE for fraction 9 showed two bands at the level corresponding to 
the marker bands of ~188 kDa and ~98 kDa, and in the fractions from 10 to 17 
multiple bands with intermediate migration behaviour were present. Again, the 
intensity of the band at ~ 98 kDa was increasing whereas the upper bands were 
less visible in each subsequent fraction, but over a much wider elution range 
than in the case of CP4-D
K. In fractions 18 and 19, only one band was observed 
at ~ 98 kDa. The fractions 9, 14 and 18 were analysed with MALDI-TOF 
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(Fig 4.7B). In the fraction 9, MALDI-TOF showed a major peak at m/z 39,440 
and several minor peaks on both sides of the major peak. All these peaks 
corresponded to molecular masses lower than that of intact T9-C
P
4-D
K, and 
thus probably represented degraded forms of T9-C
P
4-D
K. A major peak 
corresponding to the molecular mass of the intact triblock polymer was 
detected in fraction 14 and 18. Fraction 14, however, showed three additional 
peaks to the left of the major peak, which indicates that the intact product is 
contaminated with molecules of lower mass, probably degraded T9-C
P
4-D
K 
species. 
By analysis of chromatograms, we attempted to estimate the amounts of the 
intact and degraded protein in the original sample. The fraction of the intact 
protein was taken to be the ratio of the area under the last peak divided by the 
total area under all peaks. The fractions of the degraded species were derived 
accordingly. For CP4-D
K, the fully intact form of protein polymer constituted 
43% of the total sample. The T9-C
P
4-D
K protein polymer could not be properly 
separated using SEC, therefore we could not obtain correct distribution for the 
intact and degraded species. Referring to MALDI-TOF spectrum, the fraction 
14 contained both intact and degraded species (Fig 4.7B). 
Figure 4.7: MALDI-TOF of selected HPLC elution fractions of (A) CP 4-DK and (B) T9-CP 4-DK. 
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Most likely, the chromatography of T9-C
P
4-D
K is influenced by the presence of 
the T9 block. This module can form trimeric (T9)3 intermolecular cross-links, 
and therefore the separation of T9-C
P
4-D
K is probably not as straightforward as 
that of CP4-D
K. It is likely that part of the intact T9-C
P
4-D
K molecules elutes 
too early, viz. when they are incorporated in mixed trimers consisting of both 
intact and degraded molecules. 
The SDS-PAGE and MALDI-TOF analysis indicates that the formation of 
triple helixes by T9 may indeed interfere with the process of separation, 
whereas the present cation exchange chromatography procedure is a suitable 
method to separate intact CP4-D
K from degraded or contaminating molecules. 
The purification process for T9-C
P
4-D
K needs to be optimized by preventing 
T9 self-assembly, for instance by adding urea to the application and elution 
buffers, 39 or by working at elevated temperature (e.g. 50 °C) 36. Additional 
concern is the contamination of the samples with the unattached fragments of 
the DK module. Although the chances are low, we cannot rule out the 
possibility that the cleaved forms of the DK module might co-purify in AS 
precipitation with the intact and partly intact molecules and be present in the 
bulk sample. Such small peptides are not in the detection range of SDS-PAGE 
and MALDI-TOF used here, therefore analysis in this mass range (~2 kDa) 
should be performed. 
4.3.4. Analysis of hydrogel formation 
To test the functionality of the heterodimer-forming modules incorporated into 
protein-based polymers, we used Dynamic Light Scattering-based (DLS-based) 
microrheology to study gel formation in 1:1 mixtures of T9-C
P
4-D
E and T9-
CP4-D
K at concentrations of 40 g L-1 and 80 g L-1. DLS was used to track the 
diffusion of small amounts of latex tracer particles (diameter 112 nm) added to 
the protein solutions. The relative viscosity (η/η0) of the protein polymer 
solutions was taken to be equal to the ratio D0/D of (z-averaged) diffusion 
constants, where D0 is the diffusion constant of the tracer particles in the 
aqueous solvent and D is the diffusion constant of the tracer particles in the 
protein polymer solutions.  
Relative viscosities were measured as a function of temperature, and results are 
shown in Fig 4.8. For both 1:1 mixtures and pure components  T9-C
P
4-D
E and 
T9-C
P
4-D
K,  no gelation was observed at a total protein polymer concentration 
of 40 g L-1. A small but noticeable increase in viscosity at low temperatures 
was found for the 1:1 mixtures. At a concentration of 80 g L-1, both the 1:1 
mixed system and the T9-C
P
4-D
E system formed a hydrogel at temperatures 
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below 35 °C, whereas the T9-C
P
4-D
K system only showed an increase 
in viscosity below 35 °C. 
Figure 4.8: Relative viscosity (η/η0) versus temperature (˚C) measured for protein solutions (A) 
1:1 mixture of T9-CP4-DE and T9-CP 4-DK, (B) T9-CP 4-DE or (C) T9-CP4-DK. The relative viscosity 
(η/η0) of the protein solutions versus temperature. The blue triangles represent the solutions at 
total protein concentration 40 g L-1 and the red triangles at concentration 80 g L-1. 
The formation of collagen-like triple helices (trimers) by the T9 block is 
dependent on both temperature and concentration 40. For example, a previously-
studied polymer, T9-C
P
4-T9, forms hydrogels with a clearly apparent stiffness 
only at concentrations higher than 40 g L-1 (~1 mM) and temperatures lower 
than 30 °C 40. Since T9-C
P
4-T9 contains two T9 blocks, 1:1 mixture of T9-C
P
4-
DE and T9-C
P
4-D
K must contain at least 2 mM of T9 blocks, equivalent to a 
total protein polymer concentration of 80 g L-1, in order for the mixture to form 
a network through the association of both the T9 blocks and the D
E/DK 
heterodimers, and this is also what we observe. If the DE and the DK modules 
would only form heterodimers, the hydrogels should not be formed in the 
control samples of pure components at 80 g L-1, but only in the 1:1 mixtures of 
T9-C
P
4-D
E and T9-C
P
4-D
K. However, gelation occurred both for the 1:1 mixed 
system, and for the T9-C
P
4-D
E system, suggesting that for this case, there must 
also be strong homotypic DE/DE associations. Likewise, the strong increase in 
the viscosity of the 80 g L-1 T9-C
P
4-D
K system points to homotypic DK/DK 
associations. 
Next, shear moduli were determined using oscillatory shear measurements. 
Protein polymers were dissolved in 10 mM sodium phosphate buffer (pH 7) 
and mixed in a 1:1 ratio at total protein concentrations 160 g L-1 (~4 mM). Prior 
to the measurement, the sample was heated at 50 °C for 20 min. and then 
introduced into the preheated geometry. The system was subsequently 
quenched to 20 °C. The process of gelation was followed in time by online 
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measurement of the storage (G′) modulus at 1 Hz at a strain of 0.1%. This 
measurement was performed at constant temperature (20 °C) for 3.5 h (Fig 
4.8A). Subsequently, the temperature was increased by 10 °C every 3.5, up to 
50 °C (Fig 4.9B). At 20 °C, the mixture formed a gel with a storage modulus of 
905 Pa after 3.5h. An increase of temperature resulted in a decrease of storage 
modulus and at 40 °C, the storage modulus was zero. Hence, the mixed gels 
show a temperature dependence that is very similar to that of the gels of the T9-
CP4-T9 triblocks 
40. 
Figure 4.9: Storage modulus (G’) of 160 g L-1 gels made of a 1:1 mixture of T9-CP4-DE and T9-
CP 4-DK. (A) Time resolved gel formation at 20 °C; (B) temperature dependence. 
Further, we investigated gel formation of the 1:1 T9-C
P
4-D
E/T9-C
P
4-D
K 
mixture at a lower concentration of 80 g L-1. This time we also tested T9-C
P
4-
DE alone and T9-C
P
4-D
K alone at a concentration of 80 g L-1. The sample pre-
treatment and measurement settings were the same as for the 1:1 mixed system 
at 160 g L-1. The increase of the modulus was monitored for 5 h at a constant 
temperature (20 °C). After 5 h of measurement, the T9-C
P
4-D
K system had not 
gelled, whereas the T9-C
P
4-D
E sample and the T9-C
P
4-D
E/T9-C
P
4-D
K mixture 
reached storage moduli of 104 Pa and 55 Pa, respectively (Fig 4.10). The 
higher value found for T9-C
P
4-D
E, as compared to the T9-C
P
4-D
E/T9-C
P
4-D
K 
mixture, might indicate that only the formation of DE homodimers contributes 
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to gel formation in both samples. Hence, results for the mixed system do not 
yet indicate that there is an interaction between DE and DK. However, our 
results do show that fully intact DE itself is an interesting module to be studied 
for self-assembling systems. Furthermore, it should also be taken into account 
that for the T9-C
P
4-D
K protein polymers, a certain fraction (which we did not 
manage to quantify here) has completely or partly truncated DK modules. This 
means that the sample has lower concentration of potentially gel-forming 
molecules and it also might contain the free DK fragments capable of binding to 
the remaining intact molecules. This causes a seemingly (i.e. apparent or 
falsely) low tendency of the polymers to take part in the bond formation. 
Therefore, a more definitive test for the heterodimeric association of the DK and 
DE modules, will need to be done with 100% intact T9-C
P
4-D
K protein 
polymers. 
Figure 4.10 Time course of increase in storage G’ modulus for 80 g L-1 gels made of T9-CP 4-DE 
(black),  T9-CP4-DK (red), and a 1:1 mixture of T9-CP4-DE and T9-CP4-DK (blue). 
4.3.5. Detection of heterodimeric association of DE and DK modules 
A first attempt at directly measuring the heterodimeric association of the DE 
and DK  modules in the context of protein polymers was done using isothermal 
titration calorimetry. A concentrated stock solution of CP4-D
K of 2.9 mM 
was used as the titrant. Ligand aliquots of 4 µl were titrated into 1.4 ml of 
0.2 mM solution of CP4-D
E protein solution inside the calorimeter cell under 
continuous stirring. Unfortunately, for these conditions, we found only a 
very small exothermic signal, with a preliminary analysis of the data giving 
a very high value for the resulting dissociation constant (Kd on the order of 
mM). From the work of Litowski et al 20, the dissociation constant of the 
free peptide pair should be very much lower (Kd value around 70 nM). 
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There may be a number of reasons why no strong exothermic signal was found 
in these preliminary ITC measurements, foremost of which the dissociation of 
homomultimers occurring in parallel to the association of heterodimers might 
cause the net heat effect to be muted. 
4.4. Concluding remarks 
We have shown that polymers containing the DE and the DK coiled coils can be 
efficiently produced in Pichia pastoris. The protein polymers containing the DK 
coiled coil were partly degraded. This degradation could not be resolved by 
performing the fermentation at pH 5, or by using a yapsin 1 protease disruptant. 
Using cation exchange chromatography, we did separate the intact CP4-D
K 
protein polymer from the degraded protein polymers and we estimated its 
content in the bulk sample. Although homomerization has not been previously 
reported for the free DE and DK peptides at  pH 7, our rheology data indicate 
strong homotypic associations, especially for DE, when fused to T9-C
P
4. Note 
that homotrimer-formation has been reported previously for the DE module, 
however only at pH 5 (and at low concentrations) 41.  
Here we have not yet been able to demonstrate the direct interaction of the DE 
and the DK modules in the context of larger protein polymers. This may be in 
part due to competition by the strong homotypic associations that we have 
found, and in part by the fact that the protein polymers with the DK modules 
were partly degraded.  
Possibly the DE module (produced fully intact in P. pastoris) might be 
developed into a homomultimer-forming block for self-assembling protein 
polymers. In past, several interesting protein-based architectures have been 
developed using homotypic interaction between coiled coils. The Tirrell group 
reported on the hydrogel with the tunable erosion rate that was formed by 
aggregation of coiled coils 42. A very interesting example of the use of 
homodimeric coiled-coils is the provided by the self-assembling coiled-coil 
tetrahedrons described by group of Jerala 43. Therefore, a further analysis of the 
T9-C
P
4-D
E and CP4-D
E protein polymers is certainly interesting, and may 
reveal new and useful features of the DE modules, when used as a self-assembly 
domain in the context of larger protein polymer constructs. 
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Production in Pichia pastoris of 
complementary protein-based polymers 
with heterodimer-forming WW and PPxY 
domain 
Abstract 
Specific coupling of de novo designed recombinant protein polymers for the 
construction of precisely structured nanomaterials is of interest for 
applications in biomedicine, pharmaceutics and diagnostics. An attractive 
coupling strategy is to incorporate specifically interacting peptides into the 
genetic design of the protein polymers. An example of such interaction is the 
binding of particular proline-rich ligands by so-called WW-domains. In this 
study, we investigated whether these domains can be produced in the yeast 
Pichia pastoris as part of otherwise non-interacting protein polymers, and 
whether they bring about polymer coupling upon mixing. We constructed two 
variants of a highly hydrophilic protein-based polymer that differ only in their 
C-terminal extensions. One carries a C-terminal WW domain, and the other a 
C-terminal proline-rich ligand (PPxY). Both polymers were produced in P. 
pastoris with a purified protein yield of more than 2 g L-1 of cell-free broth. 
The proline-rich module was found to be O-glycosylated, and uncommonly a 
large portion of the attached oligosaccharides was phosphorylated. 
Glycosylation was overcome by introducing a Ser  Ala mutation in the 
PPxY peptide. Tryptophan fluorescence monitored during titration of the 
polymer containing the WW domain with either the glycosylated or 
nonglycosylated PPxY-containing polymer revealed binding. The 
complementary polymers associated with a Kd of ~3 µM, regardless of 
glycosylation state of the PPxY domain. Binding was confirmed by isothermal 
titration calorimetry, with a Kd of ~9 µM. This chapter presents a blueprint for 
the production in P. pastoris of protein polymers that can be coupled using the 
noncovalent interaction between WW domains and proline-rich ligands. The 
availability of this highly specific coupling tool will hereafter allow us to 
construct various supramolecular structures and biomaterials. 
Published as: Domeradzka, N.E.; Werten, M.W.T.; de Vries, R. and de Wolf, 
F.A. Microb Cell Fact 2016, 15(1), 1. 
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5.1. Introduction 
Protein-based block copolymers (or protein polymers, for short) are de novo 
designed polypeptides that consist of different blocks, where each of the blocks 
adopts a specific conformation and fulfills a specific function 1. Self-
assembling protein polymers are being intensively explored for use as 
biomaterials for drug encapsulation, controlled drug release, tissue engineering, 
tissue augmentation, and biosensors 2-8. Protein polymers are produced via 
recombinant DNA technology, and thus, aside from possible problems with the 
biological production, in principle have a defined sequence, mass, and chemical 
composition. They are biodegradable, often biocompatible, and easy to 
functionalize by inclusion of bioactive sequences in the genetic design 1,7. 
In early work, the sequences of protein polymers were typically inspired by 
naturally occurring self-assembling structural proteins such as silk, elastin, 
collagen, and resilin, with inherent attractive properties as soft materials 9,10. 
The repertoire of useful motifs for self-assembly has been expanded over the 
years with sequences designed or modified using molecular modelling. Several 
self-assembling modules can be combined into a multifunctional polypeptide 
block copolymer that can spontaneously self-organize via non-covalent 
interactions into nanostructures such as micelles, fibrils, or hydrogels 11-13. 
However, peptide blocks that can facilitate the assembly of supramolecular 
structures with particularly high precision are still highly sought after in 
biomaterial science 14-16. 
Our group has successfully produced several protein polymers at high yield 
using the yeast Pichia pastoris 17-23. Many of these are block copolymers that 
self-organize into stimulus-responsive supramolecular structures. We currently 
aim to expand our library of functional protein blocks with modules that allow 
highly precise heterodimerization, in an effort to gain more control over the 
self-assembly of supramolecular structures. A pair of block copolymers fitted 
with complementary interacting modules could then self-assemble into higher 
order structures upon mere mixing of the two 24. Besides providing crosslinks 
in self-assembled structures, heterodimerizing modules can also be used for 
incorporation of functionalities such as growth factors, antimicrobial peptides, 
and cell-adhesive peptides 25. 
The so-called WW domain is found in various natural proteins and binds 
particular proline-rich peptides with a high degree of specificity 26. As its name 
suggests, the amino acid sequence of the WW domain contains two highly 
conserved tryptophans. The domain consists of a slightly bent three-stranded 
antiparallel β-sheet, the concave side of which forms a binding pocket for the 
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proline-rich ligand 27. Wong Po Foo et al. successfully used the interaction 
between two different WW domains (CC43 and Nedd4.3) and a so-called group 
I proline-rich peptide (PPxY) to generate two-component hydrogels 28. Here, 
we investigate the separate incorporation of this same PPxY peptide derived 
from p53-binding protein-2 29 and another WW domain (WWP1-1; one of three 
WW domains present in the human ubiquitin ligase homolog WWP1 29) at the 
C-terminus of the CP4 protein polymer previously developed by us 
18. The CP4  
polymer (formerly referred to as ‘P4’) consists of four identical copies of a 99 
amino acid long, highly hydrophilic random coil polypeptide 18. We report the 
high-yield secretory production of these polymers in Pichia pastoris and their 
characterization. Undesired O-glycosylation of the PPxY peptide was 
overcome, and the polymers interacted as intended. We have thus expanded our 
toolkit towards the creation of well-defined supramolecular topologies for new 
biomaterials. 
5.2. Materials and methods 
5.2.1. Construction of expression vectors and strains 
The double-stranded gene fragments encoding DWW and DPPxY were assembled 
via overlap extension PCR 50 from the oligonucleotides shown in Supplementary 
data 1: Table 5.1.S1. The gene fragments were digested with XhoI/EcoRI and 
cloned into XhoI/EcoRI-digested vector pMTL23ΔBsaI 51, in order to obtain 
two vectors pMTL23ΔBsaI-DWW and pMTL23ΔBsaI-DPPxY. The vector 
pMTL23-CP4 contains the sequence encoding C
P
4 (previously referred to as 
‘P4’) 18, and was opened at the 3’ end of the CP4 gene with Van91I/EcoRI. The 
newly prepared constructs pMTL23ΔBsaI-DWW and pMTL23ΔBsaI-DPPxY 
were digested with DraIII/EcoRI to release inserts DWW and DPPxY. The inserts 
were ligated into the opened pMTL23-CP4 vector, resulting in pMTL23-C
P
4-
DWW and pMTL23-CP4-D
PPxY. 
A Ser12  Ala mutant of the DPPxY module was prepared by annealing of a 
pair of largely complementary oligos (Supplementary data 1: Table 
5.1.S1), and is referred to as DPPxY*. 
This double-stranded adapter with DraIII/EcoRI overhangs was ligated into 
vector pMTL23-CP4 previously digested with Van91I/EcoRI (at the 3’ end of 
the CP4 gene), resulting in pMTL23ΔBsaI-CP4-DPPxY*. The CP4-DWW, CP4-
DPPxY, and CP4-D
PPxY* inserts were then released with XhoI/EcoRI and cloned 
into the likewise-digested Pichia pastoris expression vector pPIC9 
(ThermoFisher, Bleiswijk, The Netherlands). This resulted in the construction 
of the vectors: pPIC9-CP4-DWW,  pPIC9-CP4-DPPxY and  pPIC9-CP4-DPPxY*,
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respectively. The vectors were linearized with SalI to target for integration 
at the his4 locus. Transformation of P. pastoris GS115 by 
electroporation and selection of Mut+ transformants were performed as 
described previously 17  
5.2.2. Fermentation 
The fermentation setup consisted of a 2.5-L Bioflo 3000 stirred-tank bioreactor 
(New Brunswick Scientific, Nijmegen, The Netherlands) interfaced with 
BioCommand Software (New Brunswick Scientific, Nijmegen, The 
Netherlands) and a homebuilt methanol sensor-controller. The fermentations 
were performed as described previously 19, as follows. A starting volume of 
1.25 L minimal basal salts medium 52 was used. The cultures were always 
inoculated with precultures grown to similar OD600. Growth temperature was 
30 °C, and the pH was controlled at 3.0 throughout the entire fermentation. The 
air was supplemented with 20% (v/v) oxygen during the glycerol fed-batch 
phase and the methanol fed-batch phase. During the latter protein production 
phase, lasting two days, methanol levels were kept at 0.2% (w/v). Wet biomass 
was typically ~150 g L-1 at the end of the glycerol fed-batch phase, and ~500 g 
L-1 at the end of the fermentation. After harvesting, cells were removed from 
the broth by centrifugation for 20 min. at 15,000 × g (RT), followed by 
microfiltration. 
5.2.3. Protein purification 
Purification of all protein polymers was done by ammonium sulfate 
precipitation essentially as described 19, except that heating of the supernatant 
and acetone precipitation were omitted. Shortly, medium salts were removed by 
raising the pH of the cell-free broth to 8.0 with sodium hydroxide, followed by 
30 min. of centrifugation at 20,000 × g (RT). The protein was precipitated from 
the supernatant by addition of ammonium sulfate to 40% of saturation, 
followed by incubation on ice for 30 min. and centrifugation for 30 min. at 
20,000 × g (4 °C). The protein pellet was resuspended in Milli-Q water and 
precipitated using ammonium sulfate at 40% of saturation as before. The pellet 
was then resuspended in Milli-Q water, desalted by extensive dialysis against 
Milli-Q water, and finally lyophilized. 
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5.2.4. SDS-PAGE 
SDS-PAGE was performed using the NuPAGE Novex System (ThermoFisher, 
Bleiswijk, The Netherlands) with 10% Bis-Tris gels, MES SDS running buffer, 
and SeeBlue Plus2 pre-stained molecular mass markers. Prior to 
electrophoresis, all samples were heated for 10 min. at 70 °C in NuPAGE LDS 
Sample Buffer with NuPAGE Sample Reducing Agent, as per manufacturer's 
recommendations for denaturing and reducing PAGE. Gels were stained using 
Coomassie SimplyBlue SafeStain (ThermoFisher, Bleiswijk, The Netherlands). 
For detection of glycosylated proteins, SDS-PAGE gels were stained using 
Periodic acid-Schiff staining 33. The gel was incubated for 1 h in 12.5% TCA, 1 
h in 1% periodic acid/3% acetic acid, 1 h in 15% acetic acid (replaced every 
10 min.), and 1 h at 4 °C in the dark in Schiff's reagent (Sigma-
Aldrich, Zwijndrecht, The Netherlands). The gel was then washed two times 
for 5 min. in 0.5% sodium bisulfite and destained in 7% acetic acid. 
5.2.5. Treatment of proteins with α-mannosidase or phosphatase 
For α-mannosidase digestions, 30 µg of glycoprotein was incubated for 24 h at 
37 °C under mild agitation with 0.9 U of jack bean α(1-2,1-3,1-6) mannosidase 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) in 60 µL of 20 mM sodium 
acetate, 0.4 mM zinc chloride, pH 5. Dephosphorylation involved incubation of 
30 µg of glycoprotein for 24 h at 37 °C under mild agitation with 60 U of calf 
intestinal alkaline phosphatase (NEB, Ipswich, MA) in 60 µL of 50 mM Tris-
HCl, 10 mM magnesium chloride, pH 8.5. 
For consecutive α-mannosidase/phosphatase digestions, the enzyme after each 
step was inactivated by heating for 15 min. at 100 °C, followed by desalting 
using Micro Bio-Spin P-6 columns (Bio-Rad, Veenendaal, The Netherlands). 
To allow mass spectrometric analysis of the reaction products, it was verified 
that such analysis of enzyme-only digestions revealed no significant peaks in 
the relevant ~38-41 kDa range (not shown). 
5.2.6. Mass spectrometry 
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry was performed using an ultrafleXtreme mass spectrometer 
(Bruker, Leiderdorp, The Netherlands). Proteins were desalted using Micro 
Bio-Spin P-6 columns (Bio-Rad, Veenendaal, The Netherlands), and samples 
were prepared by the dried droplet method on a 600 µm AnchorChip target 
(Bruker, Leiderdorp, The Netherlands), using 5 mg mL-1 
2,5-dihydroxyacetophenone, 1.5 mg mL-1 diammonium hydrogen citrate, 25% 
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(v/v) ethanol and 3% (v/v) trifluoroacetic acid as matrix. Spectra were derived 
from ten 500-shot (1,000 Hz) acquisitions taken at non-overlapping locations 
across the sample. Wide mass-range measurements were made in the positive 
linear mode, with ion source 1, 25.0 kV; ion source 2, 23.3 kV; lens, 6.5 kV; 
pulsed ion extraction, 680 ns. Detailed analyses of glycoproteins in the ~38-41 
kDa range were done with ion source 1, 20.0 kV; ion source 2, 18.4 kV; lens, 
6.2 kV; pulsed ion extraction, 450 ns, and spectra were derived from ten 1,000-
shot (1,000 Hz) acquisitions. Protein Calibration Standard II (Bruker, 
Leiderdorp, The Netherlands) was used for external calibration. 
5.2.7. Steady-state fluorescence spectroscopy 
Steady-State Fluorescence Spectroscopy was performed on a Cary Eclipse 
Fluorescence Spectrophotometer (Agilent Technologies, Amstelveen, The 
Netherlands), monitoring the intrinsic fluorescence emission of the tryptophan 
residues in the WW domain at 340 nm, with excitation at 295 nm. Proteins 
were dissolved overnight in 10 mM sodium phosphate buffer (pH 7) at RT. The 
binding assays for both couples CP4-D
PPxY / CP4-D
WW, and CP4-D
PPxY* / CP4-
DWW were conducted in triplicate at RT. A 500 μL aliquot of 10 μM CP4-D
WW 
was pipetted into a quartz fluorescence cuvette (Sigma-Aldrich, Zwijndrecht, 
The Netherlands). A 500 µM solution of ligand was stepwise added to the 
cuvette, up to a final ligand concentration of ~24 µM. The time interval 
between additions was 30 min. The final volume of added ligand solution did 
not exceed 5% of the starting volume of CP4-D
WW. Curve fitting for Kd 
determination was done on averaged data of triplicate titrations. 
5.2.8. Isothermal titration calorimetry 
ITC was conducted on a MicroCal VP-ITC (Malvern Instruments, Malvern, 
United Kingdom) at 25 °C. All purified protein polymers were dissolved in 10 
mM sodium phosphate buffer, pH 7 and filtrated with 0.2 μm Minisart NML 
Syringe Filters (Sigma-Aldrich, Zwijndrecht, The Netherlands). Prior to 
titration, each protein polymer solution was degassed under vacuum for 60 min. 
at RT. The ligand concentration of CP4-D
PPxY or CP4-D
PPxY* in the titration 
syringe was 2.9 mM. Each titration consisted of 63 injections at an interval of 
250 sec. Ligand aliquots of 4 µL were titrated into 1.4 mL of a 200 µM CP4-
DWW protein solution inside the calorimeter cell under continuous stirring at 
329 rpm. Data obtained from the injection of ligand molecules into 1.4 mL of 
10 mM PBS buffer (Fig. 5.1.S2) were subtracted as blanks from the 
experimental data before the data were analyzed using MicroCal Origin 
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Software (Malvern Instruments, Malvern, United Kingdom). Titrations were 
performed in triplicate and Kd values were averaged after curve fitting. 
5.3. Results and discussion 
5.3.1. Protein production and purification 
The WW and PPxY domains are referred to hereafter as DWW and DPPxY, 
respectively (D for Dimerization). For amino acid sequences see Table 5.1. 
Table 5.1: Amino acid sequences of the C-terminal Dww, DPPxY and DPPxY* modules. All sequences 
end C-terminally in the cloning-derived amino acid sequence PAGG (not indicated). 
Module Amino acid sequence 
D
WW LPSGWEQRKDPHGRTYYVDHNTRTTTWERPQPLPPGA
D
PPxY
 EYPPYPPPPYPSG
D
PPxY*
 EYPPYPPPPYPAG
The domains were cloned at the 3’ end of the gene encoding the previously 
reported CP4 protein polymer 
18. The encoded proteins CP4-D
WW and CP4-
DPPxY were produced in secretory fashion using genetically modified P. 
pastoris, grown in methanol fed-batch mode. Proteins were purified from the 
cell-free broth by differential ammonium sulfate precipitation, and 
subsequently dialyzed and lyophilized. Previous studies showed that 
ammonium sulfate precipitation of protein polymers containing the CP4 block 
typically results in a purity of ~99% at the protein level 19,30. The 
gravimetrically determined yields, expressed in g per L of cell-free broth, were 
2.2 g L-1 for CP4-D
WW, and 2.3 g L-1 for CP4-D
PPxY. Although several reports 
describe the production of proteins with WW domains and proline-rich ligands 
in Escherichia coli, yields have not been reported 28,31,32. To our knowledge, 
production of WW and PPxY domains in P. pastoris has not been reported 
before. The non-optimized yields are in the same g L-1 range as for CP4 18, 
showing that the DWW and DPPxY modules are not a significant bottle-neck. This 
offers good prospects towards their further use in the construction of complex 
supramolecular architectures and biomaterials. 
5.3.2. Protein characterization 
CP4-D
WW and CP4-D
PPxY were characterized by SDS–PAGE (Fig. 5.1). Based 
on the well-established aberrant migration behavior of the CP4 block in SDS-
PAGE, the proteins were expected to migrate much more slowly in SDS-PAGE 
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than would be expected on the basis of their theoretical molecular weights of 
~41 and ~39 kDa, respectively 18,19,23,30. This is due to the highly hydrophilic 
character and consequent low SDS-binding capacity of the CP4  block 
18. The 
13-residue DPPxY block resembles the proline-rich nature of the CP4 block, and 
as such is not expected to much affect the mobility of the protein in SDS-PAGE 
relative to that of CP4 alone. On the other hand, the 37-residue hydrophobic 
DWW block likely will, because attachment to CP4 of peptides that improve 
SDS binding is known to increase the mobility of the polymer 23,30. Indeed, the 
proteins migrated accordingly in SDS-PAGE (Fig. 5.1): CP4-D
PPxY migrates as 
slowly as the control CP4 protein, and C
P
4-D
WW migrates faster than CP4. 
Although SDS-PAGE is not informative about the molecular mass of the 
polymers, it does show the proteins are relatively pure and intact. 
Figure 5.1: SDS-PAGE analysis of the purified protein polymers. Lane 1, CP4-DWW; lane 2, CP4-
DPPxY; lane 3, CP4-DPPxY*; lane M, protein molecular weight marker; lane 4, control protein CP4. 
Samples were loaded at 13 µg of protein per lane. 
The molecular weight distribution of purified CP4-D
WW and CP4-D
PPxY was 
further investigated by MALDI-TOF mass spectrometry. A peak at m/z 41,440 
was observed in the spectrum of CP4-D
WW (Fig. 5.2A). This peak corresponds, 
within experimental error, to the expected molecular weight of the intact 
protein (41,437 Da). The small shoulder represents a minor fraction of the 
molecules with an N-terminal (Glu-Ala)2 extension. Such extensions 
commonly occur in P. pastoris due to incomplete processing of the α-factor 
prepro secretory signal 17. The MALDI-TOF analysis confirms the conclusion 
from SDS-PAGE that the CP4-D
WW protein is pure and intact. The MALDI-
TOF spectrum for CP4-D
PPxY (Fig. 5.2B), however, showed several peaks. The 
minor low mass peak at m/z 38,553 is in accordance with the expected 
molecular weight of the intact protein (38,552 Da). It seems likely that the other 
peaks of higher molecular mass represent glycosylated species. Indeed, SDS-
PAGE followed by Periodic acid-Schiff staining 33 confirmed that CP4-D
PPxY is 
88
glycosylated (Fig. 5.3). Although the sequence of CP4-D
PPxY contains no N-x-
[ST] N-glycosylation motifs, P. pastoris is also capable of O-glycosylation 34. 
Because CP4, as a separate protein, is known to be nonglycosylated 
18 (see also 
Fig. 5.3) most likely the single Ser residue in the added DPPxY block has been 
modified with O-glycans. 
Figure 5.2: MALDI-TOF analysis of the purified protein polymers. (A) CP4-DWW, (B) CP 4-DPPxY, 
(C) CP4-DPPxY*. 
Figure 5.3: Detection of glycosylation by SDS-PAGE. Lane 1, CP4 control; lane 2, CP4-DPPxY; lane 
M: protein molecular weight marker. (A) Stained with Coomassie Brilliant Blue. (B) Stained using 
Periodic acid-Schiff staining. Lanes 1 and 2 were loaded with equal amounts of protein. 
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5.3.3. Construction of a Ser12  Ala PPxY mutant 
Glyosylation of therapeutic proteins by P. pastoris may cause adverse immune 
responses 35. Also from a nanomaterials point of view, the polydispersity 
resulting from glycosylation is undesirable, and desired interactions may well 
be hindered by the presence of oligosaccharides. To abolish the observed 
glycosylation of CP4-D
PPxY, we constructed a variant with a Ser12 → Ala 
mutation in the PPxY module (Table 5.1). This variant, denoted CP4-D
PPxY*, 
was produced in P. pastoris and purified as described above. SDS-PAGE 
shows a single band (Fig. 5.1), and the yield of purified protein was 2.5 g L-1 of 
cell-free broth. MALDI-TOF of CP4-D
PPxY* no longer showed the extensive 
pattern of glycosylated species (Fig. 5.2C). Instead, a major peak at m/z 38,536 
is seen, matching the expected molecular weight of 38,536 Da. The shoulder 
represents a minor fraction of the protein not fully processed by P. pastoris 
dipeptidylaminopeptidase, as mentioned above. 
The absence of glycosylation in CP4-D
PPxY* shows that indeed Ser12 of the 
PPxY module in CP4-D
PPxY was glycosylated. Although there is no known 
consensus sequence for O-glycosylation, serine/threonine rich sequences 
appear relatively susceptible, particularly when prolines are in the vicinity of 
the hydroxyl residues 36. Although both CP4 and D
PPxY are rich in proline and 
serine, interestingly, all serines in CP4 are followed by proline, while in D
PPxY 
the single serine is preceded by proline. The observed exclusive glycosylation 
of serine in the PPxY module seems to agree with the reported enhancement of 
mannosyl transfer in S. cerevisiae for peptide substrates with proline N-
terminal to the hydroxyl amino acid 37, and with its inhibition when proline is 
the C-terminal neighbor 38. However, this should not be taken to imply that 
such simple motifs are sufficient to determine O-glycosylation. 
5.3.4. Limited glycan characterization 
The fact that exclusively Ser12 in the PPxY module was glycosylated allows a 
direct interpretation of the mass spectrum of the glycosylated protein in terms 
of the oligosaccharide composition of the population of attached glycans. 
Although relatively few studies have reported O-glycosylation in P. pastoris, it 
is clear that O-glycans in this host usually consist of up to five mannose 
units 34, with dimers and trimers being the most abundant species 39,40. 
However, longer glycan chains of up to nine mannose residues have been 
described 41, as well as a phosphorylated Man6 O-glycan 
40. The glycosidic 
links between the mannose units are mostly in α1-2 arrangement 39,40, although 
also α1-3 and α1-6 links have been reported 41,42, as well as ß1-2 links 40. 
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For closely studying the glycan mass distribution, the MALDI-TOF analysis of 
CP4-D
PPxY was repeated with optimal settings for the m/z range of the relevant 
[M+H]+ ions (Fig. 5.4A). Table 5.2 provides an interpretation of the observed 
peaks, all of which can be explained in terms of mannose units (+162 Da mass 
shift) and phosphorylation (+80 Da mass shift). Applying Occam's razor, we 
assumed maximally one phosphate per glycan structure. 
Hypothetically, the CP4-D
PPxY protein itself may have been phosphorylated, 
rather than the oligosaccharides attached to it. Because a nonglycosylated peak 
shifted by +80 Da is not observed in the MALDI-TOF spectrum of CP4-D
PPxY, 
and because both CP4 
18 and the nonglycosylated CP4-D
PPxY* are not 
phosphorylated, such hydroxyl amino acid phosphorylation would need to have 
occurred specifically in the glycosylated fraction of the CP4-D
PPxY molecules. 
This unlikely notion can be excluded because treatment with alkaline 
phosphatase did not result in significant changes to the MALDI-TOF spectrum 
(Fig. 5.1.S1). This finding furthermore indicates that the phosphorylated 
oligosaccharides do not contain phosphomonoesters, but rather contain 
phosphorylated Man in diester linkage, in agreement with the findings by 
Trimble et al. for the above-mentioned phosphorylated Man6 O-glycan 
40. 
When CP4-D
PPxY was treated with the exoglycosidase jack bean α(1-2,1-3,1-6) 
mannosidase, a clearly altered mass distribution was obtained in MALDI-TOF 
(Fig. 5.4B, Table 5.2). Repeated digestions using increasing amounts of 
enzyme and incubation time all resulted in similar spectra (not shown), 
suggesting that the glycan structure is partially resistant to the α(1-2,1-3,1-6) 
mannosidase. The observed phosphorylation provides a likely explanation. 
Nonphosphorylated species were hardly detectable after digestion with jack 
bean mannosidase (Fig. 5.4B; Table 5.2). Furthermore, a peak corresponding to 
Man2+P is absent in the undigested sample, but appears upon α-mannosidase 
digestion at the apparent expense of Man3+P and larger phosphorylated forms. 
Although jack bean α-mannosidase can trim terminal mannoses linked to 
phosphate, it cannot thereafter proceed further 43-45. Thus, the digestion likely 
halted upon generation of the phosphorylated species observed in Fig. 5.4B 
(Man2+P, Man3+P, and Man6+P). Treatment of the mannosidase-digested 
sample with alkaline phosphatase resulted in a shift by -80 Da for these three 
phosphorylated species (Fig. 5.4C; Table 5.2), confirming that they were 
present as phosphodiesters prior to α-mannosidase digestion, and that indeed, as 
assumed above, each glycoform contains only one phosphate. Moreover, 
dephosphorylation rendered the remaining glycan structures susceptible to 
further digestion by α-mannosidase (Fig. 5.4D; Table 5.2). Possibly, the minor 
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amount of remaining Man6 is capped with a resistant β1-2 Man disaccharide, as 
has been described for P. pastoris 40.  
Figure 5.4: MALDI-TOF of CP 4-DPPxY treated with α(1-2,1-3,1-6) mannosidase and phosphatase. 
(A) Untreated CP 4-DPPxY. The protein was digested with (B) α-mannosidase, then with (C) 
phosphatase, and finally digested again with (D) α-mannosidase. Enzymes were thermally 
inactivated between consecutive digestions. See Table 5.2 for observed m/z values and theoretical 
masses of the indicated glycoforms. 
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Table 5.2. Masses observed in MALDI-TOF and tentative glycan structures 
m/z
a Additional  
mass (Da)
b
Tentative  
glycan structure
c
Theoretical mass of tentative 
glycan structure (Da)
d
 
C
P
4-D
PPxY
 
38,553 - - - 
39,042 489   Man3 486 
39,122 569 Man3 + P 566 
39,202 649   Man4 649 
39,283 730 Man4 + P 729 
39,444 891 Man5 + P 891 
39,529 976   Man6 973 
39,609 1056 Man6 + P 1053 
39,688 1135   Man7 1135 
39,767 1214 Man7 + P 1215 
C
P
4-D
PPxY
 digested with α-mannosidase
38,558 - - - 
38,963 405 Man2 + P 404 
39,121 563 Man3 + P 566 
39,611 1053 Man6 + P 1053 
C
P
4-D
PPxY 
digested with (1) α-mannosidase, and (2) phosphatase
e
38,553 - - - 
38,878 325 Man2 324 
39,039 486 Man3 486 
39,526 973 Man6 973 
C
P
4-D
PPxY 
digested with (1) α-mannosidase, (2) phosphatase, and (3) α-mannosidase
e
38,553 - - - 
39,526 973 Man6 973 
a See Fig. 5.4 (only true peaks are listed; minor inflections in the spectra are ignored) 
b Relative to the m/z value corresponding to the nonglycosylated protein in the same mass spectrum 
c Assuming mannose (Man) units only, and maximally one phosphate (P) per glycan 
d Theoretical glycoform masses calculated using 162.14 Da for Man and 79.98 Da for P 
e Enzymes were thermally inactivated between consecutive digestions 
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A detailed study of O-glycans chemically released from C4-D
PPxY would be 
needed to determine their precise structure with certainty, but is beyond the 
scope of this work. Nonetheless, it is clear that the heterogeneous mixture of 
glycans attached to Ser12 in the PPxY module contains phosphorylated species 
in diester linkage. Similarly phosphorylated  O-glycans have been described for 
several proteins in S. cerevisiae 44-46. To our knowledge, the present study 
represents the first confirmation of the occurrence of phosphorylated O-glycans 
in P. pastoris as reported by Trimble et al. 40. Interestingly, the phosphorylated 
Man6 previously reported was described as only a minor component 
40, whereas 
most of the oligosaccharides on C4-D
PPxY are phosphorylated. 
5.3.5. Binding of proline-rich ligands by the WW domain 
Because tryptophans are exclusively present in the WW domain, tryptophan 
fluorescence can be used to monitor binding of CP4-D
WW to its proline-rich 
ligands. Upon binding, the local environment of the tryptophans becomes more 
hydrophobic, causing a blue-shift of the emission maximum and increased 
fluorescence. Tryptophan fluorescence of a fixed amount of CP4-D
WW (10 µM) 
was thus followed during titration with a concentrated stock solution of either 
CP4-D
PPxY or CP4-D
PPxY*. 
An excitation wavelength of 295 nm was used to prevent excitation of 
tyrosines 47, which are present in the PPxY domain. With increasing 
concentration of the ligand, the maximum emission wavelength of CP4-D
WW 
decreased, indicating the transition of at least one tryptophan of CP4-D
WW from 
a solvent-exposed to a more hydrophobic environment (Fig. 5.5). As expected, 
this was accompanied by an increased fluorescence quantum yield. From the 
titration plots in Fig. 5.5, a Kd of 2.5 µM was calculated by non-linear 
regression for CP4-D
PPxY, and a Kd of 2.7 µM for C
P
4-D
PPxY*. Apparently, the 
WW domain binds equally well to glycosylated and nonglycosylated CP4-
DPPxY. 
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Figure 5.5: Steady-state tryptophan fluorescence of CP4-DWW upon titration with (A) CP 4-DPPxY and 
(B) CP4-DPPxY*. The top graphs present tryptophan fluorescence spectra obtained for CP4-DWW 
upon addition of different concentrations of CP4-DPPxY and CP4-DPPxY*. The bottom graphs show 
titration of CP 4-DWW with CP4-DPPxY and CP 4-DPPxY*, where fluorescence was monitored at 340 nm. 
Error bars represent s.d. (n=3). 
Binding affinities were further established using isothermal titration 
calorimetry. A fixed amount of CP4-D
WW (200 µM) was titrated with 
concentrated ligand stock solution (Fig. 5.6). Control experiments where buffer 
was titrated with ligand, resulted in a relatively small and constant heat of 
dilution (Fig 5.1.S2A and 5.S2B). Also CP4-D
WW titrated with control protein 
CP4 showed only heat of dilution (Fig. 5.1.S2C). The binding isotherms of both 
CP4-D
PPxY and CP4-D
PPxY* showed an immediate decrease in differential power 
for each consecutive injection (Fig 5.6). 
The Kd values derived from the integrated heat plots in Fig. 5.6 are 9.3 and 9.2 
µM for CP4-D
PPxY and CP4-D
PPxY*, respectively. Both values are similar, and in 
reasonable agreement with the fluorescence spectroscopy results. In general, 
the Kd of various WW-domains and their proline-rich ligands are in the high 
nM to low µM range 48. According to Russ et al., the PPxY peptide, also used 
in our DPPxY block, binds the CC43 WW domain with Kd = 1.7 µM, and the 
Nedd4.3 WW domain with Kd = 11.2 µM 
49. Wong Po Foo et al. used the same 
couples in the context of protein polymers and found relatively high Kd values 
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of 4.6 µM and 62 µM, respectively, for polymers containing three PPxY 
motifs, interacting with polymers containing three CC43 or Nedd4.3 domains. 
The combination of PPxY (p53BP-2) and WWP1-1 used by us was among the 
best performing pairs tested by Porozzi et al. 29, but to our knowledge no Kd 
values have been published. In our protein polymer context, the Kd of this 
combination (~3 to 9 µM) is in a similar range as the above-mentioned 
literature values for other WW/PPxY combinations. This range is quite 
sufficient for various supramolecular systems, and multiple D blocks could be 
introduced into the polymer for applications that require even lower working 
concentrations. We did attempt to produce the CC43 domain as well, but 
encountered proteolytic degradation in P. pastoris that could not be readily 
resolved. The stoichiometry (N) determined for both CP4-D
PPxY and CP4-D
PPxY* 
is around 0.9, which, given unavoidable inaccuracies in preparing stock 
solutions from lyophilized proteins, is in good agreement with the expected 1:1 
stoichiometry. 
Figure 5.6: Binding study using isothermal titration calorimetry. (A) CP4-DPPxY titrant, (B) CP 4-
DPPxY* titrant. The top graphs show the heat response upon titration of CP4-DWW with the proline-
rich ligands. Bottom graphs represent the integrated peak areas per mole of ligand. 
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5.4. Conclusion 
We have shown that polymers containing the WW domain and a proline-rich 
ligand can be efficiently produced in Pichia pastoris. The PPxY module was 
found to be O-glycosylated, and remarkably a considerable fraction of the 
oligomannose structures was phosphorylated. O-glycosylation was abolished 
by changing the serine in the PPxY sequence to alanine. The WW domain 
effectively bound both the glycosylated and nonglycosylated PPxY modules, 
with similar binding affinities. This work provides proof-of-concept that 
otherwise noninteracting protein polymers can be brought together using the 
specifically interacting WW and PPxY modules. This will allow us to create 
protein materials with still better controlled structures at the nanoscale, and 
hence biomedical materials with more precisely defined interactions with living 
cells. 
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5.1 Supplementary data 
Table 5.1.S1: Oligonucleotides used in gene construction 
Insert Oligonucleotide 
Name 
Oligonucleotide sequence 
D
WW
 
WW-FW1 5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTTTGCCTTCTGGTTGGGAA-3’
WW-RV1 5’GGTCAACGTAATAAGTACGACCGTGAGGATCCTTTCTTTGTTCCCAACCAGAAGGCAAAG-3’
WW-FW2 5’GTCGTACTTATTACGTTGACCATAACACTAGGACTACCACATGGGAAAGACCACAGCCATTGCCA-3’
WW-RV2 5’GTACGAATTCTATTAGCCACCGGCTGGTGCTCCAGGTGGCAATGGCTGTGGTCTT-3’
D
PPxY
 
PPxY-FW 5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTGAATACCCTCCATACCCACCAC-3’
PPxY-RV 5’GTACGAATTCTATTAGCCACCGGCTGGACCAGATGGATAAGGAGGTGGTGGGTATGGAGGGTA-3’
D
PPxY*
 
PPxY*-FW 5’GTGCTGAATACCCTCCATACCCACCACCTCCTTATCCAGCTGGTCCAGCCGGTGGCTAATAG-3’
PPxY*-RV 
5’AATTCTATTAGCCACCGGCTGGACCAGCTGGATAAGGAGGTGGTGGG
TATGGAGGGTATTCAGCACCGG-3’
Figure 5.1.S1: MALDI-TOF of CP 4-DPPxY before (A) and after (B) phosphatase treatment. The 
same glycoforms are seen in both spectra. 
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Figure 5.1.S2:Control ITC measurements. (A) Titration of buffer with CP4-DPPxY, (B) titration of 
buffer with CP4-DPPxY*, (C) titration of CP 4-DWW with CP 4 (protein without binding domain). 
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5.2 Supplementary data 
Material and Methods 
Construction of Expression Vectors and Strains 
Similarly as in Chapter 5, the double-stranded gene fragments encoding DCC43, 
DPPxY-1 and DPPxY-1* (Table 5.2.S1) were assembled via overlap extension PCR 
from the oligonucleotides shown in Table 5.2.S2. The gene fragments were 
digested with XhoI/EcoRI and cloned into XhoI/EcoRI-digested vector 
pMTL23ΔBsaI, in order to obtain vectors pMTL23ΔBsaI-DCC43, 
pMTL23ΔBsaI-DPPxY-1 and pMTL23ΔBsaI-DPPxY-1*. The vector pMTL23-T9-
CP4 contains the sequence encoding T9-C
P
4, and was opened at the 3’ end of 
the T9-C
P
4 gene with Van91I/EcoRI. The newly prepared constructs, as well as 
pMTL23ΔBsaI-DWW, pMTL23ΔBsaI-DPPxY and pMTL23ΔBsaI-
DPPxY* (discussed in Chapter 5) were digested with DraIII/EcoRI to release 
inserts DCC43, DWW, DPPxY, DPPxY*, DPPxY-1 and DPPxY-1*. The inserts were 
ligated into the opened pMTL23-T9-C
P
4 vector, resulting in pMTL23-T9-C
P
4-
DCC43, pMTL23-T9-C
P
4-D
WW, pMTL23-T9-C
P
4-D
PPxY, pMTL23-T9-C
P
4-
DPPxY, pMTL23-T9-C
P
4-D
PPxY-1 and pMTL23-T9-C
P
4-D
PPxY-1*. 
Table 5.2.S1: Amino acid sequences of the C-terminal DCC43, DPPxY-1 and DPPxY-1* modules. All 
sequences end C-terminally in the cloning-derived amino acid sequence PAGG (not indicated). 
Module Amino acid sequence 
D
CC43 RLPAGWEQRMDVKGRPYFVDHVTKSTTWEDPRPE
D
PPxY-1
 YPGPLPPPTYSPSSI
D
PPxY-1*
 YPGPLPPPTYSPASI
The vectors pMTL23-CP4-D
WW (discussed in Chapter 5) was opened at the 5’ 
end of the CP4-D
WW gene with XhoI/Van91I. The vector pMTL23ΔBsaI-DWW 
was digested with XhoI/DraIII to release insert DWW. The insert was ligated 
into the opened vector, resulting in pMTL23-DWW-CP4-D
WW. 
The T9-C
P
4-D
CC43, T9-C
P
4-D
WW, DWW-CP4-D
WW, T9-C
P
4-D
PPxY, T9-C
P
4-
DPPxY*, T9-C
P
4-D
PPxY-1 and T9-C
P
4-D
PPxY-1* inserts were then released with 
XhoI/EcoRI and cloned into the likewise-digested Pichia pastoris expression 
vector pPIC9 (ThermoFisher, Bleiswijk, The Netherlands). This resulted in the 
construction of the vectors: pPIC9-T9-C
P
4-D
CC43, pPIC9-T9-C
P
4-D
WW, pPIC9-
DWW-CP4-D
WW, pPIC9-T9-C
P
4-D
PPxY, pPIC9-T9-C
P
4-D
PPxY*, pPIC9-T9-C
P
4-
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DPPxY-1 and pPIC9-T9-C
P
4-D
PPxY-1* respectively. The vectors were linearized 
with SalI to target for integration at the his4 locus. Transformation of P. 
pastoris GS115 by electroporation and selection of Mut+ transformants were 
performed as described previously. 
Table 5. 2.S2: Oligonucleotides used in gene construction. 
Module 
Oligonucleotide 
Name 
Oligonucleotide sequence 
D
CC43
CC-FW1
5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTAG
ATTGCCTGCTGG-3’
CC-RV1
5’ATGGCCTACCCTTAACATCCATTCTTTGTTCCCATCCAGCAGGC
AATCTAGCACC-3’
CC-FW2
5’GGATGTTAAGGGTAGGCCATACTTTGTTGATCATGTCACTAAAT
CTACTACCTGGGAAG-3’
CC-RV2
5’GTACGAATTCTATTAGCCACCGGCTGGCTCTGGACGAGGGTCTT
CCCAGGTAGTAGATTTAG-3’
D
PPxY-1
 
PPxY-1-FW
5’GCGCTCGAGAAAAGAGAGGCTGAAGCTGGTCCACCCGGTGCTTA
TCCAGGTCCATTGCCTCCACCTAC-3’
PPxY-1-RV
5’GTACGAATTCTATTAGCCACCGGCTGGAATAGAGGAAGGAGAGT
AAGTAGGTGGAGGCAATGGAC-3’
D
PPxY*
 
PPxY*-1-1FW
5’GTGCTTATCCAGGTCCATTGCCTCCACCTACTTACTCTCCTGCC
TCTATTCCAGCCGGTGGCTAATAG-3’
PPxY*-1-1RV
5’AATTCTATTAGCCACCGGCTGGAATAGAGGCAGGAGAGTAAGTA
GGTGGAGGCAATGGACCTGGATAAGCACCGG-3’
Protein Production and Characterization 
All protein polymers were produced, purified and characterized as described in 
Materials and Methods in Chapter 5. 
101
Isothermal Titration Calorimetry 
ITC was performed as described in Chapter 5. The ligand concentration (CP4-
DPPxY or CP4-D
KPPxY*) in the titration syringe was 2.9 mM. Each titration 
consisted of 63 injections at an interval of 150 sec. Ligand aliquots of 4 µl were 
titrated into 1.4 ml of a 200 µM DWW-CP4-D
WW protein solution inside the 
calorimeter cell under continuous stirring at 329 rpm. 
Rheology. 
Freeze-dried proteins purified by ammonium sulphate precipitation were first 
dissolved in 10 mM sodium phosphate buffer, then vortexed and incubated 
overnight at RT to allow proper dissolution. Solutions of protein polymers with 
the DWW domain and with the proline-rich domains were mixed in a 1:1 ratio in 
different combinations. Samples were prepared at concentration 180 g L-1. Prior 
to the measurement all samples were heated at 50 °C for at least 20 min to 
allow any triple helices in the sample to melt completely. Rheological 
measurements were done with an Anton Paar MCR 501 rheometer equipped 
with C10/TI Couette geometry, with bob and cup diameter of 9.991 and 10.840 
mm, respectively. The temperature was controlled by a Peltier system, which 
allows quick heating and cooling. A solvent trap containing oil was used to 
minimize evaporation. The couette was preheated (50 °C) before adding sample 
solutions. After inserting the bob into the cup, the temperature was lowered to 
20 °C. The gel formation was monitored by applying a sinusoidal deformation 
to the hydrogel (frequency 1 Hz and amplitude 1%). 
Results 
Binding of WW domains with proline-rich ligands 
The CC43 and PPxY-1 domains are referred to hereafter as DCC43 and DPPxY-1, 
respectively. The DPPxY-1* domain is a variation of DPPxY-1, where Ser13→Ala. 
For amino acid sequences see Table 5.2.S1. The DCC43 belongs to WW domain 
family 28 and was discussed in Chapter 5. The DPPxY-1 domain is a proline-rich 
domain 53. As reported by Wong Po Foo et al. DCC43 can bind DPPxY 28. Mosser 
et al. showed that DWW can bind DPPxY-1 53. In Chapter 5, we showed that DWW 
can alternatively bind DPPxY and its variant with Ser12→Ala, DPPxY*. Building 
upon that, we attempted to study interaction between WW domains and 
proline-rich domains in different combinations in the context of T9-C
P
4 protein 
polymer that can form trimers via T9 tripel helix formation 
19. 
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Protein production and characterization 
Following procedure described in Chapter 5, all protein polymers were 
produced in genetically modified P. pastoris and purified via ammonium 
sulfate precipitation. The gravimetrically determined yields, expressed in g per 
L of cell-free broth, are given in Table 5.2.S3. The non-optimized yields are in 
the same g L-1 range as shown in Chapter 5. 
Table 5.2.S3: Theoretical and measured molecular masses of protein polymers produced in this 
study. 
Protein polymer 
Theoretical 
Molecular Weight 
(Da) 
Measured 
Molecular 
Weight (Da) 
Product 
Yield 
(g L-1)** 
T
9
-C
P
4
-D
CC43
43637 42171 Degraded 0.75 
T
9
-C
P
4
-D
WW
 43897 43895 Intact 1.8 
D
WW
-C
P
4
-D
WW
 46060 46051 Intact 2.4 
T
9
-C
P
4
-D
PPxY
 41012 41737* Glycosylated 1.6 
T
9
-C
P
4
-D
PPxY*
 40996 40994 Intact 1.4 
T
9
-C
P
4
-D
PPxY-1
 41124 41127* Glycosylated 1.85 
T
9
-C
P
4
-D
PPxY-1*
 41108 41113* 
Glycosylated (to a 
lesser degree than  
T
9
-C
P
4
-D
PPxY-1
)
1.6 
* The peak of the highest intensity is mentioned, but several peaks of different sizes were observed
* The gravimetrically determined yield is expressed as g of lyophilized product per L of cell-free 
broth 
Obtained protein polymers were characterized by SDS–PAGE (Fig. 5.2.S1). An 
observed migration is similar as for protein polymers discussed in Chapter 5: 
protein polymers with proline-rich modules migrated as slowly as the control 
CP4 protein, and those with WW domains migrated faster than C
P
4 due to 
better binding of SDS. Although SDS-PAGE is not informative about the 
molecular mass of the polymers, it does show the proteins are relatively pure 
and intact, except T9-C
P
4-D
CC43, were multiple bands indicated protein 
degradation. The molecular weight distribution of purified protein polymers 
was further investigated by MALDI-TOF mass spectrometry. For all produced 
protein polymers, the measured molecular weights 17 are compared with 
theoretical MW in Table 5.2.S3. 
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Figure. 5.2.S1: SDS-PAGE analysis of the purified protein polymers. Lane 1, T9-CP4-DCC43; lane 
2, T9-CP4-DWW; lane 3, DWW-CP4-DWW; lane 4, T9-CP4-DPPxY; lane 5, T9-CP 4-DPPxY*; lane 6, T9-
CP 4-DPPxY-1; lane 7,T9-CP4-DPPxY-1*; lane M, protein molecular weight marker, lane 8, control 
protein CP4. 
Figure 5.2.S2: MALDI-TOF analysis of the purified protein polymers. (A) T9-CP 4-DCC43, (B) T9-
CP 4-DWW, (C) DWW-CP4-DWW. 
Multiple peaks were observed in the spectrum of T9-C
P
4-D
CC43 (Fig. 5.2.S2A), 
which is consistent with SDS-PAGE results. Moreover, the weight indicated by 
the main peak was lower than expected MW, which confirmed that protein is 
degraded. One peak was observed in spectrum of T9-C
P
4-D
WW (Fig. 5.2.S2B) 
and spectrum of DWW-CP4-D
WW (Fig. 5.2.S2C). These peaks correspond, 
within experimental error, to the expected MW of the intact proteins, which 
confirms the conclusion from SDS-PAGE that these proteins are pure and 
intact. The MALDI-TOF spectra for T9-C
P
4-D
PPxY, T9-C
P
4-D
PPxY-1 and T9-
CP4-D
PPxY-1* (Fig. 5.2.S3), showed several peaks of higher MW than expected. 
Referring to diblock discussed in Chapter 5, these peaks most certainly 
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represent glycosylated species of proteins. Similarly as CP4-D
PPxY* (Chapter 
5), MALDI-TOF of T9-C
P
4-D
PPxY* no longer showed the extensive pattern of 
glycosylated species (Fig. 5.2.S3). Although the mutation of the DPPxY-1 block 
to DPPxY-1* did not remove all glycosylation, it has clearly become less 
(compare Figures 5.2S3C and D). 
Figure 5.2.S3: MALDI-TOF analysis of the purified protein polymers. (A) T9-CP4-DPPxY, (B) T9-
CP 4-DPPxY*, (C) T9-CP 4-DPPxY-1, (D) T9-CP 4-DPPxY-1*. 
Protein Binding Study 
Binding affinities between DWW-CP4-D
WW and its glycosylated ligand (CP4-
DPPxY) and nonglycosylated ligand (CP4-D
PPxY*) were established using 
isothermal titration calorimetry. A fixed amount of DWW-CP4-D
WW (200 µM) 
was titrated with concentrated ligand stock solution (Fig. 5.2.S4). Control 
experiments where buffer was titrated with ligand, resulted in a relatively small 
and constant heat of dilution (Fig 5.1.S2A and S2B). The binding isotherms of 
both CP4-D
PPxY and CP4-D
PPxY* showed an immediate decrease in differential 
power for each consecutive injection (Fig. 5.2.S4). The Kd values derived from 
the integrated heat plots in Fig. 5.2.S4 are 58.8 and 20.8 µM for CP4-D
PPxY and 
CP4-D
PPxY*, respectively. Based on these results, the DWW-CP4-D
WW binds 
nonglycosylated ligand ~3-fold stronger than glycosylated ligand. This is in 
contrast to results discussed in Chapter 5, were CP4-D
WW binds both ligands 
with similar affinity. In comparison, CP4-D
WW binds glycosylated ligand ~6-
fold stronger and nonglycosylated ligand ~2-folds stronger than DWWCP4-D
WW. 
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The stoichiometry (N) determined for both CP4-D
PPxY and CP4-D
PPxY* is around 
0.9, which, given unavoidable inaccuracies in preparing stock solutions from 
lyophilized proteins, is in good agreement with the expected 1:1 stoichiometry. 
Figure. 5.2.S4. Binding study using isothermal titration calorimetry. (A) CP 4-DPPxY titrant, (B) 
 CP 4-DPPxY* titrant. The top graphs present the heat response upon titration of DWW-CP4-DWW with 
the proline-rich ligands. Bottom graphs represent the integrated peak areas per mole of ligand. 
Hydrogel Formation 
Each of four solutions of triblocks with proline-rich domains was mixed with 
the solution of T9-C
P
4-D
WW and similarly with the solution of DWW-CP4-D
WW. 
Eight obtained samples containing equimolar mixtures were analyzed by 
oscillatory rheology. The total concentration of samples was 4 mM, which is 
sufficient concentration allowing formation of T9 triple helix. For all of 
analyzed samples, the gel formation was not confirmed by rheology. 
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Concluding Remarks 
Here, we presented an additional information on production of triblocks with 
WW domains and proline-rich domains. From seven produced protein 
polymers only T9-C
P
4-D
CC43 was degraded. The protein polymers T9-C
P
4-
DPPxY and T9-C
P
4-D
PPxY-1 were glycosylated. The modification of amino acid 
sequence resulted in nonglycosylated T9-C
P
4-D
PPxY*, but did not completely 
resolve this issue for T9-C
P
4-D
PPxY-1*. In preparing DPPxY-1*, we did not want to 
modify more than one residue in the DPPxY-1 sequence in view of the risk of 
disturbing binding functionality, but besides Ser13 apparently also Thr9 and/or 
Ser11 are glycosylated. 
Further, we also showed primary analysis of interaction between the 
heterodimer-forming domains incorporated into triblock. Regarding ITC 
results, in Chapter 5 we have envisioned that multiple D blocks could be 
introduced into the protein polymer for applications that require very low 
working concentrations. Here, however, we found that it is not so 
straightforward, since DWW-CP4-D
WW showed lower affinity towards its ligands 
in comparison to the variant with only one binding domain. The decrease in 
binding affinity for DWWCP4-D
WW is not entirely clear. We might assume that 
very flexible CP4 linker might allow the D
WW domains to align sterically 
towards each other in such a way that it affects ligand recognition, however, 
this is just a speculation and has not been verified. An inability to form 
hydrogels by any of tested combinations at concentration 4 mM was also very 
surprising, since in Chapter 5 we showed that CP4-D
WW binds its ligands with 
affinity within a micromolar range. Since T9 is also proline-rich, we speculate 
that DWW might also bind to T9, which disturbs network formation. This could 
be answered by monitoring of tryptophan fluorescence during the titration of 
protein polymers containing DWW with T9-C
P
4-T9 
19. The interaction of WW 
domain with proline-rich modules should be investigated further in order to 
find optimal conditions for its application. 
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Cross-linking and bundling of 
self-assembled protein-based polymer 
fibrils via heterodimeric coiled coils 
Abstract 
Previously, we developed triblock protein polymers that form fibrillar 
hydrogels at low protein polymer concentrations (denoted C2-S
H
48-C2). We 
here demonstrate that the structure of these hydrogels can be tuned via 
heterodimeric coiled coils that cross-link and bundle the self-assembled 
protein-polymer fibrils. We fused well-characterized, 47 amino acids-long 
heterodimeric coiled coil “linkers” (DA or DB) to the C-terminus of the 
triblock polymer. The resulting C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B 
polymers, were successfully produced as secreted proteins in Pichia pastoris, 
with titers of purified protein in the order of g L-1 of clarified broth. Atomic 
force microscopy showed that fibrils formed by either C2-S
H
48-C2-D
A or C2-
SH48-C2-D
B alone already displayed extensive bundling, apparently as a result 
of homotypic (DA/DA and DB/DB) interactions. For fibrils prepared from 
protein polymers having no linkers, plus a small fraction of polymers 
containing either DA or DB linkers, no cross-linking and bundling was 
observed. At these same low concentrations of linkers, fibrils containing both 
the DA and the DB linkers did show cross-linking and bundling as a 
consequence of heterodimer formation. This work shows that coiled coil 
modules can be employed to control bundling of supramolecular fibrils, which 
is promising for the further development of materials that mimic the 
extracellular matrix. 
Submitted in modified form as: Domeradzka, N.E.; Werten, M.W.T.; de Vries, 
R. and de Wolf, F.A. Cross-linking and bundling of self-assembled protein-
based polymer fibrils via heterodimeric coiled coils. 
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6.1. Introduction 
The extracellular matrix (ECM) is a network of fibrous proteins 1 that provides 
structural and biochemical support to the cells 2. Considerable effort has been 
devoted to the development of artificial extracellular matrices for medical 
applications such as tissue engineering and drug delivery 3-7. Different 
hydrogels made of synthetic polymers 8-11, natural polymers 12-14 or short 
synthetic peptides 15-17 have been explored for this purpose. Various 
recombinant protein polymers (collagen-inspired, elastin-inspired, and silk-
inspired) that form various types of physical hydrogels have been developed in 
our laboratory 18-23. The triblock protein polymer C2-S
H
48-C2, which forms 
fibrillar hydrogels at pH values above 6 and at low protein concentrations, is a 
promising candidate for use as an ECM-mimicking material 24. Fibril formation 
is driven by the silk-like middle block SH48 = (GAGAGAGH)48, and the fibrils 
are stabilized against aggregation by two end-blocks denoted C2 
19. Each end-
block consists of two repeats of a 99 amino acid-long hydrophilic random coil 
“C” block 25. The C2-S
H
48-C2 protein polymer self-assembles under 
physiological conditions and is not cytotoxic 24. 
The structure and mechanics of the ECM are determined by a range of complex 
interactions 26. For example, there is a wide range of proteins that form 
different types of physical cross-links between different ECM components. A 
key role is also played by the precisely controlled bundling of collagen fibrils 
into fibers 27. A notable demonstration of the impact of fibril bundling on the 
properties of hydrogels is provided by Kouwer et al. 28. The well-defined fibers 
in their system, consisting of multiple bundled fibrils, were much stiffer than 
the individual fibrils. Consequently, hydrogel formation already occurred at 
very low concentrations (1 g L-1) 28. 
Our laboratory has similarly sought to influence the cross-linking and bundling 
of fibrils in C2-S
H
48-C2 hydrogels. For example, shortening the stabilizing end-
blocks leads to some degree of fibril cross-linking, fibril bundling, and modulus 
increase 29. Also, variants of the C2-S
H
48-C2 protein polymer were developed 
with N-terminal heparin-binding domains. Fibrils formed by these modified 
protein polymers could be made to cross-link and bundle via the addition of 
heparin, again leading to an increased modulus 30. 
Here, we explore the use of heterodimerizing peptide modules as an alternative 
strategy to obtain more control over the physical cross-linking and bundling of 
fibrils formed by the C2-S
H
48-C2 triblock protein polymer. As we will show, it 
is possible to produce C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B tetrablock protein 
polymers by secretory expression in Pichia pastoris. Using atomic force 
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microscopy (AFM), we demonstrate that fibrils prepared from mixtures of C2-
SH48-C2, C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B have a degree of cross-linking 
and bundling that can be controlled via the relative ratio of the three polymers. 
6.2. Materials and methods 
6.2.1. Construction of expression vectors and strain 
The construction of vector pMTL23ΔBsaI-C2-SH48-C2, which contains the 
gene encoding the C2-S
H
48-C2 triblock copolymer, was previously described 
by Golinska et al. 19. The construction of two vectors pMTL23ΔBsaI-DA and 
pMTL23ΔBsaI-DB was previously described by Domeradzka et al 31. These 
vectors contain gene fragments encoding, respectively, the relatively acidic 
heterodimer-forming leucine zipper peptide DA and the relatively basic leucine 
zipper DB. To add DA and DB modules to the C-terminus of the C2-S
H
48-C2 
triblock, restriction sites were added to the corresponding DA and DB DNA 
fragments by PCR, using forward primers that contain a BanI restriction site, 
and reverse primers that contain a NotI site and a downstream XhoI site. 
The DA block was amplified using the primers 5’-
TATGGTGCCTTAGAAATTAGAGCTGCCTTTTTGAGAC-3’ (forward) and 
5’-ATACTCGAGCGGCCGCTTAACCCTTTCCACCTCCAAGTGGACC-3’ 
(reverse). The DB block was amplified using the primers 5’-
TATGGTGCCTTGGAAATTGAAGCCGCCTTTCTTG-3’ (forward) and 5’-
ATACTCGAGCGGCCGCTTAACCCTTTCCACCTCCCAATGGACC-3’ 
(reverse). The vector pMTL23ΔBsaI-C2-SH48-C2 was opened at the 3’ end of 
the C2-S
H
48-C2 gene with BanI/XhoI. The DA and DB PCR products were 
digested with BanI/XhoI to obtain sticky ends. The inserts were then ligated 
into the opened vector, resulting in pMTL23ΔBsaI-C2-SH48-C2-DA  and 
pMTL23ΔBsaI-C2-SH48-C2-DB, respectively. These two inserts were then 
released with EcoRI/NotI and cloned into the likewise-digested Pichia pastoris 
expression vector pPIC9 (ThermoFisher, Bleiswijk, The Netherlands). This 
resulted in the vectors pPIC9-C2-S
H
48-C2-D
A and pPIC9-C2-S
H
48-C2-D
B. The 
vectors were linearized with SalI to target for integration at the his4 locus. 
Transformation of P. pastoris GS115 by electroporation and selection of Mut+ 
transformants were performed as described previously 23. For the expected 
protein sequences upon expression see Supplementary data Table 6.1.S1. 
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6.2.2. Protein production and purification 
Fermentations were done using 2.5-L Bioflo 3000 stirred-tank bioreactors 
(New Brunswick Scientific, Nijmegen, The Netherlands), using BioCommand 
Software (New Brunswick Scientific, Nijmegen, The Netherlands) and a 
homebuilt methanol sensor-controller. The fermentations were performed under 
conditions optimal for DA and DB, as described previously 31. A starting volume 
of 1.25 L minimal basal salts medium 32 was used, and the growth temperature 
was 30 °C. The pH was controlled at 3.0 throughout the entire fermentation. 
The inlet air was supplemented with 20% oxygen for the duration of the 
glycerol fed-batch phase and the methanol fed-batch phase. During the 
induction phase, methanol levels were kept at a constant level of 0.2% (w/v). 
The last 40 min prior to methanol induction the temperature was linearly 
decreased from 30 °C to 20 °C. Approximately 10 min before methanol 
induction the medium was supplemented with 1% casamino acids. 
The purification of C2-S
H
48-C2-D
A
 and C2-S
H
48-C2-D
B was similar to the 
procedure described previously for C2-S
H
48-C2 
19. The proteins were 
precipitated from the supernatant by addition of ammonium sulfate to 45% of 
saturation, followed by incubation on ice for 30 min and centrifugation for 30 
min at 20,000 × g (4 °C). The protein pellet was resuspended in 50 mM formic 
acid and precipitated once more. The pellet was then resuspended in 50 mM 
formic acid, and desalted by extensive dialysis using Spectra/Por 7 tubing 
(Spectrum Laboratories, Breda, The Netherlands) with a 1 kDa molecular 
weight cut-off against 10 mM formic acid. The desalted protein was freeze-
dried for storage until use. The lyophilized C2-S
H
48-C2 protein was produced as 
described previously by Golinska et al. 19. 
6.2.3. SDS-PAGE 
SDS-PAGE was performed using a NuPAGE Novex System (ThermoFisher, 
Bleiswijk, The Netherlands) with 10% Bis-Tris gels, MES SDS running buffer, 
and SeeBlue Plus2 pre-stained molecular mass markers. Prior to 
electrophoresis, all samples were heated for 10 min at 70 °C in NuPAGE LDS 
Sample Buffer with NuPAGE Sample Reducing Agent, as per manufacturer’s 
recommendations for denaturing and reducing PAGE. For gel staining, 
Coomassie SimplyBlue SafeStain (ThermoFisher, Bleiswijk, The Netherlands) 
was used. 
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6.2.4. Mass spectrometry 
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry was 
performed using an ultrafleXtreme mass spectrometer (Bruker, Leiderdorp, The 
Netherlands). Samples were prepared by the dried droplet method on a 600 µm 
AnchorChip target (Bruker, Leiderdorp, The Netherlands), using 5 mg mL-1 
2,5-dihydroxyacetophenone, 1.5 mg mL-1 diammonium hydrogen citrate, 25% 
(v/v) ethanol and 3% (v/v) trifluoroacetic acid as matrix. Spectra were derived 
from ten 500-shot (1,000 Hz) acquisitions taken at non-overlapping locations 
across the sample. Measurements were made in the positive linear mode, with 
ion source 1, 25.0 kV; ion source 2, 23.3 kV; lens, 6.5 kV; pulsed ion 
extraction, 680 ns. Protein Calibration Standard II (Bruker, Leiderdorp, The 
Netherlands) was used for external calibration. 
6.2.5. Atomic force microscopy (AFM) 
Stock solutions of purified protein polymers for atomic force microscopy 
(AFM) were prepared by suspending the lyophilized product in 5 mM HCl at a 
concentration of 10 g L-1, followed by overnight incubation at room 
temperature to allow complete dissolution. 
In a first experiment, aimed at investigating whether the incorporated DA/DB 
modules disturb self-assembly of the silk-inspired polymers, fibrils were 
prepared exclusively from either C2-S
H
48-C2-D
A or C2-S
H
48-C2-D
B. The 
influence of pH was investigated as well. To start fibril formation, the pH 
values of the stock solutions were adjusted to the desired value with NaOH, and 
the solutions were diluted to 1 g L-1 with 10 mM sodium phosphate buffer of 
the same pH. The pH values evaluated were pH 7, 9, 10, and 12. 
In a second experiment, heterodimer formation by C2-S
H
48-C2-D
A and C2-
SH48-C2-D
B was tested in the presence of excess unmodified C2-S
H
48-C2, such 
that the final protein concentration was always 10 g L-1. To this end, equimolar 
mixtures of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B were prepared and 
immediately added to a solution of C2-S
H
48-C2 in four different ratios. In this 
manner, the final weight fraction of the combined modified polymers 
constituted 1, 2, 4, or 8% of the total protein. That is, each modified polymer 
was present at 0.05, 0.1, 0.2, or 0.4 g L-1, respectively. As controls for possible 
homodimerization under these conditions, analogous mixtures were prepared of 
C2-S
H
48-C2 with either C2-S
H
48-C2-D
A or C2-S
H
48-C2-D
B. Thus, always only one 
modified polymer was present, at concentrations of 0.1, 0.2, 0.4, or 0.8 g L-1 , 
respectively.  Fibril  formation  was induced  by adjusting the pH to 7.4 with 
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NaOH, and dilution to a final protein concentration of 1 g L-1 with 10 mM 
sodium phosphate (pH 7.4). 
For AFM imaging, the above polymer solutions were first incubated at room 
temperature to allow supramolecular assembly to occur. After 24 h, a drop (6 
μL) of sample was deposited onto a clean silica wafer and incubated for 20 
min. The wafer was then rinsed with 600 μL of Milli-Q water to remove salts, 
and carefully dried under a stream of nitrogen. Dry samples were imaged using 
a Nanoscope V (Veeco, NY, U.S.A.) in Scan Asyst imaging mode, using 
nonconductive silicon nitride probes with a spring constant of the cantilever 
0.32 N m-1. Images were recorded at frequency of 0.997 Hz and further 
processed with NanoScope Analysis 1.20 software (Veeco Instruments Inc. 
2010, U.S.A.). 
6.2.6. Rheology 
Stock solution of purified proteins C2-S
H
48-C2, C2-S
H
48-C2-D
A and C2-S
H
48-
C2-D
B, were prepared by dissolving the lyophilized polymers in 5 mM HCl, 
followed by overnight incubation at room temperature. To start self-assembly 
into fibrils and hydrogels, the pH was adjusted to pH 7.4 with NaOH, and 
samples were diluted with Milli-Q to the desired concentrations. 
The rheological properties of hydrogels consisting exclusively of C2-S
H
48-C2, 
C2-S
H
48-C2-D
A, or C2-S
H
48-C2-D
B were compared at a concentration of 10 g 
L-1. We also analyzed hydrogels that consisted of an equimolar mixture of C2-
SH48-C2-D
A and C2-S
H
48-C2-D
B, which was subsequently mixed with 
unmodified C2-S
H
48-C2. In these hydrogels, the summed weight fraction of 
polymers containing the DA/DB modules was 2, 4, 8, 16, 32, 64, 80 or 100% of 
the total protein concentration (10 g L-1). That is, the two modified polymers 
are each present at final concentrations of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 4.0, or 5.0 
g L-1. Finally, a series of measurements at a range of concentrations was 
performed for (i) an equimolar mixture of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B, 
and (ii) C2-S
H
48-C2 alone. In these cases, samples were analyzed at total 
protein concentrations of 5 g L-1, 7.5 g L-1, 10 g L-1, 15 g L-1, 20 g L-1, and 30 g 
L-1. 
All rheological measurements were performed using an Anton Paar MCR 501 
Rheometer (Anton Paar, Oosterhout, The Netherlands) equipped with a 
CC10/T200 Couette geometry (Anton Paar, Oosterhout, The Netherlands), with 
bob and cup diameter of 10.002 and 10.845 mm, respectively. A solvent trap 
was used to minimize evaporation. Frequency sweeps with angular frequency 
(ω) between 0.01 and 100 rad s-1 were performed at a strain of 0.1%. Strain 
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sweeps were performed between 0.1 and 100% deformation and a frequency of 
1 Hz. For measuring the build-up of the modulus in time, oscillatory shear 
measurements were done at an oscillation frequency of 1 Hz, and a fixed strain 
of 0.1%. The temperature was kept at 20 °C using a Peltier system. 
6.3. Result and discussion 
6.3.1. Protein production and characterization 
The two protein polymers, C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B, were 
biosynthesized in genetically modified Pichia pastoris. Their full amino acid 
sequences are listed in Table S1. The yield of purified protein was 2.3 g L-1 of 
cell-free broth for C2-S
H
48-C2-D
A and 1.4 g L-1 for C2-S
H
48-C2-D
B. To assess 
product identity, purified samples were subjected to SDS–PAGE and MALDI-
TOF. For both polymers, a main protein band was detected in SDS-PAGE at a 
position corresponding to the marker band of ~98 kDa, and it was accompanied 
by a smear at lower molecular weight (Fig. 6.1). 
Figure 6.1: SDS-PAGE analysis of the purified protein polymers. The purified protein polymers (5 
µg) were subjected to electrophoresis under denaturing and reducing conditions. Lane 1, CP 2-SH48-
CP 2-DA; lane 2, CP 2-SH48-CP 2-DB; lane M, protein molecular weight marker. 
The MALDI-TOF spectrum showed only a single peak for both C2-S
H
48-C2-
DA and C2-S
H
48-C2-D
B, at m/z 71,569 and m/z 71,642, respectively (Fig. 6.2). 
This corresponded well with the predicted molecular weights of 71,607 Da and 
71,689 Da, respectively, within experimental error. The anomalous molecular 
weights apparent from SDS-PAGE were expected and are related to the 
hydrophilic nature of the C block that poorly binds SDS 20, 21, 31, 34-36. A similar 
migration pattern in SDS-PAGE was previously observed for C2-S
H
48-C2 
24. 
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The protein polymers C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B migrate slightly 
faster than C2-S
H
48-C2 because the D
A and DB modules have substantial SDS-
binding 31. The smear visible in SDS-PAGE could indicate that the C2-S
H
48-
C2-D
A and C2-S
H
48-C2-D
B samples contained impurities. MALDI-TOF, 
however, did not show any evidence of that, and in C2-S
H
48-C2 a similar smear 
was shown to be an SDS-PAGE artifact 24. 
Figure 6.2: MALDI-TOF analysis of the purified protein polymers. (A) CP 2-SH 48-CP2-DA; (B) CP2-
SH48-CP2-DB. 
6.3.2. Pure C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B fibrils 
The C2-S
H
48-C2 protein polymer forms fibrils at pH ≥6 
19. The morphology of 
these fibrils was studied by tapping mode AFM (Fig 6.3). Using AFM we 
investigated whether the attachment of DA/DB modules at the C-terminus of the 
C2-S
H
48-C2 protein polymer influenced its ability to form fibrils. Fibril 
formation of separate C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B solutions was 
studied, at a concentration of 1 g L-1 and at different pH values. As shown in 
Fig. 6.4A and 6.4B both proteins formed long fibrils. In contrast to C2-S
H
48-C2  
(Fig. 6.3), the fibrils appear to be cross-linked and bundled. While fibrils 
formed by C2-S
H
48-C2 were evenly spread over the surface of the silica wafer, 
cross-linked and bundled fibrils of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B were 
observed as patches on an otherwise empty surface (Fig. 6.1.S1). The presence 
of bundles suggests that both DA and DB can undergo homotypic (DA/DA and 
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DB/DB) interaction. This is in agreement with our previous study, where we 
showed that DA/DA and DB/DB homotypic association may occur at 
concentrations above ~100 μM 31. The bundling was found to be strongly pH 
dependent. C2-S
H
48-C2-D
A fibrils do not appear to bundle when pH ≥ 10, and 
C2-S
H
48-C2-D
B fibrils do not appear to bundle when pH ≥ 12. The 
disappearance of bundles at high pH is most likely caused by electrostatic 
repulsion as a consequence of the larger negative charge of the fibrils at these 
pH values. Also, interactions between coiled-coils are typically at least partly 
electrostatic in nature 37, and hence the homotypic DA/DA and DB/DB 
associations might be pH-dependent. 
To selectively suppress homotypic interaction while maintaining 
heterodimerization, the concentration of DA and DB must be below the afore-
mentioned ~100 µM. For the samples studied with AFM, the overall protein 
polymer concentration was 14 μM. However, the local DA and DB 
concentration in the fibrils is much larger, and apparently large enough to 
trigger homotypic associations. Next, we focus on controlling fibril cross-
linking and bundling via heterotypic interactions between DA and DB modules 
in fibrils. 
Figure 6.3: AFM images of 0.1 % (w/v) ) CP 2-SH48-CP2. Protein solution was incubated for 24 
hours at pH 7.4 at room temperature, followed by 20 minute deposition on the silica wafer, rising 
and drying. 
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Figure 6.4: AFM analysis of fibrils of (A) CP2-SH 48-CP2-DA and (B) CP 2-SH48-CP 2-DB as a function 
of pH, 1 g L-1 protein solutions were incubated for 24 h at different pH values at room temperature, 
followed by 20 min of deposition on the silica wafer, rinsing, and drying. 
6.3.3. Heterodimer-driven fibrils bundling 
It has been shown previously that mixing of C2-S
H
48-C2 with an N-terminally 
extended variant does not interfere with fibril formation, and that hybrid fibrils 
are formed with both polymer types incorporated into one fibril 38. We here 
similarly mixed an excess of C2-S
H
48-C2 with its modified linker-containing 
variants with the aim of decreasing the local concentration of DA and DB, while 
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maintaining a constant total protein concentration. This allows the formation of 
fibrils (at pH 7.4) that contain only a small fraction of randomly incorporated 
DA and DB modules. The protein polymers with heterodimerizing DA/DB 
modules together constituted 1, 2, 4, or 8% of the total protein polymer 
concentration (1 g L-1). To determine whether homotypic DA/DA and DB/DB 
still play a role, we also studied fibrils formed from solutions of C2-S
H
48-C2 
mixed with either C2-S
H
48-C2-D
A or C2-S
H
48-C2-D
B (Fig. 6.5). 
We find that, for the control sample where C2-S
H
48-C2 was mixed with only 
C2-S
H
48-C2-D
A, fibrils did not form bundles at a C2-S
H
48-C2-D
A content of up 
to 8%. For the control sample consisting of C2-S
H
48-C2 and C2-S
H
48-C2-D
B, 
however, we find that at a relative content of 4% and 8%, fibrils are already 
spread less evenly over the surface, and show some bundling. A DB-content of 
4 % corresponds to an average distance along the fiber of ~25 nm between the 
DB-modules, similar to the average intermolecular distance in a ~100 µM 
solution. Thus, these fiber results correspond well with our previous findings on 
concentration dependent DB homodimer formation 31. For the samples 
containing C2-S
H
48-C2 and different amounts of an equimolar mixture of C2-
SH48-C2-D
A and C2-S
H
48-C2-D
B, we observe a clear bundling of fibrils, except 
at the lowest relative content of linker-containing polymers of 1%. AFM 
images of samples with 2 and 4% of DA/DB-containing proteins appear similar, 
and show fibrils of a few microns long, linked into straight bundles. For the 8% 
sample, bundling was much more extensive. 
The controls show that the DA/DA and DB/DB homotypic interactions only occur 
when the fraction of linkers is high. Also, the fact that the homotypic 
interaction is strongest for the DB linker, is in agreement with our previous 
findings 31. This shows that only a small fraction of DA/DB modules need to be 
incorporated into C2-S
H
48-C2 fibrils to quite drastically change the organization 
of the fibrils. 
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Figure 6.5: Control over CP 2-SH48-CP2 cross-linking and bundling using DA/DB heterodimers. AFM 
images are shown of CP2-SH 48-CP2 protein solutions containing different weight fractions of (A) 
CP 2-SH48-CP2-DA, (B) CP 2-SH48-CP 2-DB, or (AB) an equimolar mixture of CP2-SH48-CP2-DA and 
CP 2-SH48-CP2-DB. All proteins solutions were 1 g L-1, and were incubated for 24 h at pH 7.4 at 
room temperature, followed by 20 min of deposition on the silica wafer, rinsing, and drying. 
6.3.4. Mechanical properties of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B 
hydrogels 
6.3.4.1. Gel formation and recovery 
The gelation behavior of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B polymers was 
investigated using oscillatory shear measurements. Prior to the measurement, 
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the pH was raised to 7.4 in each sample, to trigger gelation. All measurements 
were performed at a constant temperature of 20 °C. The gelation behavior of 
the two protein polymers was compared with that of the previously developed 
C2-S
H
48-C2 
19, 24. At a concentration of 10 g L-1, all samples formed transparent 
hydrogels. Visually, the consistency of the protein solutions appeared to change 
immediately after the pH was increased, and approximately 2 hours later, all 
samples had formed self-supporting gels. 
Gel formation and gel recovery after mechanical failure were followed in time 
by continuous measurement of the storage (G′) modulus of 10 g L-1 protein 
polymer solutions, at an oscillation frequency of 1 Hz, and at a shear strain of 
0.1 % (Fig. 6.6A). The speed of gelation was similar for all three proteins. After 
10 h of gelation, the storage modulus of the C2-S
H
48-C2 gel was 182 Pa, 
whereas that of the C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B gel was 276 Pa and 
409 Pa, respectively. The storage modulus (G’) dominated the loss modulus 
(G”) in all cases. After rupture, network recovery was observed for all gels. The 
recovery of C2-S
H
48-C2 gel was nearly complete after 10 h of healing and 
reached a storage modulus of 142 Pa, in agreement with previous results 19, 24. 
In contrast, C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B gels recovered only partly 
with respect to their original modulus. After 10 h of healing, the storage 
modulus for C2-S
H
48-C2-D
A hydrogel reached a final value of 172 Pa and the 
storage modulus of C2-S
H
48-C2-D
B hydrogel reached the final value of 181 Pa. 
After fracture, all three hydrogels had a similar modulus. 
The increased storage moduli of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B 
hydrogels, in comparison to the storage modulus of the C2-S
H
48-C2 hydrogel, 
indicate that both DA and DB contributed to network formation via homotypic 
interactions. Moreover, the storage modulus of C2-S
H
48-C2-D
B was higher than 
the storage modulus of C2-S
H
48-C2-D
A, which again suggests the DB module 
has stronger homotypic interactions than the DA module, as we concluded 
earlier 31. The inability of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B hydrogels to 
fully recover from mechanical failure suggests that fibril-fibril interactions 
mediated by homotypic DA/DA and DB/DB association somehow hindered or 
blocked recovery. Previous findings by our group showed that while full 
recovery of pure C2-S
H
48-C2 hydrogels was obtained after mechanical failure at 
lower concentrations, only partial recovery was observed at higher 
concentrations 19, 24. The protein polymer variant C2-S
E
48-C2, which contains a 
glutamic acid instead of a histidine, was previously shown to form fibrillar 
hydrogels with a higher storage modulus than C2-S
H
48-C2 but with no capacity 
to recover, after mechanical failure 39. As suggested by Golinska et al. 19, while 
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stronger physical cross-links may give rise to higher moduli, they may possibly 
also impede recovery of the gel after failure. 
Figure 6.6: (A) Time course of storage modulus G’ for 10 g L-1 gels made of CP 2-SH48-CP2 (black), 
CP 2-SH48-CP2-DA (red), or CP2-SH 48-CP 2-DB (blue). The gels were formed at pH 7.4 and 20 ˚C. 
After 10 h the gels were broken by applying a 100% deformation and the recovery was measured as 
a function of time. Measurements were made in a Couette configuration at 1 Hz and 0.1 % 
deformation. (B) Strain sweep at 1 Hz for 10 g L-1 gels made of CP2-SH 48-CP 2 (black),  CP2-SH 48-
CP 2-DA (red), or CP2-SH 48-CP2-DB (blue). The storage modulus (G’) is plotted as a function of 
deformation (ɣ). 
6.3.4.2. Stiffening behavior 
For the samples discussed in the previous paragraph we also tested whether 
they exhibited strain stiffening, which is a hallmark feature in the rheology of 
many fibrillar hydrogel systems such as the ECM. Hydrogels were exposed to a 
strain sweep up to the point of mechanical failure. While hydrogels composed 
of the original C2-S
H
48-C2 triblock protein polymer showed significant strain 
stiffening before failure, this was not the case for hydrogels composed of C2-
SH48-C2-D
A or C2-S
H
48-C2-D
B only (Fig. 6.6B). Note that strain stiffening has 
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not only been reported for hydrogels of C2-S
H
48-C2, but also for hydrogels of 
the glutamic acid-containing C2-S
E
48-C2 variant 
39. Both C2-S
H
48-C2 and C2-
SE48-C2 hydrogels are composed of mostly non-crosslinked and non-bundled 
semi-flexible fibrils that undergo significant thermal deformations 19, 39. The 
characteristic strain-hardening of fibrillar hydrogels occurs when stretching 
forces have pulled out all thermal deformations of the fibrils 40. The extensive 
cross-linking and bundling of the fibrils in C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B 
may have affected the thermal deformations of the fibrils in such a way that 
shear stiffening was abolished. 
6.3.5. Mechanical properties of mixed C2-SH48-C2/C2-SH48-C2-
DA/C2-S
H
48-C2-D
B hydrogels as a function of linker concentration 
6.3.5.1. Gel formation and recovery 
Next, we studied hydrogels composed of C2-S
H
48-C2 plus different amounts of 
an equimolar mixture of C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B. Here we can use 
the fraction of protein polymers with DA/DB linkers as a tuning parameter for 
the degree of fibril cross-linking and bundling. The total protein polymer 
concentration was again 10 g L-1 and the weight fractions of protein polymers 
with DA/DB linkers were chosen to be 2, 4, 8, 16, 32, 64, 80, and 100% (so e.g. 
2% means 1% C2-S
H
48-C2-D
A and 1% C2-S
H
48-C2-D
B). Gelation and recovery 
after mechanical failure were studied as in the previous paragraph. The storage 
modulus obtained after 10 h of incubation time was plotted against the fraction 
of protein polymers with DA/DB in the fibrils (Fig. 6.7). The final modulus of 
the hydrogels increased with the fraction of protein polymers with DA/DB 
modules. This shows that the DA/DB modules do indeed strengthen the network 
of fibrils by cross-linking and bundling the fibrils. Since the rheology 
experiments were done at concentrations that are a factor 10 higher than those 
used in the AFM experiments, we expect that especially for the fibrils with a 
higher content of the DA/DB modules, this strengthening is a consequence of 
both hetero- and homotypic associations. Consistent with the results obtained 
with hydrogels made from either C2-S
H
48-C2-D
A or C2-S
H
48-C2-D
B alone, we 
find that the incorporation of more DA/DB modules impedes recovery after 
mechanical failure. For a few selected samples, Fig. 6.8A shows the 
development of the storage modulus as a function of time, during gel formation 
and during recovery. Rheological data for additional hydrogels, including 
frequency sweeps as the analysis of the behaviour of the samples at different 
changes of stress, can be found in Supplementary material, Fig. 6.1.S2. 
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Figure 6.7: Storage modulus (G’) after 10 h of 10 g L-1 CP2-SH 48-CP2 gels containing different 
weight fractions of a 1:1 mixture of CP2-SH 48-CP 2-DA and CP 2-SH48-CP 2-DB. 
Figure 6.8: (A) Time course of storage modulus G’ for 10 g L-1 gels made of CP 2-SH48-CP2
containing different fractions of a 1:1 mixture of CP2-SH 48-CP2-DA and CP 2-SH48-CP 2-DB. (B) 
Strain sweep at 1 Hz for the same samples. 
6.3.5.2. Stiffening behavior 
Also for the hydrogels with mixed fibrils, we studied their possible strain 
hardening. In Fig. 6.8B, the storage modulus is plotted against strain for 
hydrogels formed by mixed fibrils containing a range of concentrations of the 
DA/DB linkers. 
We find that strain hardening is lost completely for the case of mixed fibrils 
with 100% DA/DB linkers (i.e. fibrils that contain 50% of C2-S
H
48-C2-D
A and 
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50% of C2-S
H
48-C2-D
B). Hydrogels composed of fibrils with 2%, 32% and 
80% of linkers did show an upturn of the storage modulus, but were broken at 
lower values of the strain than hydrogels composed of fibrils without linkers. 
6.3.6. Concentration dependence 
We studied the concentration dependence of the modulus of hydrogels 
composed exclusively of polymers with linkers, i.e. gels that contain 50% of 
C2-S
H
48-C2-D
A and 50% of C2-S
H
48-C2-D
B. Storage moduli were determined 
after 10 h of gelation for samples with total protein polymer concentrations of 
5, 7.5, 10, 15, 20, and 30 g L-1, both for the mixed fibrils with 100% linkers and 
for a C2-S
H
48-C2 control (without linkers). Results are shown in Fig. 6.9. For 
all concentrations, the storage moduli obtained were higher for the hydrogels 
composed of fibrils with linkers, but otherwise the concentration dependence 
was quite similar for the cases with and without linkers. At a concentration of 5 
g L-1, a storage modulus could be detected for the hydrogels with linkers, but 
not for the hydrogels without the linkers. 
Figure 6.9: Storage modulus (G’) as a function of concentration of a 1:1 mixture of CP2-SH 48-CP2-
DA and CP2-SH 48-CP2-DB (red), and of a CP2-SH 48-CP2 control  (black). 
6.3.7. Separation of DA and DB in different fibers 
We tried to investigate whether there is a difference between a situation where 
the DA/DB modules are mixed within each fibril (as a result of mixing solutions 
prior to inducing self-assembly, as considered here), and a situation where 
fibrils with only DA modules are mixed with fibrils containing only 
DB modules. We expected stronger fibril-fibril interactions in the latter case. 
Unfortunately it is difficult to realize such a mixture of ‘DA-only’ and ‘DB-
only’ fibers in practice. One would need to mix samples that have already 
gelled, or mix dilute samples and then concentrate. 
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As a preliminary test, we performed the following experiment. At a low 
concentration of 7.5 g L-1, we induced fibril formation by pH adjustment, and 
allowed fibril formation to proceed for 2h for separate C2-S
H
48-C2-D
A and C2-
SH48-C2-D
B samples. Next, these solutions were mixed. We also prepared a 
control sample that was mixed before pH adjustment as normal. We find that 
delaying the mixing of the protein polymers with DA and DB linkers by 2h, 
leads to an increase of the modulus by a factor of about 2 (Fig. 6.1.S3). This is 
an interesting result, which suggests there is much to be gained in terms of 
achieving still stronger gels when a convenient procedure could be developed 
to prepare concentrated hydrogels consisting of fibrils with only DA and fibrils 
with only DB linkers. 
6.4. Conclusion 
We have produced recombinant protein polymers C2-S
H
48-C2-D
A and C2-S
H
48-
C2-D
B with DA and DB linkers that mediate cross-linking and bundling of C2-
SH48-C2 fibrils, via D
A/DB heterodimerization. The system allows for a 
systematic control over the extent of cross-linking and bundling of the fibrils, 
by varying the concentration of linkers in the fibrils, even though unintended 
homotypic DA/DA and DB/DB associations probably do play a role at higher 
concentrations of linkers in the fibrils. This is an important result, since in 
many systems developed as artificial ECM, there is some degree of fibril cross-
linking and bundling, but it typically cannot be tuned 28. We found that in 
mixed hydrogels consisting of only protein polymers with DA/DB linkers, both 
strain stiffening and full recovery after mechanical failure were lost. This is 
reminiscent of results for collagen type I hydrogels, where the degree of strain 
stiffening was found to be smaller for gels at higher concentration and in those 
displaying thick fibril bundles 41. 
The cross-linking and bundling approach we have developed here can be used 
as an alternative to our previously developed approach, in which heparin was 
used to cross-link and bundle heparin-binding fibrils30. More generally, we 
have made an important first step to the design of protein polymers for which 
fibril cross-linking and bundling can be controlled by merely adjusting fibril 
composition through mixing. Given the exquisite sensitivity of cells for the 
structure and mechanics of the ECM, the development of approaches that 
enable control over the nano- and microscale architecture of fibrillar hydrogels 
is an important challenge for the development of better artificial ECM 
hydrogels with properties matched to the needs of specific cell types.  
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Supplementary data 6.1 
Table 6.1.S1: Amino acid sequence of newly constructed proteins. The silk-like SH48 blocks are 
underlined, and the heterodimer-forming modules are highlighted in bold red. 
Code Amino acid Sequence 
C
2
-S
H
48
-C
2
-D
A
 
YVEFGLGAGAPGEPGNPGSPGNQGQPGNKGSPGNPGQPGNEGQPGQPGQNGQPGEPGSNGPQGSQG
NPGKNGQPGSPGSQGSPGNQGSPGQPGNPGQPGEQGKPGNQGPAGEPGNPGSPGNQGQPGNKGSPG
NPGQPGNEGQPGQPGQNGQPGEPGSNGPQGSQGNPGKNGQPGSPGSQGSPGNQGSPGQPGNPGQPG
EQGKPGNQGPAGEGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAG
AGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAG
HGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHG
AGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAG
AGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAG
AGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAG
HGAGAPGEPGNPGSPGNQGQPGNKGSPGNPGQPGNEGQPGQPGQNGQPGEPGSNGPQGSQGNPGKN
GQPGSPGSQGSPGNQGSPGQPGNPGQPGEQGKPGNQGPAGEPGNPGSPGNQGQPGNKGSPGNPGQP
GNEGQPGQPGQNGQPGEPGSNGPQGSQGNPGKNGQPGSPGSQGSPGNQGSPGQPGNPGQPGEQGKP
GNQGPAGEGALEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETRYGPLGGGKG
C
2
-S
H
48
-C
2
-D
B
 
YVEFGLGAGAPGEPGNPGSPGNQGQPGNKGSPGNPGQPGNEGQPGQPGQNGQPGEPGSNGPQGSQG
NPGKNGQPGSPGSQGSPGNQGSPGQPGNPGQPGEQGKPGNQGPAGEPGNPGSPGNQGQPGNKGSPG
NPGQPGNEGQPGQPGQNGQPGEPGSNGPQGSQGNPGKNGQPGSPGSQGSPGNQGSPGQPGNPGQPG
EQGKPGNQGPAGEGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAG
AGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAG
HGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHG
AGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAG
AGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAG
AGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAGHGAGAGAG
HGAGAPGEPGNPGSPGNQGQPGNKGSPGNPGQPGNEGQPGQPGQNGQPGEPGSNGPQGSQGNPGKN
GQPGSPGSQGSPGNQGSPGQPGNPGQPGEQGKPGNQGPAGEPGNPGSPGNQGQPGNKGSPGNPGQP
GNEGQPGQPGQNGQPGEPGSNGPQGSQGNPGKNGQPGSPGSQGSPGNQGSPGQPGNPGQPGEQGKP
GNQGPAGEGALEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGGGKG
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Figure 6.1.S1: The distribution of fibrils on the surface of the AFM silica wafer. Fibrils formed by 
(A) C2-SH48-C2 are evenly spread, while (B) C2-SH 48-C2-DA and (C) C2-SH48-C2-DB are gathered 
in patches exposing the empty surface. 
Figure 6.1.S2: (A) Time course of storage modulus G’ for 10 g L-1 gels made of CP 2-SH48-CP 2
containing different fractions of a 1:1 mixture of CP2-SH 48-CP2-DA and CP 2-SH48-CP 2-DB. (B) 
Angular frequency (ω) dependence of the storage modulus (G’) at 20 ˚C. 
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Figure 6.1.S3: Time course of storage modulus G’ for 7.5 g m-1 gels made of CP2-SH 48-CP2 (blue), 
CP 2-SH48-CP2-DA (green), CP2-SH48-CP 2-DB (purple), and CP2-SH 48-CP2-DA and CP2-SH 48-CP2-DB 
mixed in a 1:1 ratio before pH was adjusted to 7.4 (black) or 2 h after pH was adjusted to 7.4 (red). 
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General Discussion 
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7.1. Heterodimerizing modules as means to better control protein-
polymer assembly 
Protein self-assemblies present in nature are remarkably complex and diverse. 
Their assembly and disassembly is a sensitive function of physical-chemical 
parameters such as pH, ionic strength and temperature 1, and this makes the 
design of protein-polymers that assemble into desired structures particularly 
difficult. At the same time, the enormous potential of proteins as building 
blocks for the "bottom-up" fabrication of novel biomaterials with versatile 
functionalities is clearly recognized in nanotechnology 2,3. 
In this thesis, we explore supramolecular strategies in order to be able to better 
control protein polymer self-assembly. So far, in our laboratory, we have 
developed a number of protein polymers that can self-assemble via homotypic 
associations into simple supramolecular structures such as fibrils or micelles 4-6. 
In this thesis we go one step further, by focusing on the construction and 
physical characterization of protein polymers that additionally have modules 
with heterotypic interactions, in particular module A and B that form A/B 
heterodimers but (preferably) do not show A/A or B/B association. 
To put the research described in this thesis into a broader context, we first 
review other general strategies that have been used before to direct protein 
polymer assembly. We then argue why there is a need for an additional, 
complementary strategy involving reversible heterodimerizing modules. Next, 
we summarize the most important outcomes of this research and do some 
recommendations for further steps that could be taken. Finally, we briefly 
reflect on the potential applications of our results, present a risk analysis and 
technology assessment, finally comment on future perspectives for the field of 
self-assembling protein polymers. 
7.2. Strategies to direct protein polymer self-assembly 
7.2.1. Strategies to obtain well-defined space-filling networks 
Natural protein self-assemblies often exhibit distinct symmetries, that reflect 
the symmetries of the underlying protein components (e.g. bacterial S-layers, or 
polyhedral virus particles) 1. Building on that observation, general strategies for 
designing large protein assemblies have been recently proposed for building 
structures from units, where each unit has multiple self-assembling blocks. For 
example, if a protein block A that forms a tetramer is fused to a protein block B 
that forms a dimer, a tetrameric unit (AB)4 is formed that in turn can assemble 
into much larger structures via B-B associations 7,8. Regular structures can be 
formed in the A-B linkage is rigid. With flexible A-B linkages, more irregular 
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assemblies are formed 9. Several interesting symmetrical peptide self-
assemblies designs along these lines have recently been reviewed by Yeates et 
al. 10. A variation on this theme is the protein polymer T9-C
P
4-T9 
11 on which 
we develop variations in this thesis. In this protein polymer, a long hydrophilic 
random coil midblock (CP4) chemically links two trimer-forming blocks (T9). 
Above a critical concentration, and at low enough temperatures, the resulting 
triblock protein polymer forms space-filling networks. 
7.2.2. Strategies to obtain well-defined nanoparticles using templates 
strategies 
Another nature-inspired strategy, templating, can be used to obtain well-defined 
finite-sized protein assemblies. This holds in particular for linear assemblies. 
Precise length control for linear protein assemblies is difficult to achieve, but a 
beautiful example where precise control is obtained is provided by the linear 
viruses, where the length of the protein assembly is set by the length of a 
nucleic acid template. 
At least two domains are required for templated self-assembly: a domain that 
allows for the interaction between neighbouring protein polymers, and a 
domain that interacts with the template 3. A first example of the implementation 
of this strategy was described by Grigoryan et al, where a peptide was designed 
that assembles around a carbon nanotube 12. Another example is provided by 
work from our group, where a protein polymer was designed that co-assembles 
with DNA to form rod-shaped virus-like particles 13.  
7.2.3. Biochemical strategies for covalent cross-linking 
These strategies have been reviewed in the Chapter 2 of this thesis. In brief, 
another powerful approach to assemble protein components is via biochemical 
reactions between proteins 14. In our group we have explored use of the 
enzymes glutaminase 15 and sortase 16 to cross-link different type of protein 
polymers. In both cases it was found to be difficult to optimize the process of 
cross-linking. Also the need for an additional component (an enzyme) can be 
seen as a disadvantage. An example of biochemical cross-linking that does not 
need an additional component is described by the group of Tirrell et al. and 
spontaneously occurs between the peptide pair called SpyTag/SpyCatcher 17, 
where the SpyCatcher is in essence a small autocatalytic cross-linking enzyme. 
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7.2.4. Strategies for reversible cross-linking using blocks with homotypic 
interactions 
While for some applications it is best to use covalently cross-linked protein 
assemblies, for other applications, reversible, physical cross-links are preferred. 
For instance, for the construction of smart materials that can self-heal and 
disassemble in response to particular stimuli such pH or temperature 18, it is 
crucial to have assemblies be built up via reversible physical bonds, and these 
are also the types of materials that we aim at in this thesis. As also described in 
Chapter 2, in reversible cross-linking strategies, protein polymer designs 
include blocks A that have homotypic A/A interactions that drive association of 
the A blocks into dimers, trimers etc. When multiple A blocks are present on a 
single protein polymer, space filling networks can be formed 3. Many natural 
domains with known sequences can be used that show such self-associations. In 
addition, computational protein design is now also starting to result in 
functional de novo designed self-associating 19. Indeed, the toolbox of available 
self-association domains is still expanding and one can choose between 
domains with widely differing sizes and association strengths 20,21. The choice 
depends on the ultimate application of protein polymer self-assemblies 22. 
Indeed, depending on whether we aim to fabricate a nanoreactor, a sensor or a 
stimuli-responsive material, requirements on the assembly and the final 
properties will be very different, and this translates into different choices for 
protein polymer designs and self-association blocks to be used 23. 
7.2.5. Reversible cross-linking using blocks with heterotypic interactions 
An additional level of control is obtained when not homotypic A/A associations 
are being used, but heterotypic A/B associations. Ideally of course, in this case, 
there are no homotypic A/A or B/B associations. The specific case that we 
focus on is that of A/B heterodimer formation. Employing heterodimerization 
to form supramolecular structures from protein polymers allows to construct 
two-component systems, that assemble upon mixing. This can also be used to 
direct hierarchical assembly, for example a system involving only A first 
assembles into thin fibrils, and then, by adding another protein polymer that 
contains B, the fibrils are cross-linked or bundled up into higher-order 
structures. Heterodimerization could be also used as a tool to combat protein 
production problems. For example, the low yield of production for T16-C
P
4-T16
triblock protein polymers was attributed to network formation during 
biosynthesis 24. This problem could possibly be solved by producing the protein 
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polymer as two halves, that later are made to stick together via A/B 
heterodimer association.  
Heterodimers studied in this thesis have been heterodimeric coiled-coils, and 
WW domains and their proline-rich peptide ligands. In both cases, the 
mechanism of interaction is based on hydrophobic forces and/or attraction of 
the opposite charges 25-28. The choice for these particular heterodimer couple 
was partly dictated by the medical applications that are foreseen for protein 
polymers 29. Another criterion was the possibility to produce the chosen peptide 
sequences in the P. pastoris expression system that we use for protein polymer 
production. We chose sequences for heterodimeric couples that were short: less 
than 50 amino acid. This improves chances that the newly introduced blocks do 
not interfere too much with the behavior of the template protein polymer in 
which they are incorporated. Also, heterodimers should still form at 
physiological conditions (i.e. ~37 ˚C and ~ 7 pH). With these conditions being 
met, we expect that the risk that the introduction of the heterodimerizing blocks 
will compromise features such as biocompatibility and biodegradability is 
rather low. In the next paragraph, we discuss in more detail the functionality of 
the chosen heterodimers as blocks for controlled assembly of protein polymers. 
7.3. Recombinant protein polymers with heterodimer-forming 
modules 
7.3.1. A-B guided protein self-assemblies: from concept to practice 
In this thesis, we use the previously developed protein polymers CP4 
30, T9-
CP4 
11 and C2-S
H
48-C2 
5 as template protein polymers that we extend/modify 
by the introduction of heterodimerizing blocks, referred hereafter as modules. 
The self-assembly behaviour of each these (unmodified) protein polymers in 
aqueous solutions is summarized in Fig. 7.1. 
We aimed to constructed A and B variants of each of above mentioned protein 
polymers (Table 7.1). Here, A and B stand for the two different but 
complementary peptides that self-assemble with high affinity. By mixing 
variants A and B, we envisioned that several protein self-assemblies could be 
achieved, as illustrated in Fig. 7.2. Although the system that we envisioned is 
still rather simple in comparison to natural protein self-assemblies 1, it is a good 
starting point in a quest for more and more complex nanostructures 31. 
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Figure 7.1: Protein polymers used in this thesis to test in combination with heterodimer-forming 
modules. (A) The CP 4 block (blue) is a hydrophylic random coil block with a high content of 
glycines and prolines. (B) The T9 block of the T9-CP 4 fusion (T9 block in red) forms tripe helixes at 
protein concentrations higher than 2 mM and temperatures below 35 ˚C. (C) The C2-SH 48-C2 
triblock forms stiff, long fibrils at pH > 6. It consists of a silk-like midblock SH48 (yellow) C2 
terminal blocks (blue) that act as stabilizers. They are similar in sequence to the CP 4 block but 
shorter (half as long). 
Table 7.1: Heterodimeric modules studied in this thesis. D stands for dimer-forming. The 
superscript indicates the identity of the modules: A and E for the more acidic and B and K for the 
more basic coils of the coiled/coil pairs. WW and CC43 are both WW domains, and the general 
abbreviation for their proline-rich ligands is PPxY. 
Codes for A/B heterodimer-forming couple Type of interaction 
D
A
 D
B
 Heterodimeric coiled coil 
27
D
E
 D
K
 Heterodimeric coiled coil 
28
D
WW
,D
CC43†
 D
PPxY
, D
PPxY*
,
D
PPxY-1 
or D
PPxY-1*†
 
WW binding domain and proline-rich 
ligand
25,26
 
† WW domains can recognize different type of proline-rich peptide ligands 
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Figure 7.2: Examples of protein self-assemblies that could be formed in various mixtures of A and 
B variants of CP4, T9-CP 4 and C2-SH 48-C2. The reaction labelled as A+B symbolizes that variant A 
is mixed with variant B in a 1:1 ratio. (*) Here also an alternative network is possible, where A and 
B are reversed. 
7.4. Biosynthesis of protein polymers 
For completeness, we give an overview of all new protein polymers produced 
in this thesis. All protein polymers were produced in P. pastoris production 
strain GS115 in a process established by Werten et al (i.e. standard 
fermentation) 30. A list of produced protein polymers with DA/DB modules is 
given in Table 7.2. For the DE /DK pair, see Table 7.3, and for the WW/PPxY 
pairs, see Table 7.4. Protein polymers listed in these tables were obtained in 
high yields. In some cases, the standard fermentation resulted in partly 
degraded products. This could not be resolved by employing the protease 
deficient strains 32 (Chapter 3 and Chapter 4). Conditions tested to reduce 
degradation are also indicated in the tables. Of the parameters that were varied, 
we found that a low temperature in the induction phase is best to reduce 
degradation (Chapter 3). We also showed that Pichia-derived glycosylation of 
protein polymers can be resolved by suitable modifications of the protein 
sequence (Chapter 5). In a few cases no proteins were produced during 
fermentation, or only protein polymer genes were constructed but no 
fermentations were done. These cases are listed in Table 7.5. 
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Table 7.2: Protein polymers with DA and DB coiled coils analyzed in this thesis. 
Code Fermentation 
parameters Yields* Product Function 
C
P
4
-D
A
 
SMD1168 strain 0.3 Partly degraded Not tested 
Best-guess 0.6 Nearly intact Forms both homotypic and 
heterotypic bonds 
T
9
-C
P
4
-D
A
 
Standard 1.2 Partly degraded 
Not tested 
pH 5 0.7 Degraded 
C conditions 0.9 Partly degraded 
B conditions 0.2 Nearly intact 
A conditions 0.6 Partly degraded 
Best-guess 0.3 Nearly intact Forms both homotypic and 
heterotypic bonds 
C
P
4
-D
B
 
SMD1168 strain 0.3 Partly degraded Not tested 
Best-guess 1 Nearly intact Forms both homotypic and 
heterotypic bonds 
T
9
-C
P
4
-D
B
 
Standard 1.1 Partly degraded Not tested 
C conditions 0.7 Partly degraded 
B conditions 0.6 Nearly intact 
A conditions 0.6 Nearly intact 
Best-guess 0.4 Nearly intact Forms both homotypic and 
heterotypic bonds 
C
2
-S
H
48
-C
2
-D
A
 B conditions 2.3 Intact Forms both homotypic and 
heterotypic bonds 
C
2
-S
H
48
-C
2
-D
B
 B conditions 1.4 Intact 
* The gravimetrically determined yield is expressed as g of lyophilized product per L of cell-free 
broth, 
Abbreviations of fermentation conditions: Best-guess: 20 ˚C, no additional oxygen supply, 
supplementation with ascorbic acid and casamino acids, A conditions: 20 ˚C, no additional oxygen 
supply, supplementation with ascorbic acid, B conditions: 20 ˚C, supplementation with casamino 
acids, C conditions: 30 ˚C, supplementation with casamino acids 
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Table 7.3: Protein polymers with DE and DK coiled coils analysed in this thesis. 
Code Fermentation 
parameters Yields* Product Function 
C
P
4
-D
E
 Standard 2.3 Intact Data unclear 
T
9
-C
P
4
-D
E
 Standard 1.6 Intact Only homotypic interaction 
confirmed 
C
P
4
-D
K
 Standard 2.5 Partly degraded Data unclear 
T
9
-C
P
4
-D
K
 
Standard 2 Partly degraded Only homotypic interaction 
confirmed 
pH 5 1.9 Degraded Not tested 
Yapsin 1 disruptant 
strain  2.3 Partly degraded 
Only homotypic interaction 
confirmed 
* The gravimetrically determined yield is expressed as g of lyophilized product per L of cell-free 
broth 
Table 7.4: Protein polymers with WW domains and proline-rich domains analysed in this thesis. 
Code Fermentation 
parameters Yields* Product Function 
C
P
4
-D
WW
 Standard 2.2 Intact Forms heterotypic bonds 
T
9
-C
P
4
-D
WW
 Standard 1.8 Intact Data unclear 
D
WW
-C
P
4
-D
WW
 Standard 2.4 Intact 
Forms heterotypic bonds 
C
P
4
-D
PPxY
 Standard 2.3 Glycosylated 
T
9
-C
P
4
-D
PPxY
 Standard 1.6 Glycosylated Data unclear 
C
P
4
-D
PPxY*
 Standard 2.5 Intact Forms heterotypic bonds 
T
9
-C
P
4
-D
PPxY*
 Standard 1.4 Intact  Data unclear 
C
P
4
-D
CC43
Standard 1.64 Degraded 
Not tested 
T
9
-C
P
4
-D
CC43
Standard 0.73 Degraded 
T
9
-C
P
4
-D
PPxY-1
 Standard 1.85 Glycosylated 
Not tested 
T
9
-C
P
4
-D
PPxY-1*
 Standard 1.6 Glycosylated 
* The gravimetrically determined yield is expressed as g of lyophilized product per L of cell-free 
broth 
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P. pastoris has become a popular host for the expression of recombinant 
proteins. In our laboratory, we have successfully produced many protein 
polymers in large quantities in P. pastoris 13,30,33-35. Nonetheless, referring to the 
results compiled in Tables 7.2-4, when using P. pastoris as an expression 
system, it is not easy to predict how certain products will be processed and, 
whether they will be secreted or not. The production of recombinant proteins in 
P. pastoris requires luck, patience and empirical knowledge. Parameters 
influencing product yield in P. pastoris have been described in a few recent 
reviews 36-38 and such information is crucial for planning protein production in 
P. pastoris. 
Table 7.5: The list of genes encoding protein polymers that were constructed but not produced 
Code Production stage 
D
E
-C
P
4
-D
E
 Transformed GS115 P. pastoris 
D
K
- C
P
4
-D
K
Transformed GS115 P. pastoris 
D
B
-C
P
4
-D
B
 Transformed GS115 P. pastoris 
C
P
4
-D
PPxY-1
 Transformed GS115 P. pastoris 
C
P
4
-D
PPxY-1*
 pPIC9 in E. coli 
D
PPxY-1
-C
P
4
-D
PPxY-1
 Transformed GS115 P. pastoris 
D
CC43
-C
P
4
-D
CC43
Product absent in the free-cell broth 
D
PPxY
-C
P
4
-D
PPxY
 Product absent in the free-cell broth 
D
B
-C
P
4
-D
B
 Product absent in the free-cell broth 
7.5. Recommendation for follow up research 
This study has resulted in many interesting findings, and most of these have 
already been published in peer reviewed scientific journals. At the same time, 
many fascinating questions remains unanswered. With respect to the DA and the 
DB modules, fused to different protein polymers, we were able to show that 
they were functional, and that their dissociation constant was on the order of 
µM (Chapter 3), but we would like to have a more precise value for the Kd. 
Possibly, such a more precise value can be obtained, for instance, using 
fluorescence resonance energy transfer (FRET). Furthermore, using circular 
dichroism (CD), the preferential formation of heterodimers by the DA and the 
DB modules could be analyzed, as well as structures formed through homotypic 
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interaction of these modules 39. This would allow defining the concentration 
regime where we may still find heterodimer-driven self-assembly. In case of 
C2-S
H
48-C2 hydrogels containing heterodimer-forming modules (Chapter 6), 
more information on their structure could be obtained from cryo-transmission 
electron microscopy. Włodarczyk-Biegun et al. already studied the pore size 
and erosion of C2-S
H
48-C2 hydrogels 
29. A similar analysis could be done for 
the hydrogels studied in this thesis. Referring to work of Rombouts et al. on 
composite hydrogels with improved mechanical properties, investigating the 
effect of mixing two types of protein polymers C2-S
H
48-C2-D
A/DB and T9-C
P
4-
DA/DB on the mechanics of the resulting hydrogels would also be very 
interesting 16. 
Although the DE /DK pair did not give the anticipated results (Chapter 4), 
further research could still be useful. First, it is important to obtain fully intact 
DK protein polymers variants by testing different protease deficient stain, or, by 
exploring fermentation conditions as described in Chapter 3. Furthermore, also 
for protein polymers with this heterodimer couple it would be interesting to 
perform CD at different pH values. Since the intact T9-C
P
4-D
E can form 
hydrogels, it would be also interesting to compare its properties to properties of 
hydrogels formed by T9-C
P
4-T9. The group of Tirrel et al, for instance, showed 
that hydrogels made of asymmetric protein polymers with terminal coiled coils 
had a tunable erosion rate 40. 
In the case of the DWW domain and its proline-rich peptide ligands (Chapter 5), 
the high Kd value obtained from ITC for D
WW-CP4-D
WW, should be verified 
using tryptophan fluorescence studies, as it was done for CP4-D
WW. In case of 
T9-C
P
4-D
WW/T9-C
P
4-D
PPxY* hydrogels, the interaction of the T9 block and the 
DWW domain could be analysed by monitoring tryptophan fluorescence during 
titration of the DWW domain protein polymer variant with T9-C
P
4-T9. Since the 
protein polymer with DCC43 domain was degraded, we did not proceed with its 
further analysis. Foo et al. showed, however, that this WW domain has the 
strongest affinity towards DPPxY 25. Therefore, it would also be worthwhile to 
try to remedy the degradation problems for these protein polymers. In Fig. 7.2, 
we showed many architectures that could be achieved using A/B heterodimer-
forming modules. Unfortunately, in this thesis, not all of these possibilities 
could be tested.  
7.6. Protein polymer self-assemblies as functional nanomaterials 
Protein polymers are considered as useful building blocks for the “bottom-up” 
fabrication 41,42 of nanostructured biomaterials. To date, dozens of peptide- and 
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protein-based nanomaterials have been developed as for very diverse range of 
applications such as nanoreactors, sensors, electronics, and stimulus-responsive 
materials 43,44. Our main interest has been in eventual applications as 
nanostructured biomaterials for medical use 45, and for that case, certain 
requirements must be fulfilled simultaneously 46. First, the protein polymer 
materials should display appropriate mechanical and chemical properties that 
trigger a desired cellular response 45. Next, their toxicity, antigenicity, and 
inflammation should be lower than established thresholds 46. The property of 
protein materials to decompose naturally over time into nontoxic components is 
a big advantage 46. General advantages of recombinant protein polymers as 
biomaterials are that the protein polymers are very monodisperse, and that one 
can include various bioactive peptide motifs in the designs. Furthermore, they 
allow for programmable biodegradation and can potentially be produced at low 
cost and large scale 47. 
So far, the only protein-polymer discussed in this thesis that has been 
investigated as a future biomaterial is the C2-S
H
48-C2 triblock, hydrogels of 
which have been investigated as a scaffold for cell growth, in the context of 
tissue engineering (TE) 29. Results obtained were very encouraging, and 
warrant further efforts to improve performance of these hydrogels as an 
artificial extracellular matrix (ECM). This is exactly what we have done by 
investigating the use of heterodimerizing modules for cross-linking and 
bundling fibrils, thus better mimicking the actual structure of the ECM. In TE, 
the aim is to repair, maintain or replace tissue function 48. TE involves growing 
cell in scaffolds. The scaffold is a highly porous artificial ECM used to 
accommodate cells and guide their growth 48. Biomaterials made of 
recombinant protein polymers are considered as very promising scaffolds 49-51. 
This is because of the possibility to combine protein blocks with different 
functionalities within one protein polymer 49. The most commonly used protein 
blocks are collagen-like, silk-like, elastin-like or resilin-like 49. A common 
problem is that scaffolds lack the required mechanical strength and 
porosity 29,49. Coming back to the example of the C2-S
H
48-C2 protein polymer, 
heterodimers can be used to modulate architecture of scaffold (Chapter 6). 
Heterodimers can be also used to construct hybrid scaffolds made of different 
types of co-assembling protein polymers. Such hybrid scaffolds have been 
shown to have promising mechanical properties 52. Furthermore, heterodimers 
can be employed to construct two-component mixing-induced hydrogels and 
shear-thinning hydrogels that are very desired for applications in situ 25. 
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Protein polymers with heterodimer-forming modules can also be used for the 
targeted delivery and/or controlled release of therapeutic agents 53, in which 
medicines are delivered to specific locations in the body and released in 
response to local stimuli 18. For example, heterodimers can be used to 
physically immobilize bioactive in a matrix from which it is slowly released. 
While recombinant protein polymers have many interesting features as future 
biomaterials for the medical industry, they still need to improve in order to be 
useful for actual applications. Using supramolecular strategies such 
heterodimerization, may be one way to obtain biomaterials that perform better, 
and therefore should be investigated further. But, we should not forget to also 
look at the risks that might arise from use of protein polymers as future 
biomaterials, and this will be done next. 
7.7. Risk analysis 
The focus of the research described in this thesis was development of a strategy 
for improving performance of supramolecular and bio-inspired materials from 
the perspective of the future use in medicine as scaffolds for tissue engineering 
or controlled drug delivery. This research was designed for the Nanomaterials 
theme and was funded by the NanoNextNL-consortium. The mission of the 
Nanomaterial theme is to study how to build materials of well-defined structure 
via “bottom-up” approach in order to provide to society high quality, cost 
effective and cutting-edge products of diverse functions. As the theme 
presumes a transition from academic findings to industrial products, the 
NanoNextNL program obliges the scientists working within this theme to 
identify and address potential human, environmental and societal risks which 
may arise from their inventions. 
The “bottom-up” construction based on supramolecular self-assembly has 
already led to development of many nanomaterials with very attractive physical 
and chemical properties. While still in their early stages of development, 
nanomaterials have already made a tremendous impact on the medical 
industry 23,45. Concerning the rapid progress in the field of nanomaterials, it 
might be that answers on the risks posed by nanomaterials are years away and, 
in any event, are likely to emerge on a case-by-case basis. There is a lot of 
speculation around the use of nanomaterials and these negatively affect public 
perception. A critical challenge for the emerging nanomaterials industry is to 
ensure that the potential health and environmental impacts of nanomaterial 
fabrication and use are small 54. Therefore, the assessment of the possible 
effects, from benefits to risks, and health hazards associated with exposure to 
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nanomaterials should be considered already at the research and development 
stage. 
The recombinant protein polymers produced at our laboratory are still at a very 
early stage of development. Ultimately, the aim is to use them for medical 
purposes, however, specific applications have not been yet defined. The risk 
that arises from the production and use of protein polymers has not really been 
investigated yet, therefore we can only speculate here. Concerning the source of 
the protein polymers, the use of modified P. pastoris cells in production may 
appear hazardous to society. Generally, genetically modified organisms are 
perceived by the general public in a rather negative way, but this negative 
perception does not seem to exist for recombinant pharmaceuticals and medical 
devices. A good example is the recombinant production of insulin 55, which has 
been approved for human use in 1982. Many recombinant medicines are now 
available 56 and this does not seem to cause much resistance in society. 
When it comes to the general process of using of P. pastoris for large-scale 
production, several approaches for assessment of this technology are 
available 57. The effort to generate certified high-purity products is low 
compared with other expression systems, where media components or by-
products of the cells’ metabolism can give rise to purification problems 58. 
Pichia-derived post-translational modification of products that could cause 
immunogenicity can be also escaped 37. On the down side, the methanol 
required for induction, although relatively cheap, presents a fire hazard and a 
considerable health risk, especially in large-scale operations in which large 
methanol quantities must be stored on-site 59. 
The recombinant protein polymers described in this thesis are made of natural 
amino acids and are expected to be easily biodegradable and biocompatible, 
meaning that they are non-toxic, hemocompatible, and histocompatible. 
Biocompatibility is typically first tested on cell lines selected for relevance to 
the envisaged application and, in the later stages, in vivo in animal studies and 
clinical studies 60. Since there is always a risk that some recombinant protein 
polymers have unintended side-effects or toxicity, it is crucial that such test are 
performed in order for new recombinant protein polymer biomaterials to be 
safe and effective. 
7.8 Concluding remarks and perspectives 
In this study the small heterodimer-forming modules were used to trigger 
hierarchical self-assembly of recombinant protein polymers. We designed, 
produced and characterized a number of self-assembling protein polymers that 
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contain different heterodimer-forming modules. We presented several steps that 
can be applied in case of unwanted product processing in Pichia pastoris. 
Finally, we showed that coiled coils can be successfully employed to modulate 
morphology of pH-responsive supramolecular network consisting of silk-like 
proteins polymers. 
What about future protein polymer designs? The enormous diversity of protein 
structures and functions present in nature continuously inspires scientists to 
come up with new designs 23. Employing new computational techniques such as 
free-energy-based simulations for predicting protein native structures and 
ligand-binding affinities could be very useful, although it is not yet a guarantee 
of success when designing new proteins. The detailed analysis of natural and 
man-made supramolecular systems will help to elucidate the fundamental 
design considerations that determine the success or failure of self-assembling 
systems, such as the use of complementary shapes, complementary forces, and 
appropriate levels of plasticity 31. 
From a different angle, the field of genetic engineering is also progressing 
rapidly and is offering better and better tools to synthesize protein polymers 
differing in size and complexity, even containing non-natural amino acids 61. 
Looking into the future, a better understanding of cell physiology may enable 
the development of new expression systems with low probabilities of product 
degradation, proper protein folding, protein post-translational modification and 
the growth of cells on cheap feedstocks. This may also include systems based 
on plant- and mammalian cells. Furthermore, ongoing automation technology 
may mean that less and less human involvement will be needed for producing 
proteins that are both better and cheaper. 
Finally, protein self-assembly is a complex phenomenon that can only be 
understood through a multidisciplinary effort involving disciplines such as 
biology, chemistry, physics and materials science. But, given its promise for 
new biomaterials that address important needs in society, it is also an important 
topic for which ground-breaking discoveries may certainly be expected in the 
near future. 
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Supramolecular assemblies formed by protein polymers are attractive 
candidates for future biomaterials. Ideally, one would like to be able to define 
the nanostructure, in which the protein polymers should self-assemble, and then 
design protein polymer sequences that assemble exactly into such 
nanostructures. Despite progress towards ‘programmability’ of protein polymer 
self-assembly, we do not yet have such control. This holds especially for 
hierarchical structures such as self-assembled fibril bundles, where one would 
like to have independent control over the structures at the different length-
scales. In this thesis we explore the use of heterodimerization as a strategy to 
control self-assembly of protein polymers at multiple length-scales. We tested a 
selected set of heterodimer-forming peptide modules. The heterodimer-forming 
modules are genetically incorporated at the C-terminus of protein polymers 
with a previously characterized self-assembly behavior. Several newly 
constructed protein polymers were biosynthesized in the yeast Pichia pastoris 
and, for these new protein polymers we investigated whether the inclusion of 
the heterodimer-forming blocks improved the control over the assembly of 
nanostructures. 
The incorporation of heterodimer-forming modules into protein polymers is not 
the only tool that can be used for improving programmability of assembly. In 
Chapter 2 we present an overview of several tools that can be use, and we 
highlighted their advantages and disadvantages. 
In Chapter 3 we test de novo designed heterodimerizing coiled coils DA = 
LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETRYGPLGGGK and DB = 
LEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGGGK. These 
peptides were fused to hydrophilic random coil protein polymer (CP4) and 
homotrimer forming protein polymer (T9-C
P
4). We present data on the 
production, characterization and functionality for four new protein polymers: 
CP4-D
A, CP4-D
B, T9-C
P
4-D
A and T9-C
P
4-D
B. When the new protein polymers 
were produced using the fermentation process established previously for other 
protein polymers such as CP4 (i.e. standard fermentation), we found the new 
protein polymers to be partly degraded. The use of a protease deficient strain, 
as well as changes in aeration or pH were found ineffective in preventing 
degradation, but nearly intact products were obtained from a fermentation in 
which the induction was done at 20 ˚C and in which the medium was 
supplemented with casamino acids. With respect to the physical properties of 
the new protein polymers, size exclusion chromatography (SEC) showed that 
an equimolar mixture of CP4-D
A and CP4-D
B contained mostly dimers, whereas 
unmixed CP4-D
A and CP4-D
B contained only monomers. However, we also 
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found that CP4-D
B forms homooligomers at concentrations ≥100 µM. A 
mixture of T9-C
P
4-D
A and T9-C
P
4-D
B forms a hydrogel, most probably due to 
both homotypic and heterotypic DA/DB associations. We conclude that when 
used at low concentration, this pair of coiled coils seems to be suitable to 
control self-assembly of protein polymers produced in Pichia Pastoris. 
Next, in Chapter 4 we test another pair of de novo designed coiled coils. These 
are much shorter and have lower reported values of the association constant as 
compared to the DA/DB coiled coils. The systems consist of a peptide DE = 
(EIAALEK)3 and a peptide D
K = (KIAALKE)3. The two peptides were C-
terminally fused to protein polymers CP4 and T9-C
P
4. The standard 
fermentations resulted in intact CP4-D
E and T9-C
P
4-D
E, but protein polymers 
CP4-D
K and T9-C
P
4-D
K were found to be partly degraded. The degradation of 
variants with DK module could not be readily resolved by fermentation at 
higher pH or using proteases deficient strain. For CP4-D
K, ion exchange 
chromatography showed that about 40% of protein polymer (by mass) was 
intact. We find that for this pair of coiled-coils, homotypic interactions are so 
strong that they can drive gel formation in the case of T9-C
P
4-D
E, and a strong 
increase in viscosity for T9-C
P
4-D
K. Mixtures of the complimentary triblocks 
also form hydrogels, but it is not yet clear to what extent this is due to 
homotypic DE/ DE and DK/ DK associations, and to what extent it is due to DE/ 
DK heterodimer formation. 
A very different type of heterodimer-forming block is the so-called WW 
domain that is found in many natural proteins, and which forms heterodimers 
with proline-rich peptides PPxY. In Chapter 5 we test the interaction between 
a naturally occurring WW domain (DWW) and its proline-rich ligand (DPPxY). 
Both were C-terminally fused to the hydrophilic random coil protein polymer 
CP4. The new protein polymers C
P
4-D
WW and CP4-D
PPxY were produced intact 
during standard fermentations, but CP4-D
PPxY was shown to be glycosylated. 
Using genetic engineering, we mutated the CP4-D
PPxY protein polymer 
sequence by the substitution Ser12→Ala. A standard fermentation resulted in 
an intact and non-glycosylated protein polymer CP4-D
PPxY*. Interaction studies 
(ITC and steady state tryptophan fluorescence quenching), showed that both 
CP4-D
PPxY and CP4-D
PPxY* bind to CP4-D
WW with an equilibrium dissociation 
constant on the order of µM. 
Finally, to demonstrate that heterodimer-forming blocks can be used to 
independently control protein polymer self-assembly at multiple length-scales, 
we selected the heterodimer-forming modules DA and DB to control the lateral 
interactions of fibrils self-assembled from the previously designed triblock 
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protein polymer C2-S
H
48-C2. In Chapter 6 we construct the protein polymers 
C2-S
H
48-C2-D
A and C2-S
H
48-C2-D
B. The C2-S
H
48-C2 protein polymers 
assemble into long and stiff fibrils at neutral pH. The aim of the C-terminal 
attachment of the DA/DB blocks was to be able to control subsequent 
physical cross-linking and bundling of the fibrils. Both protein polymers C2-
SH48-C2-D
A and C2-S
H
48-C2-D
B were produced intact and with high 
yield during fermentation at optimal conditions as discussed in Chapter 
3. Using Atomic Force Microscopy (AFM) we show that at neutral pH, 
fibrils consisting of 100% C2-S
H
48-C2-D
A or C2-S
H
48-C2-D
B protein 
polymers bundle up and cross-link via homotypic DA/DA and DB/DB 
associations. Control over the degree of cross-linking and bundling can be 
obtained by using mixed fibrils consisting of C2-S
H
48-C2 with controlled 
amounts of the newly developed protein polymers C2-S
H
48-C2-D
A and C2-
SH48-C2-D
B. While the effect of the heterodimers on the structure of the fibril 
network as judged from AFM is very strong, oscillation rheology shows that 
the inclusion of the heterodimer forming blocks merely leads to a moderate 
increase in gel stiffness.
In order to place the research discussed in this thesis into the broader 
perspective, in Chapter 7 we provide a General Discussion. We discuss several 
general strategies that can be used to control protein polymer self-assembly 
and discuss why and when there is a need for using heterodimer forming 
blocks. After providing an overview over results obtained in this thesis, we 
highlight the most urgent questions that need to be answered next. This is 
followed by a discussion on the benefits that heterodimer-driven self-assembly 
may bring to possible future applications of protein polymers as 
biomaterials. We also discuss the possible risks for human health end 
environment that might arise from the use of protein polymers 
technology. Finally we present some speculations about the future of the 
field of self-assembling protein polymers. 
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Pennsylvania State University, where she will continue research in the field of 
material science. 
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Overview of completed training activities 
Discipline specific 
Advanced course of Microbial Physiology and 
Fermentation Technology  
Delft 2014 
Colloid Science Wageningen 2013 
Gordon Conference: Bioinspired materials* 
Sunday River, 
USA 
2014 
Integration and combination of microscopy 
techniques 
Amsterdam 2015 
Knowledge transfer with Utrecht University Wageningen 2013 
Network meeting, Nanonext NL† Utrecht 2012 
Network meeting, Nanonext NL† Utrecht 2013 
Network meeting, Nanonext NL† Utrecht 2013 
Network meeting, Nanonext NL† Utrecht 2014 
NanoCity 2014* Utrecht 2014 
NanoCity 2015* Amersfoort 2015 
General 
VLAG PhD week Baarlo 2012 
Project and time management (WGS) Wageningen 2013 
Communication with the Media and the General 
Public (Hertz) 
Wageningen 2012 
Interpersonal communication for PhD students 
(Hertz) 
Wageningen 2013 
Mobilising your Scientific network (Dicuore) Wageningen 2012 
Scientific Publishing (WGS) Wageningen 2013 
Dutch for Foreigners Wageningen 2015 
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Intellectual property and valorisation awareness 
(NanonextNL) 
Amersfoort 2013 
Risk analysis and technology assessment 
(NanonextNL) 
Amersfoort 2013 
Techniques for writing and presenting scientific 
papers (WGS) 
Wageningen 2013 
Teaching and Supervising Thesis students 
(ESD&PS) 
Wageningen 2014 
Entrepreneurship in and outside Science (StartLife 
Center of Entrepreneurship) 
Wageningen 2015 
Writing Grant proposals (Wageningen in'to 
Languages) 
Wageningen 2015 
Optional 
PhD study tour USA 2013 
PhD study tour; Chairwoman of organization 
committee 
UK 2014-
2015 
Group meetings at Physical Chemistry and Soft 
Matter 
Wageningen 2012-
2016 
Group meetings at Bioconversion 
Wageningen 2012-
2016 
PhD council member 
Wageningen 2012-
2016 
† oral presentation, * poster presentation 
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